US20100241185A1 - Steerable epicardial pacing catheter system placed via the subxiphoid process - Google Patents
Steerable epicardial pacing catheter system placed via the subxiphoid process Download PDFInfo
- Publication number
- US20100241185A1 US20100241185A1 US12/741,710 US74171008A US2010241185A1 US 20100241185 A1 US20100241185 A1 US 20100241185A1 US 74171008 A US74171008 A US 74171008A US 2010241185 A1 US2010241185 A1 US 2010241185A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- epicardial pacing
- epicardial
- pacing catheter
- communication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 101
- 230000008569 process Effects 0.000 title description 5
- 210000003484 anatomy Anatomy 0.000 claims abstract description 29
- 210000000038 chest Anatomy 0.000 claims abstract description 16
- 210000001370 mediastinum Anatomy 0.000 claims abstract description 14
- 230000006378 damage Effects 0.000 claims abstract description 7
- 238000004891 communication Methods 0.000 claims description 97
- 239000012530 fluid Substances 0.000 claims description 35
- 230000006641 stabilisation Effects 0.000 claims description 33
- 238000011105 stabilization Methods 0.000 claims description 33
- 239000003381 stabilizer Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000004020 conductor Substances 0.000 claims description 16
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 12
- 239000012811 non-conductive material Substances 0.000 claims description 9
- 229920001296 polysiloxane Polymers 0.000 claims description 8
- 239000000523 sample Substances 0.000 claims description 8
- 238000001356 surgical procedure Methods 0.000 claims description 8
- 239000004809 Teflon Substances 0.000 claims description 7
- 229920006362 TeflonĀ® Polymers 0.000 claims description 7
- 229920002635 polyurethane Polymers 0.000 claims description 7
- 239000004814 polyurethane Substances 0.000 claims description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000956 alloy Substances 0.000 claims description 6
- 229910045601 alloy Inorganic materials 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052741 iridium Inorganic materials 0.000 claims description 6
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052697 platinum Inorganic materials 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 230000000087 stabilizing effect Effects 0.000 claims description 5
- 239000000560 biocompatible material Substances 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 239000011810 insulating material Substances 0.000 claims 4
- 238000013152 interventional procedure Methods 0.000 claims 2
- 238000002324 minimally invasive surgery Methods 0.000 claims 2
- 230000002457 bidirectional effect Effects 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 210000003516 pericardium Anatomy 0.000 description 16
- 210000005246 left atrium Anatomy 0.000 description 14
- 210000005245 right atrium Anatomy 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 13
- 210000005240 left ventricle Anatomy 0.000 description 13
- 210000005241 right ventricle Anatomy 0.000 description 13
- 210000003748 coronary sinus Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000002604 ultrasonography Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 238000002679 ablation Methods 0.000 description 4
- 230000003073 embolic effect Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 210000001782 transverse sinus Anatomy 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 206010016654 Fibrosis Diseases 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- -1 but not limited to Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 210000003811 finger Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000003492 pulmonary vein Anatomy 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699662 Cricetomys gambianus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000012266 Needlestick injury Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000000718 qrs complex Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0587—Epicardial electrode systems; Endocardial electrodes piercing the pericardium
Definitions
- the present technology relates generally to the field of medical devices to be used for cardiological procedures. More specifically, the technology is in the subfield of catheterization devices to be used for epicardial pacing.
- LV leads left ventricular leads
- the electrical lead can not be placed directly into the LV due to the unacceptably high risk of stroke.
- the lead must, therefore, be placed on the surface of the LV.
- a lead is threaded through the right atrium (RA) using a venous system, and passed through the coronary sinus (CS) to any of a number of small veins in communication with the surface of the LV.
- RA right atrium
- CS coronary sinus
- An aspect of an embodiment (or partial embodiment thereof) of the present invention includes an apparatus and means for treating congestive heart failure and arrhythmias (both bradycardias and tachycardias) of the heart.
- the invention provides for a novel means and method of placing an epicardial lead within a patient for the purpose of permanent multi-site, cardiac pacing and defibrillation, including left ventricular pacing.
- An aspect of an embodiment (or partial embodiment thereof) of the present invention includes a lead that paces LV, RV, LA and RA at the same time or in sequence. It could even pace two separate points on the same chamber (the LV or the RV) at the same time or at some offset. This has an important advantage, for example, if a region of tissue ever dies in heart attack, the present invention method can still pace from elsewhere.
- An aspect of an embodiment (or partial embodiment thereof) of the present invention may include placing a bipolar pacing lead through a subxiphoid incision and then channeling it back to a pacemaker.
- the procedure may evolve through three distinct stages. In the earliest stage, one would place the lead on the left ventricle and tunnel it underneath the pectoral muscle back to the chest wall where the pacemaker would normally be placed. In the second, one would place the lead back to the subxiphoid process, attach it to a battery that is positioned just on the outside of the xiphoid process and have it wirelessly communicate with the main pacemaker. Lastly one would place a button-like object right on the top of the left ventricle and then communicate wirelessly back to the main pacemaker. Still yet, another embodiment of the means and method of the invention may include having the battery, anode and cathode means all compounded on the end of the lead so that there would not be any need to have another excision to bring any of the components back out of the heart.
- An aspect of an embodiment or partial embodiment of the present invention comprises an epicardial pacing system.
- the system may comprise: an epicardial catheter configured to be disposed in the middle mediastinum of the thorax of a subject for use in electrical pacing of the heart at one or more locations on the epicardial surface.
- the epicardial pacing catheter comprising: a proximal portion, distal portion, and a longitudinal structure there between; and at least one electrode in communication with the distal portion, wherein the at least one electrode is insulated on at least one side to allow pacing of the heart without damage to adjacent anatomical structures.
- An aspect of an embodiment or partial embodiment of the present invention comprises a method for use with an epicardial pacing catheter.
- the method may comprise: disposing the epicardial pacing catheter in the middle mediastinum of the thorax of a subject; and pacing the heart at one or more locations with electrical energy from an at least one electrode; and at least partially insulating the electrical energy to allow pacing of the heart without damage to adjacent anatomical structures.
- the epicardial pacing system and related method includes an epicardial catheter configured to be disposed in the middle mediastinum of the thorax of a subject for use in electrical pacing (and/or other diagnostic or therapeutic procedure) of the heart at one or more locations on the epicardial surface.
- the epicardial pacing catheter may include at least one electrode whereby the electrode is insulated on at least one side to allow pacing of the heart without damage to adjacent anatomical structures.
- FIG. 1 schematically illustrates the overall configuration of the epicardial pacing catheter system.
- FIG. 2 schematically illustrates the pericardium and heart alone ( FIG. 2(A) ) and an example embodiment in position relative to the heart ( FIG. 2(B) ).
- FIG. 3 schematically illustrates an example embodiment passively disposed within the pericardial sack of the heart.
- FIGS. 4 (A)-(C) schematically illustrate a number of exemplary embodiments of the steering means employed to position the distal portion of an exemplary embodiment of the epicardial pacing catheter in un-tensioned, partial steering, and full steering modes, respectively.
- FIGS. 5(A)-5(D) schematically illustrate a number of exemplary embodiments of the epicardial pacing catheter 10 near the distal portion.
- FIGS. 6(A)-6(F) schematically illustrate cross sectional views of an exemplary embodiment of the technology from the most distal end to a more proximal point.
- FIGS. 7(A) and (B) schematically illustrate cross sectional views of an exemplary embodiment of the most proximal portion of an exemplary embodiment of the epicardial pacing catheter and the most distal portion of an exemplary embodiment of the control means, respectively.
- FIGS. 8 (A)-(C) schematically illustrate cross-sectional views of an example embodiment further comprising a stabilization means for stabilizing the example embodiment.
- the stabilization means illustrated in an un-deployed position, partially deployed position, and deployed position, respectively.
- FIG. 9 schematically illustrates an example embodiment of the epicardial pacing catheter further comprising deployable electrodes fixed or adjacent to the heart.
- FIG. 10(A) schematically illustrates a top view of an exemplary embodiment of the epicardial pacing catheter.
- FIG. 10(B) schematically illustrates a bottom view of an exemplary embodiment of the epicardial pacing catheter.
- FIG. 10(C) schematically illustrates an axial view of an exemplary embodiment of the epicardial pacing catheter looking at the distal tip of the insulating hood.
- FIG. 10(D) schematically illustrates a perspective view of an exemplary embodiment of the epicardial pacing catheter.
- FIG. 11(A)-11(E) schematically illustrate cross sectional views of an exemplary embodiment of the epicardial pacing catheter from a point located proximal to the at least one electrode and distal to the distal point of curvature to a point located at the most proximal point of the epicardial pacing catheter.
- FIG. 11(F) schematically illustrates a cross sectional view of an exemplary embodiment of the control handle at the most distal point.
- FIG. 12(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in an un-deployed state.
- FIG. 12(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in a fully-deployed state.
- FIG. 13(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable screw or the like in an un-deployed state.
- FIG. 13(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable screw or the like in a fully-deployed state.
- FIG. 14(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in an un-deployed state.
- FIG. 14(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in a fully-deployed state.
- FIG. 15(A) schematically illustrates an example embodiment of an external control handle.
- FIG. 15(B) schematically illustrates an example embodiment of the proximal steering control means or a least part of the steering control means integral to the control handle.
- FIG. 15(C) schematically illustrates an example embodiment wherein the proximal steering control means or a least part of the steering control means integral to the control handle has been activated.
- FIG. 1 schematically illustrates an overview of an exemplary embodiment of the epicardial pacing system 5 comprising an epicardial pacing catheter 10 in communication with at least one electrode 43 , a control means or control handle 150 , an interface member 162 , a processor 164 or computer, power supply 166 or battery, or voice control instrumentation/system 168 .
- the control means 150 may be in communication with the proximal portion of the catheter 10 , wherein the control means 150 is controllably connected to at least one electrode 43 .
- the control means may be a control handle or controller as desired or required.
- the control handle (or control means) may be removable.
- the epicardial pacing catheter 10 may further comprises a processor 164 or computer.
- the processor 164 may be in communication with said epicardial pacing catheter 10 and system.
- the processor 164 may be located at or near the patient's shoulder, for example.
- the epicardial pacing catheter 10 further comprises an interface member 162 in communication with said epicardial pacing catheter 10 .
- the interface member 162 may be in remote and/or local communication with the processor 164 , pacing system 5 , catheter 10 , controller 150 , power supply 166 , and/or voice control instrumentation to provide information to and/or from a patient, physician, technician, or a clinician. Further, any of the components and systems illustrated in FIG. 1 may be in communication with each other, as well as other systems, computers, devices, printers, displays, PDAs, networks, memory storage, and voice control instrumentations as desired or required.
- the epicardial pacing system 5 may comprise a power supply 166 .
- the power supply 166 may comprise a small battery located at the subxiphoid area, preferably of a silicone silver-gallium kind designed specifically for use in implantable cardiac defibrillators (ICDs).
- ICDs implantable cardiac defibrillators
- the power characteristics of the particular battery may be such that it can maintain the same voltage for a long period of time before falling off suddenly.
- the epicardial pacing system 5 and epicardial pacing catheter 10 may further comprise a wireless communication system, wherein the processor 164 , power supply 166 , voice control instrumentation 168 , interface member 162 or desired components of the system 5 may be wirelessly connected to one another.
- the battery and processor 164 are both located in the subxiphoid area.
- any of the components or modules referred to with regards to any of the present technology embodiments discussed herein, may be integrally or separately formed with one another. Further, redundant functions or structures of the components or modules may be implemented. Moreover, the various components may be communicated locally and/or remotely with any user/clinician/patient or machine/system/computer/processor. Moreover, the various components may be in communication via wireless and/or hardwire or other desirable and available communication means, systems and hardwares.
- the epicardial pacing catheter 10 in accordance with the present technology may comprise a proximal portion, a distal portion, and a longitudinal structure there between. It should be appreciated that the distal portion may be considered at the distal end tip of the epicardial pacing catheter 10 ; or a portion or segment at or in the vicinity of the distal end tip of the epicardial pacing catheter 10 or a portion or segment leading up to (or partially up to but not all the way up to) the distal end of the catheter 10 as desired or required. The length and location of the distal portion may vary as desired or required in order to practice the technology according to medical procedures and anatomical considerations.
- proximal portion may be considered the tip of the beginning of the catheter 10 ; or a portion or segment at or in the vicinity of the proximal end of the catheter 10 or a portion or segment leading up to (or partially up to but not all the way up to) the proximal end of the catheter 10 as desired or required.
- the length and location of the proximal portion may vary as desired or required in order to practice the technology according to medical procedures and anatomical considerations.
- the proximal portion, distal portion and longitudinal structure there between may be integrally formed from a biocompatible material having requisite strength and flexibility for deployment within a patient.
- the proximal portion, distal portion, and longitudinal structure there between may have a lubricious outer surface comprising a material having a low coefficient of friction, such as, but not limited to, silicone, polyurethane, or Teflon, or combination thereof.
- the proximal portion, distal portion, and longitudinal structure there between may further have an outer surface comprising a drug eluting surface and/or a surface impregnated with sirilimus to prevent the production of fibrosis within a patient.
- the longitudinal structure may be between about 15 cm and about 100 cm in length, and between about 2 mm and about 6 mm in diameter. It should be appreciated that the length of the longitudinal structure may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations.
- the cross section of the longitudinal structure comprises an oval, circle, ellipse, polygon, or semi-circular shape.
- the longitudinal structure may be any one of: lumen, conduit, channel, passage, pip, tunnel or bounded tubular surface.
- the epicardial pacing catheter 10 further comprises at least one electrode 43 in communication with the distal portion, wherein the at least one electrode 43 is insulated on at least one side to allow pacing of the heart without damage to adjacent structures.
- the at least one electrode 43 may be constructed of platinum, gold, silver, iridium, or any alloy thereof, or other conducting materials known in the art.
- the at least one electrode 43 may comprise a roughened, profiled, or otherwise prepared surface to increase the total surface area for energy transmission.
- the at least one electrode 43 may be semi-cylindrical or arc-like in shape, and may be contoured to be compatible with proximate anatomical structures.
- the at least one electrode 43 may be between about 0.3 mm and about 4 mm in length, and may be spaced between about 1 mm and about 25 mm from each other.
- the at least one electrode 43 may be a pair of electrodes, commonly referred to as an anode and cathode in the art.
- the at least one electrode 43 may be deployable. It should be appreciated that the length of the electrodes may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations.
- various sheaths, catheters and guidewires, or any related components disclosed herein may have a circular or oval-shaped cross-section or various combinations thereof. Further, it should be appreciated that various sheaths, catheters and guidewires, or any related components disclosed herein may have any variety of cross sections as desired or required for the medical procedure or anatomy.
- any of the components or modules referred to with regards to any of the present invention embodiments discussed herein may be a variety of materials and/or composites as necessary or required. Still further, it should be appreciated that any of the components or modules (or combination thereof) may provide shape, size and volume contoured by adjusting its geometry and flexibility/rigidity according to the target location or anatomy (or region, including structure and morphology of any location) being treated.
- FIG. 2(A) schematically illustrates the pericardium and heart alone.
- the pericardium 22 is shown in close proximity to the epicardium 23 .
- FIG. 2(B) schematically illustrates three contiguous sections of an example embodiment implanted around the heart 21 .
- the epicardial pacing catheter 10 of the epicardial pacing system 5 is positioned in the pericardial space, cavity or sack 24 , or the area between the pericardium 22 and epicardium 23 . All of the electrodes 43 are facing the heart 21 .
- the epicardial pacing catheter 10 further comprises outward facing bumper tabs 31 and inward facing friction tabs 32 to stabilize the epicardial pacing catheter 10 from moving within the pericardial sack 24 , once it is implanted.
- an aspect of an embodiment of the present technology may be implemented with an access needle (introducer needle), conduit or the like.
- the access needle or conduit is adapted to be inserted into the epicardial region or other body part or body space so as to provide an access or guideway for the epicardial pacing catheter 10 .
- An example of an access system is disclosed in PCT International Application No. Serial No. PCT/US2008/056643, filed Mar. 12, 2008, entitled, āAccess Needle Pressure Sensor Device and Method of Use,ā of which is hereby incorporated by reference herein in its entirety. See for example, but not limited thereto, FIGS. 2 and 5 of the '056643 PCT Application.
- the access needle sensor device or the like serves as a guideway for introducing other devices into the pericardium 22 , for instance, sheath catheters that might subsequently be employed for procedures within the pericardium 22 or other applicable regions, space or anatomy.
- Other devices that the access device may accommodate with the practice of this invention include, but are not limited thereto, the following: ablation catheters, guide wires, other catheters, visualization and recording devices, drugs, and drug delivery devices, lumens, steering devices or systems, drug or cell delivery catheters, fiber endoscopes, suctioning devices, irrigation devices, electrode catheters, needles, optical fiber sensors, sources of illumination, vital signs sensors, and the like. These devices may be deployed for procedures in an integral body part or space.
- any data, feedback, readings, or communication from the system may be received by the user, clinician, physician, or technician or the like by visual graphics, audible signals (such as voice or tones, for example) or any combination thereof. Additionally, the data, feedback, or communication may be reduced to hard copy (e.g., paper) or computer storage medium. It should be appreciated that the pressure related readings and data may be transmitted not only locally, but remotely as well.
- an aspect of the invention may be in the field of voice control over medical systems and devices of use in specialized electrophysiology procedures that employ subxiphoid access for the purpose of navigating an interventional or surgical probe onto the epicardial surface of the heart, via pericardial transit.
- the invention may be in the specialized category of voice control over instruments and systems that measure the intrathoracic and intrapericardial pressures during the process of navigating said intrathoracic or surgical probe within the patient following subxiphoid insertion.
- An aspect of an embodiment or partial embodiment of the subject invention is one of providing the working electrophysiologist with a means and method for controlling the operational parameters (e.g., the display functions) of diagnostic and therapeutic cardiological equipment by voice, thus eliminating either the need to temporarily take their hands off the patient or the need to have an additional EP Lab technician available to perform such tasks. (Such personnel are often needed to insure that the clinician need never touch anything outside the sterile field.).
- voice control instrumentation that teach applications in medical applications but not in electrophysiological approaches to cardiological problems include U.S. Pat. Nos.
- present invention system and method may further comprise imaging said the access needle and the epicardial pacing system (and components thereof) with at least one of magnetic resonance imaging, computed tomography, fluoroscopy, or other radiological modalities.
- readings are provided from said sensing of pressure for navigating said needle access and the epicardial pacing system (and components thereof).
- the deploying of the epicardial pacing catheter 10 into the pericardial sack 24 may be minimally invasive, non-surgical, and/or interventional.
- the deploying of the epicardial pacing catheter 10 may be performed by a non-surgeon and/or cardiologist through use of an access needle and subsequent passage of a guidewire.
- the access needle may first be inserted through the chest and into the pericardium 22 , with the guidewire then put in place.
- the epicardial pacing catheter 10 may then be coaxially slid over the guidewire to access the pericardial sack 24 .
- the insertion of a sheath into the pericardial sack 24 may be aided by the use of an access needle and subsequent passage of a guidewire.
- the access needle may first be inserted into the epicardium, with the guidewire then put in place.
- the sheath may then be coaxially slid over the guidewire to access the pericardial sack 24 .
- the epicardial pacing catheter 10 may then be inserted through the sheath to reach the epicardium 23 .
- the guideway provides coaxial alignment for the at least one of guide wire, sheath or catheter, which can be inside or outside the needle.
- the at least one guide wire, sheath, or catheter can also be coaxially aligned with one another.
- multiple lumens may be implement and configured between the plurality of distal apertures and plurality proximal apertures. It should be appreciated that coaxial alignment does not need to be exact, but rather one conduit, lumen, sheath, or guidewire slid outside or inside of another.
- an epicardial access needle-stick may be implemented in the subxiphoid area of the chest and the epicardial pacing catheter 10 only need be advanced a short distance to get to the heart 21 . However, it may immediately be steered though an acute angle to avoid the heart itself Because of this, aspects of the present invention devices and those used in conventional techniques can be contrasted.
- conventional endocardial catheters may typically be up to 100 cm in length or longer since they must go from the shoulder to the heart, while an embodiment of the present technology could be, for example, about 20 cm or less since it may only need to go from the chest to the heart. It should be appreciated that the length may be greater than about 20 cm as well. It should be appreciated that the length of the present invention catheter may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations.
- a subject may be a human or any animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g. rat, dog, pig, monkey), etc. It should be appreciated that the subject may be any applicable human patient.
- FIG. 3 schematically illustrates an example embodiment of the epicardial pacing catheter 10 of the epicardial pacing system 5 passively disposed within the pericardial sack 24 (shown with hash marks) of the heart 21 .
- the epicardial pacing catheter 10 may be used to pace the left ventricle, right ventricle, right atrium, and left atrium. It should be appreciated that the present technology may be used to pace the left ventricle, left atrium, right atrium, right ventricle and/or any combination thereof.
- the epicardial pacing catheter 10 may first be inserted into the pericardium 22 at the insertion point 33 , which may be located at an anterior portion (towards the sternum) of the pericardium 22 , adjacent to the left ventricle. The catheter is then advanced posteriorly (towards the spine) within the pericardial sack 24 towards the left atrium, right atrium and transverse sinus. The catheter is further advanced around the posterior of the heart, and pushed anteriorly toward the right ventricle. Once the catheter is in contact with the left ventricle, right ventricle, right atrium and left atrium, a deployable stabilization means may be deployed. Both outward facing bumper tabs 31 and inward facing friction tabs 32 are shown, and prevent the catheter from moving or slipping.
- the inward facing friction tabs 32 may interact with the outside wall of structures such as, but not limited to, the transverse sinus, superior vena cava, right inferior pulmonary vein, and the right superior pulmonary vein to prevent the catheter from dislodging.
- the outward facing bumper tabs 31 may push on the pericardium to further secure the catheter 10 against the epicardium (for example, as shown in FIG. 2 ).
- FIGS. 4 (A)-(C) provide schematic illustrations of some of the operational aspects of an exemplary embodiment of the steering means, system or device associated with the epicardial pacing catheter 10 of the epicardial pacing system.
- the epicardial pacing catheter 10 further comprises a distal steering means (not shown) and a proximal steering means (not shown) which may have the steering characteristics taught by Mahapatra et al. in PCT International Application No. PCT/US2008/056816, filed Mar. 13, 2008, entitled, āEpicardial Ablation Catheter and Method of Use,ā hereby incorporated by reference herein in its entirety.
- the steering means may comprise guidewires, tensioning lines, pull strings, digitating distal tips, magnetic guidance means, wires, rods, chains, bands, chords, ropes, string tubes, filaments, threads, fibers, strands, other extended elements, or any other method known in the art.
- FIGS. 7(A)-7(B) of '056816 PCT International Application there is provided some details of an exemplary mechanism of action for directional steering of the proximal segment of the device that may be implemented for the present technology.
- proximal steering means as shown in FIG. 15(B)
- distal steering means not shown
- the proximal point of curvature 42 may be located between about 1 cm and about 25 cm from the proximal end and the distal point of curvature 41 may be located between about 1 cm and about 20 cm from the distal end. It should be appreciated that the proximal and distal points of curvature may be located at other longer or shorter points and may be implemented as may be desired or required according to medical procedures, device/system operations and anatomical considerations.
- the steering means are used to direct the epicardial pacing catheter 10 through or navigate it within a patient's body. It should be noted that, while two steering means and points of curvature are shown, the epicardial pacing catheter 10 may further comprise a third and fourth steering means for steering the epicardial pacing catheter 10 around a third and fourth point of curvature. Moreover, though a bi-directional distal point of curvature 41 is shown, it should be appreciated that all points of curvature may be uni-directional, bi-direction, tri-direction, quadra-directional, or greater than quadra-directional.
- FIG. 4(A) shows an embodiment of the epicardial pacing catheter 10 in the non-deflected state.
- FIG. 4(B) shows the epicardial pacing catheter 10 in a partially-deflected state.
- FIG. 4(C) shows the epicardial pacing catheter 10 in a fully-deflected state, as would be the case when it has been navigated into the pericardial space of a subject's heart, or other space or structure.
- the at least one electrode 43 is held against a patient's heart by the stabilization means, shown as the inward facing friction tabs 32 and outward facing bumper tabs 31 .
- FIGS. 5(A)-5(D) schematically illustrate a number of embodiments of the epicardial pacing catheter 10 of the epicardial pacing system near the distal portion.
- FIG. 5(A) schematically illustrates an exemplary embodiment wherein the epicardial pacing catheter 10 may be used to pace the left ventricle (LV) of a patient's heart.
- a number of electrodes 43 are adapted to transmit electrical energy to the left ventricle, and are shown facing the left ventricle.
- the number of electrodes 43 may vary depending on the number of locations required or desired to be paced.
- the electrodes 43 may be insulated on at least one side away from the heart, as to prevent electrical energy from being transmitted to proximate anatomical structures. The insulation may be about 2 mm thick, and may extend longitudinally through the epicardial pacing catheter 10 .
- the thickness may be wider or narrower as desired or required according to medical procedures, device/system operations and anatomical considerations.
- the insulation may comprise Teflon, silicone, polyurethane, and/or any combination thereof or any other non-conductive material known in the art.
- Outward facing bumper tabs 31 are deployable, and are used to stabilize the epicardial pacing catheter 10 by pushing against the pericardium. As shown, the outward facing bumper tabs 31 are in the non-deployed state as to allow the epicardial pacing catheter 10 to move within the pericardium. Although not shown, the epicardial pacing catheter may further comprise inward facing friction tabs 32 or other stabilization means.
- the epicardial pacing catheter 10 further comprises a distal tip 51 in communication with the epicardial pacing catheter 10 .
- the distal tip 51 extends from the body of the catheter 10 and may further insulate the electrodes 43 from proximate anatomical structures and/or be used to push through harder anatomical structures and adhesions as desired or required.
- FIG. 5(B) schematically illustrates an exemplary embodiment wherein the epicardial pacing catheter 10 may be used to pace the left ventricle (LV) and left atrium (LA) of a patient's heart. Additional electrodes 43 near the distal point of curvature 41 are shown. These electrodes 43 may be in communication with the outside wall of the left atrium in order to pace said structure. Additional outward facing bumper tabs 31 are present to press against the pericardium in more distal locations. Inward facing friction tabs 32 are now shown. The inward facing friction tabs 32 may be deployed to catch, drag, stick to, or pull on adjacent anatomical structures to keep the epicardial pacing catheter 10 from moving. FIG. 5(B) shows an example embodiment wherein both the inward facing friction tabs 32 and outward facing bumper tabs 33 are in the non-deployed state to allow movement of the catheter 10 .
- FIG. 5(C) schematically illustrates an exemplary embodiment wherein the epicardial pacing catheter 10 may be used to pace the left ventricle (LV), left atrium (LA), and right atrium (RA). Additional electrodes 43 are located near the distal point of curvature 41 . These electrodes 43 may be in communication with the outside wall of the right atrium in order to pace said structure. Further, additional outward facing bumper tabs 31 are present to press against the pericardium in more distal locations.
- LV left ventricle
- LA left atrium
- RA right atrium
- FIG. 5(D) shows an example embodiment wherein the epicardial pacing catheter 10 may be used to pace multiple points on the left ventricle (LV), left atrium (LA), right atrium (RA), and right ventricle (RV). Additional electrodes 43 are shown in a more distal location in order to transmit electrical energy to the right ventricle. Further, additional inward facing bumper tabs 32 are present to catch, drag, stick to, or pull on adjacent anatomical structures to keep the epicardial pacing catheter 10 from moving.
- LV left ventricle
- LA left atrium
- RA right atrium
- RV right ventricle
- both the number of inward facing friction tabs 32 and outward facing bumper tabs 31 may vary as desired or required to stabilize the epicardial pacing catheter 10 .
- inward facing friction tabs 32 may be located proximal or distal to any outward facing bumper tab 31 .
- outward facing bumper tabs 31 may be located proximal or distal to any inward facing friction tab 32 .
- outward facing bumper tabs 31 and inward facing friction tabs 32 may be positioned at the same location on the epicardial pacing catheter 10 as desired or required.
- each electrode 43 could be turned on separately in a unipolar or bipolar fashion, allowing for pacing of different chambers and different parts of the same chamber at different times. This has an important advantage: if a region of tissue ever dies in heart attack, pacing can be accomplished from a different location.
- inward facing friction tabs and outward facing bumper tabs may be alternated with one another, be staggered with one another, or grouped in numbers among each other as desired or required according to medical procedures, device/system operations and anatomical considerations.
- FIGS. 6(A)-6(F) schematically illustrate cross sectional views of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system from the most distal end to a more proximal point.
- FIG. 6(A) schematically illustrates a cross sectional view of an exemplary embodiment of the most distal portion of the epicardial pacing catheter 10 of the epicardial pacing system.
- the epicardial pacing catheter 10 further comprises a fluid lumen 61 .
- the fluid lumen occupies internal cross-sectional area of the epicardial pacing catheter 10 .
- the fluid lumen 61 may extend from an aperture (not shown) in the proximal end of the catheter 10 to a distal fluid aperture 55 . Both the distal fluid aperture 55 and a proximal fluid aperture (not shown) are adapted for the emitting and extracting of a fluid, drug, or agent.
- the fluid, drug, or agent may be used, but is not necessarily used, to cool the electrodes 43 , regulate heart activity, or distend proximal anatomical structures.
- the proximal fluid aperture (not shown) is connected to an external fluid, drug, or agent source (not shown).
- the emitting and extracting of a fluid, drug, or agent may be controlled by an external control handle 150 (as shown, for example, in FIG. 15 ) in communication with the proximal end and fluid, drug, or agent source.
- the fluid, drug, or agent to flow through the epicardial pacing catheter 10 may be at least one of the following: agent, substance, material, saline solutions, thrombolytic agents, clot lysis agents, chemotherapies, cell slurries, gene therapy vectors, growth factors, contrast agents, angiogenesis factors, radionuclide slurries, anti-infection agents, anti-tumor compounds, receptor-bound agents and/or other types of drugs, therapeutic agent and/or diagnostic agent or any combination thereof.
- FIG. 6(B) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 of the epicardial pacing system located proximal to the distal point of curvature 41 .
- Both the first distal steering pull-wire 68 and second distal steering pull-wire 69 occupy internal cross-sectional area of the epicardial pacing catheter 10 and extend longitudinally to the most proximal portion of said catheter 10 .
- the first distal steering pull-wire 68 and second distal steering pull-wire 69 may be controllably connected to a control means (as shown, for example, in FIG. 15 ) in communication with the proximal portion of the epicardial pacing catheter 10 .
- the epicardial pacing catheter 10 may further comprise a stabilization means.
- the stabilization means may be deployable and may comprise an inward facing friction tab 32 , an outward facing bumper tab 31 , a non-deployable protrusion, a screw, a hook, or other means known in the art.
- a tab deployment rod 64 extends longitudinally from the most proximal portion of the epicardial pacing lead 10 to the most distal inward facing friction tab 32 or outward facing bumper tab 31 .
- the tab deployment rod 64 may be a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, or rope.
- the tab deployment rod 64 made be made of a non-conductive material having high tensile strength as is known in the art.
- the tab deployment rod 64 may further be controllably connected to a control means (as shown, for example, in FIG. 15 ) in communication with the epicardial pacing catheter 10 , said control means used to control the deployment of the stabilization means.
- the tab deployment rod 64 is in communication with a number of tab deployment arms 65 , wherein each tab deployment arm 65 can be actuated to deploy the inward facing friction tab 32 or outward facing bumper tab 31 .
- FIG. 6(C) schematically illustrates a more proximal cross section of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system.
- the anode wire 62 extends longitudinally from the most proximal portion of the epicardial pacing catheter 10 to the most distal anode 63 .
- the anode wire 62 may be in communication with one or more anodes 63 located throughout the epicardial pacing catheter 10 . Further, the anode wire 62 is adapted for transmitting and receiving electrical energy.
- the anode wire 62 may be controllably connected to a control means (as shown, for example, in FIG. 15 ) in communication with the proximal portion of the epicardial pacing catheter 10 .
- An outward facing bumper tab 31 is shown in communication with the epicardial pacing catheter 10 .
- the outward facing bumper tab 31 may be deployed by a tab deployment arm 65 in communication with the tab deployment rod 64 .
- FIG. 6(D) schematically illustrates a more proximal cross section of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system located proximal to the proximal point of curvature 42 .
- the epicardial pacing catheter 10 further comprises a second steering means.
- the second steering means comprises a first proximal steering pull-wire 70 and a second proximal steering pull-wire 71 . Both the first proximal steering pull-wire 70 and second proximal steering pull-wire 71 occupy internal cross-sectional area of the epicardial pacing catheter 10 and extend longitudinally to the most proximal portion of said catheter 10 .
- the first proximal steering pull-wire 70 and second proximal steering pull-wire 71 may be controllably connected to a control means (as shown, for example, in FIG. 15 ) in communication the proximal portion of the epicardial pacing catheter 10 .
- FIG. 6(E) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 of the epicardial pacing system.
- a cathode wire 66 extends longitudinally from the most proximal portion of the epicardial pacing catheter 10 to the most distal cathode 67 .
- the cathode wire 66 may be in communication with one or more cathodes 67 located throughout the epicardial pacing catheter 10 . Further, the cathode wire 66 is adapted for transmitting and receiving electrical energy.
- the cathode wire 66 may be controllably connected to a control means (as shown, for example, in FIG. 15 ) in communication with the proximal portion of the epicardial pacing catheter 10 .
- FIG. 6(F) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 of the epicardial pacing system.
- An outward facing bumper tab 31 is shown in communication with the epicardial pacing catheter 10 .
- the outward facing bumper tab 31 may be deployed by a tab deployment arm 65 in communication with a tab deployment rod 64 .
- the number of port holes, lumens, wires or rods may vary as may be desired or required according to medical procedures, device/system operations and anatomical considerations.
- FIGS. 7(A) and 7(B) schematically illustrate a cross sectional view of an exemplary embodiment of the proximal end 73 of the epicardial pacing catheter 10 of the epicardial pacing system and the most distal end 74 of the control means 150 respectively.
- twelve electrode wires including six anode wires 62 and six cathode wires 66 , occupy internal cross-sectional area of the epicardial pacing catheter 10 .
- Each anode wire 62 and cathode wire 66 extends longitudinally through the epicardial pacing catheter 10 towards the distal portion.
- the cathode wire 66 may be in communication with one or more cathodes 67 located throughout the epicardial pacing catheter 10 .
- the anode wire 62 may be in communication with one or more anodes 63 located throughout the epicardial pacing catheter 10 .
- any number of electrodes 43 may be present as desired or required to pace a number of locations on the heart of a patient.
- a single anode wire 62 may be used to provide electrical energy to a multitude of anodes 63 , or each anode wire 62 can provide electrical energy to a single anode 63 .
- a single cathode wire 66 may be used to provide electrical energy to a multitude of cathodes 67 , or each cathode wire 66 can provide electrical energy to a single cathode 67 .
- electrical energy can be transmitted to each electrode 43 separately in a unipolar or bipolar fashion, allowing for pacing of different chambers and different parts of the same chamber at different times.
- first proximal steering pull-wire 70 , first distal steering pull-wire 68 , second proximal steering pull-wire 71 , and second distal steering pull-wire 69 occupy internal cross-sectional area of the epicardial pacing catheter 10 .
- Each first proximal steering pull-wire 70 , first distal steering pull-wire 68 , second proximal steering pull-wire 71 , and second distal steering pull-wire 69 extends longitudinally through the epicardial pacing catheter 10 towards the distal portion.
- Each first proximal steering pull-wire 70 , first distal steering pull-wire 68 , second proximal steering pull-wire 71 , and second distal steering pull-wire 69 may comprise guidewires, tensioning lines, pull strings, digitating distal tips, magnetic guidance means, wires, rods, chains, bands, chords, ropes, string tubes, filaments, threads, fibers, strands, other extended elements, or any other method known in the art.
- first tab deployment rod 64 and second tab deployment rod 72 occupy internal cross-sectional area of the epicardial pacing catheter 10 .
- Each first tab deployment rod 64 and second tab deployment rod 72 extends longitudinally from the most proximal portion 73 of the epicardial pacing lead 10 to the most distal inward facing friction tab 32 or outward facing bumper tab 31 .
- the first tab deployment rod 64 and second tab deployment rod 72 may comprise a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, magnetic guidance means, chains, bands, chords, or rope.
- the first tab deployment rod 64 and second tab deployment rod 72 may comprise a non-conductive material having high tensile strength as is known in the art.
- the first tab deployment rod 64 and second tab deployment rod 72 may further be controllably connected to the distal end 74 of a control means 150 in communication with the proximal end 73 of the epicardial pacing catheter 10 , said control means used to control the deployment of the tabs.
- first tab deployment rod 64 and second tab deployment rod 72 are shown, any number of tab deployment rods may be present as desired or required, up to an including the sum of inward facing friction tabs 32 and outward facing bumper tabs 31 (See FIGS. 6 (A)-(E)).
- a biocompatible cover may be in communication with the most proximal end 73 of the epicardial pacing catheter 10 .
- the biocompatible cover may prevent fibrosis from occurring around the exposed structures of the epicardial pacing catheter 10 .
- the proximal end 73 of the epicardial pacing catheter 10 may be located just under the skin of a patient.
- the proximal end 73 can be reached by a non-surgical, minimally-invasive incision of the skin, carried out by a clinician or cardiologist.
- proximal end 73 may protrude from said proximal end 73 of the epicardial pacing catheter 10 .
- the proximal end 73 could act as a male connector in a male-female connection. It should be appreciated that the corresponding male-female connection may be reversed as well.
- FIG. 7(B) shows a cross sectional view of an example embodiment of the most distal portion 74 of a control handle 150 .
- the control handle 150 can be controllably connected to the most proximal portion 73 of the epicardial pacing catheter 10 .
- Wire grippers 75 around each of the internal structures facilitate a secure connection between structures integral the control handle 150 and structures integral the epicardial pacing catheter 10 .
- all structures within the control handle 150 may end before the distal end 74 .
- the distal end 74 can act as a female connector in a male-female connection.
- FIGS. 8 (A)-(C) schematically illustrate cross-sectional views of an example embodiment wherein the epicardial pacing catheter 10 further comprises a stabilization means for stabilizing the epicardial pacing catheter 10 .
- the stabilization means may comprise at least one deployable member.
- the stabilization means allows the rotational orientation of the distal portion of the epicardial pacing catheter 10 to remain fixed in place relative to the surface of the heart. If the distal portion of the epicardial pacing catheter 10 were allowed to rotate so that the electrodes 43 faced away from the heart, pacing could not be achieved and adjacent anatomical structures would receive harmful electronic energy.
- FIGS. 8 (A)-(C) illustrate an exemplary embodiment wherein the stabilization means is an inward facing friction tab 32 .
- the inward facing friction tab 32 comprises a catheter-side surface 82 and an anatomical-side surface 83 .
- the anatomical-side surface 83 comprises a lubricious surface that may be navigated through anatomical structures without sticking or catching.
- the catheter-side surface 82 comprises a rough surface having a larger coefficient of friction than the anatomical-side surface.
- the catheter-side surface may further comprise a textured surface to increase friction.
- Both the catheter-side surface 82 and anatomical-side surface 83 comprise a non-conductive material, such as, but not limited to polyurethane, Teflon, silicone, a radio-opaque material, or similarly lubricious material, or other materials known in the art.
- a non-conductive material such as, but not limited to polyurethane, Teflon, silicone, a radio-opaque material, or similarly lubricious material, or other materials known in the art.
- FIG. 8(A) illustrates an exemplary embodiment wherein the stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the inward facing friction tab 32 .
- the stabilizer actuator is illustrated as a tab deployment rod 64 in communication with a tab joint 84 , tab hinge 81 , and tab deployment arm 65
- the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof.
- the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, rope, pole, thread, filament, cord, strand or other means known in the art.
- the stabilizer actuator may further comprise a micro electrical mechanical system (MEMS).
- MEMS micro electrical mechanical system
- a tab deployment rod 64 extends longitudinally from the most proximal portion of the epicardial pacing lead 10 to the most distal inward facing friction tab 32 .
- the tab deployment rod 64 may be a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, pole, thread, filament, cord, strand or rope.
- the tab deployment rod 64 made be made of a non-conductive material having high tensile strength as is known in the art.
- the tab deployment rod may further be controllably connected to a control means or control handle (as shown, for example, in FIG. 15 ) in communication with the epicardial pacing catheter 10 of the epicardial pacing system 5 , and the control means may be used to control the deployment of the tabs.
- the tab deployment rod 64 is in communication with a tab joint 84 , the tab joint 84 in connection with a tab deployment arm 65 having its endpoint within the inward facing friction tab 32 .
- the tab deployment arm is in further communication with a tab hinge 81 .
- the epicardial pacing catheter 10 When the inward facing friction tab 32 is in the non-deployed state, the epicardial pacing catheter 10 may be moved, navigated, or slid within the middle mediastinum. In this way, the epicardial pacing catheter 10 can be inserted, placed, navigated or removed from the pericardial sack.
- FIG. 8(B) illustrates an embodiment wherein the stabilization means is an inward facing friction tab 32 in the partially-deployed state.
- the tab deployment rod 64 When the tab deployment rod 64 is pushed toward the distal end of the epicardial pacing catheter 10 , the tab deployment arm 65 is pulled or tensioned. This causes the inward facing friction tab 32 to separate from the catheter body, exposing the rough catheter-side 82 to proximate anatomical structures.
- FIG. 8(C) illustrates an embodiment wherein the stabilization means is an inward facing friction tab 32 in the fully-deployed state.
- outward facing bumper tabs 31 may be deployed using the same means and methods as described above.
- the stabilization means may comprise one or more protrusions for engaging proximal anatomical structures such as the pericardium and/or the epicardium.
- the protrusions may be non-deployable.
- the protrusions may comprise a non-conductive material, such as, but not limited to, silicone, polyurethane, Teflon, a radio-opaque material, or other materials known in the art.
- hinge devices and joint devices may be a number of elements such as, but not limited thereto, a fulcrum, swivel, gear, elbow, pivot, thrust or the like.
- tab devices may be a number of elements such as, but not limited thereto, finger, stud, post, tongue, spring, projection, pin, pedestal, extension, offset, knob, protuberance or the like.
- FIG. 9 schematically illustrates an example embodiment of the epicardial pacing catheter 10 of the epicardial pacing system in relation to the heart 21 and further comprising at least one deployable member.
- the epicardial pacing catheter 10 has been steered around its distal point of curvature 41 , and is positioned in the pericardial space, cavity or sack 24 , or the area between the pericardium 22 and epicardium 23 .
- the deployable member comprises at least one electrode 43 , and each electrode 43 is facing the heart 21 .
- the electrodes 43 may be deployed from the epicardial pacing catheter 10 and are fixed to the epicardium 23 when in the fully-deployed state.
- the epicardial pacing catheter 10 may further comprises an insulating hood 101 in communication with the epicardial pacing catheter 10 .
- FIG. 10(A) schematically illustrates a top view of an example embodiment of the epicardial pacing catheter 10 of the epicardial pacing system.
- the epicardial pacing catheter further comprises a insulating hood 101 extending from beyond the distal point of curvature 41 to a distal tip 51 .
- the hood may serve as a cushioning and/or alignment means for the distal tip 51 relative to adjacent anatomical structures. It should be appreciated that some portion of the distal tip shall have insulation to protect from adjacent anatomical structures.
- the shape of the distal tip and hood may vary according to medical procedures, device/system operations and anatomical considerations.
- FIG. 10(B) schematically illustrates a bottom view of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system.
- An anode 63 and cathode 67 are shown in communication with the epicardial pacing catheter 10 .
- the contact zones containing the anode 63 and cathode 67 electrodes are about 2 mm in length and about 1 mm in width, and are located centrally within the underside surface of the insulating hood 101 . It should be appreciated that the width of the electrodes may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations.
- the insulating hood extends from a distal location beyond the distal point of curvature 41 to a distal tip 51 .
- FIG. 10(C) schematically illustrates an axial view of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system looking at the distal tip 51 of the insulating hood 101 .
- a single electrode 43 can be seen on the underside of the epicardial pacing catheter 10 .
- FIG. 10(D) schematically illustrates a side view of an exemplary embodiment of the epicardial pacing catheter 10 comprising an insulating hood 101 , distal tip 51 , and two electrodes 43 .
- the insulating hood 101 extends over the side of the epicardial pacing catheter 10 .
- each electrode 43 could be powered separately in a unipolar or bipolar fashion, allowing for pacing of different parts of the same chamber at different times.
- FIG. 11(A)-11(E) schematically illustrate cross sectional views of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system from a point located proximal to the most distal anode 62 or cathode 67 and distal to the distal point of curvature 41 to a point located at the most proximal point 73 of the epicardial pacing catheter 10 .
- FIG. 11(F) schematically illustrates a cross sectional view of an exemplary embodiment of the external control handle 150 at the most distal point 74 .
- FIG. 11(A) schematically illustrates a cross section of an example embodiment of the epicardial pacing catheter 10 located more distal than the distal point of curvature 41 and proximal to the most distal anode 62 or cathode 67 .
- An anode wire 62 , cathode wire 66 , electrode pull-wire 112 , and second-electrode pull-wire 113 occupy internal cross-sectional area of the epicardial pacing catheter 10 and extend longitudinally to the most proximal portion 73 of said catheter 10 .
- the anode wire 62 , cathode wire 66 , electrode pull-wire 112 , and second-electrode pull-wire 113 may comprise longitudinal structures, such as, but not limited to, push-rods, pull-rods, wires, strings, or ropes. Further, the anode wire 62 , cathode wire 66 , electrode pull-wire 112 , and second-electrode pull-wire 113 may be controllably connected to a control handle 150 in electrical communication with the most proximal point 73 of the epicardial pacing catheter 10 .
- the anode wire 62 and electrode pull-wire 112 extend longitudinally from the most proximal portion 73 of the epicardial pacing catheter 10 to the most distal anode 63 .
- the cathode wire 66 and second electrode pull-wire 113 extend longitudinally from the most proximal portion 73 of the epicardial pacing catheter 10 to the most distal cathode 67 .
- FIG. 11(B) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 located at the distal point of curvature 41 .
- the epicardial pacing catheter 10 further comprises a first distal steering pull-wire 68 and a second distal steering pull-wire 69 fixed to distal steering anchors 110 in communication with the epicardial pacing catheter 10 .
- the distal steering anchors 110 comprise a material with requisite strength to hold the first distal steering pull-wire 68 and second distal steering pull-wire 69 in place.
- the first distal steering pull-wire 68 and second distal steering pull-wire 69 occupy internal cross-sectional area of the epicardial pacing catheter 10 and extend longitudinally to the most proximal point 73 of said catheter 10 .
- the first proximal steering pull-wire 68 and second proximal steering pull-wire 69 may be controllably connected to a control handle 150 in communication with the most proximal point 73 of the epicardial pacing catheter 10 .
- FIG. 11(C) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 located between the distal point of curvature 41 and proximal point of curvature 42 .
- FIG. 11(D) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 located at the proximal point of curvature 42 .
- the epicardial pacing catheter 10 further comprises a proximal steering pull-wire 70 fixed to a proximal steering anchor 111 in communication with the epicardial pacing catheter 10 .
- the proximal steering anchor 111 comprises a material with requisite strength to hold the proximal steering pull-wire 70 .
- the proximal steering pull-wire 70 occupies internal cross-sectional area of the epicardial pacing catheter 10 and extends longitudinally to the most proximal point 73 of said catheter 10 .
- the proximal steering pull-wire 70 can be controllably connected to a control handle 150 or control means in communication with the most proximal point 73 of the epicardial pacing catheter 10 .
- FIG. 11(E) schematically illustrates a more proximal cross section of an example embodiment of the epicardial pacing catheter 10 located at the most proximal point 73 .
- anode wire 62 electrode pull-wire 112 , cathode wire 66 , and second electrode pull-wire 113 are shown, any number of anode wires 62 , electrode pull-wires 112 , cathode wires 66 , and second electrode pull-wires 113 may be present as desired or required, up to and including, for example, the total number of electrodes 43 (or the sum of the anodes 63 and cathodes 67 ).
- a biocompatible cover may be in communication with the most proximal end 73 of the epicardial pacing catheter 10 .
- the biocompatible cover can prevent fibrosis from occurring around the exposed wires of the epicardial pacing catheter 10 .
- the proximal end 73 of the epicardial pacing catheter 10 is located just under the skin of a patient (or location(s) as desired or required).
- the proximal end 73 can be reached by a non-surgical, minimally-invasive incision of the skin, carried out by a clinician or cardiologist.
- all structures beginning at the proximal end 73 may protrude from said proximal end 73 of the epicardial pacing catheter 10 .
- the proximal end 73 could act as a male connector in a male-female connection.
- the male-female arrangement may be reversed if desired or required.
- FIG. 11(F) schematically illustrates a cross sectional view of an example embodiment of the most distal portion 74 of a control handle 150 .
- the control handle 150 can be controllably connected to the most proximal portion 73 of the epicardial pacing catheter 10 .
- Wire grippers 75 (or other retention means or devices) around each of the internal structures facilitate a secure connection between structures integral the control handle 150 and structures integral the epicardial pacing catheter 10 .
- control handle or control means may end before the distal end 74 .
- distal end 74 can act as a female connector in a male-female connection (or female-male connection).
- FIG. 12(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system comprising a deployable stabilization means in an un-deployed state.
- the deployable stabilization means comprises an anode 63 and cathode 67 in communication with a hook 124 .
- the hook 124 , anode 63 , and cathode 67 comprise conductive materials, such as, but not limited to, copper, platinum, gold, silver or iridium, and/or alloys thereof.
- the stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the anode 63 and cathode 67 in communication with the hooks 124 .
- the stabilizer actuator is illustrated as an electrode pull-wire 112 in communication with a joint 121 , and hinge 122 , the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof.
- the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, rope, pole, thread, filament, cord, strand or other means known in the art.
- the stabilizer actuator may further comprise a micro electrical mechanical system (MEMS).
- MEMS micro electrical mechanical system
- hook devices may be a number of elements such as, but not limited thereto, pin, claw, latch, finger, stud, spring, post, tongue, projection, pin, pedestal, extension, offset, knob, protuberance or the like.
- an electrode pull-wire 112 extends longitudinally from the most proximal portion of the epicardial pacing lead 10 to the most distal electrode 43 , which may comprise an anode 63 or cathode 67 .
- the electrode pull-wire 112 is in communication with a joint 121 , the joint 121 in further communication with a hinge 122 .
- the electrode pull-wire 112 may comprise a conductive material having high tensile strength as is known in the art.
- the electrode-pull wire 112 may further be controllably connected to a control means (for example, as shown in FIG. 15 ) in communication with the epicardial pacing catheter 10 and epicardial pacing system.
- the control means may be used to control the deployment of the anode 63 and cathode 67 in communication with hooks 124 , and any of the devices, systems, subsystems, elements, and devices discussed throughout this disclosure.
- the epicardial pacing catheter 10 further comprises an insulating distal tip 51 in communication with the epicardial pacing catheter.
- the epicardial pacing catheter 10 further comprises a number of bumpers 120 in communication with the bottom of the epicardial pacing catheter 10 .
- the bumpers enable the epicardial pacing catheter 10 to sit on the surface of the heart in a non-deployed state without allowing the anode 63 or cathode 67 to be in communication with the epicardium.
- the epicardial pacing catheter 10 When the deployable anode 63 and cathode 67 are in the non-deployed state, the epicardial pacing catheter 10 may be moved or navigated within the middle mediastinum. In this way, the epicardial pacing catheter 10 can be inserted, placed, navigated or removed from the pericardial sack.
- FIG. 12(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter 10 comprising a deployable anode 63 and cathode 67 in a fully-deployed state.
- the electrode pull-wire 112 is pushed toward the distal end of the epicardial pacing catheter 10 , the anode 63 and cathode 67 are splayed outward to a 90 degree angle, or an angel(s) as desired or required. This causes the anode 63 and cathode 67 to separate from the catheter body, allowing the hooks 124 to engage proximate anatomical structures, such as the epicardial wall.
- the rotational orientation of the distal portion of the epicardial pacing catheter 10 remains fixed in place relative to the surface of the heart. If the distal portion of the epicardial pacing catheter 10 were allowed to rotate so that the electrodes 43 faced away from the heart, pacing could not be achieved and adjacent anatomical structures would receive harmful electronic energy.
- any number of deployable electrodes 43 may be present as desired or required to pace any number of locations on the heart of a patient.
- FIG. 13(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter 10 of the epicardial pacing system comprising a deployable stabilization means in an un-deployed state.
- the deployable stabilization means comprises a number of screws 130 in communication with an anode 63 and cathode 67 .
- the screws 130 , anode 63 , and cathode 67 comprise conductive materials, such as, but not limited to, copper, platinum, gold, silver and/or iridium, and/or alloys thereof.
- the stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the screws 130 in communication with the anode 63 and cathode 67 .
- the stabilizer actuator is illustrated as an electrode pull-wire 112 in communication with a gear 131
- the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof.
- the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, rope, pole, thread, filament, cord, strand, or other means known in the art.
- the stabilizer actuator may further comprise a micro electrical mechanical system (MEMS).
- MEMS micro electrical mechanical system
- screw devices may comprise a number of elements such as, but not limited thereto, any translatable protrusion or extension for instance.
- Some non-limiting examples may include: toggle, press, slide, spring, stud, post, tongue, projection, pedestal, protuberance, contact, or the like.
- an electrode pull-wire 112 extends longitudinally from the most proximal portion of the epicardial pacing lead 10 to the most distal electrode 43 , which may be an anode 63 or cathode 67 .
- the electrode pull-wire 112 may be a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, or rope.
- the electrode pull-wire 112 may be made of a conductive material having high tensile strength as is known in the art.
- the electrode-pull wire 112 may further be controllably connected to a control means (as shown, for example, in FIG. 15 ) in communication with the epicardial pacing catheter 10 and epicardial pacing system.
- the control means may be used to control the deployment of the screws 130 in communication with the anode 63 and cathode 67 .
- the epicardial pacing catheter 10 further comprises an insulating distal tip 51 in communication with the epicardial pacing catheter.
- the epicardial pacing catheter 10 When the screws 130 are in the non-deployed state, the epicardial pacing catheter 10 may be moved or navigated within the middle mediastinum. In this way, the epicardial pacing catheter 10 can be inserted, placed, navigated, translated, rotated or removed from the pericardial sack.
- FIG. 13(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter 10 comprising fully-deployed screws 130 in communication with the anode 63 and cathode 67 .
- the gears 131 are activated and the screws 130 are rotationally-actuated. This causes the screws 130 to engage proximate anatomical structures, such as the epicardial wall.
- the rotational orientation of the distal portion of the epicardial pacing catheter 10 remains fixed in place relative to the surface of the heart.
- the electrical energy is transmitted from the anode 63 and cathode 67 through the screws 130 and into the heart.
- any number of deployable screws 130 may be present as desired or required to pace any number of locations on the heart of a patient.
- FIG. 14(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter 10 epicardial pacing system comprising a deployable stabilization means in an un-deployed state.
- the deployable stabilization means comprises an anode 63 and cathode 67 in communication with a hook 124 .
- the hooks 124 , anode 63 , and cathode 67 comprise conductive materials, such as, but not limited to, copper, platinum, gold, silver and/or iridium, or alloys thereof.
- the deployable stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the anode 63 and cathode 67 in communication with the hooks 124 .
- the stabilizer actuator is illustrated as an electrode pull-wire 112 and second electrode pull-wire 113 in communication with a number of joints 121 , and hinges 122
- the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof.
- the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, thread, filament, cord, strand, rope, pole, or other means known in the art.
- the stabilizer actuator may further comprise a micro electrical mechanical system (MEMS).
- MEMS micro electrical mechanical system
- an electrode pull-wire 112 and second electrode pull-wire 113 extend longitudinally from the most proximal portion of the epicardial pacing lead 10 to the most distal anode 63 and cathode 67 respectively.
- the electrode pull-wire and second electrode pull-wire 113 are in communication with a number of joints 121 , the joints 121 in further communication with a number of hinges 122 .
- the electrode pull-wire 112 and second electrode pull-wire 113 may comprise longitudinal structures, such as, but not limited to, push-rods, pull-rods, wires, thread, filament, cord, strand, strings, or ropes.
- the electrode pull-wire 112 and second electrode pull-wire 113 may be made of a conductive material having high tensile strength as is known in the art.
- the electrode-pull wire 112 and second electrode pull-wire 113 may further be controllably connected to a control means (for example, as shown in FIG. 15 ) in communication with the epicardial pacing catheter 10 and epicardial pacing system.
- the control means may used to control the deployment of the anode 63 and cathode 67 in communication with hooks 124 .
- the epicardial pacing catheter 10 further comprises an insulating distal tip 51 in communication with the epicardial pacing catheter.
- the epicardial pacing catheter 10 may further comprise a number of bumpers 120 in communication with the epicardial pacing catheter 10 .
- the bumpers 120 enable the epicardial pacing catheter 10 to sit on the surface of the heart in a non-deployed state without allowing the anode 63 or cathode 67 to communicate with the heart.
- the epicardial pacing catheter 10 When the deployable anode 63 and cathode 67 are in the non-deployed state, the epicardial pacing catheter 10 may be moved or navigated within the middle mediastinum. In this way, the epicardial pacing catheter 10 can be inserted, placed, navigated, translated, rotated or removed from the pericardial sack.
- FIG. 14(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter 10 comprising a deployable anode 63 and cathode 67 in a fully-deployed state.
- the electrode pull-wire 112 and second electrode pull-wire 113 are pulled toward the proximal end of the epicardial pacing catheter 10 , the anode 63 and cathode 67 are splayed outward to a 90 degree angle. This causes the anode 63 and cathode 67 to separate from the catheter body, allowing the hooks 124 to engage proximate anatomical structures, such as the epicardial wall.
- the rotational orientation of the distal portion of the epicardial pacing catheter 10 remains fixed in place relative to the surface of the heart.
- the electrical energy is transmitted from the anode 63 and cathode 67 through the hooks 124 and into the heart.
- any number of deployable anodes 63 and cathodes 67 may be present as desired or required to pace any number of locations on the heart of a patient.
- FIG. 15(A) schematically illustrates an example embodiment of an external control handle 150 (that may be associated with, although not shown, the epicardial pacing catheter of the system).
- the epicardial pacing catheter and system further comprises a control means, wherein said control means is an external control handle 150 .
- the external control handle 150 may be in communication with the most proximal point 73 of the epicardial pacing catheter 10 .
- the external control handle 150 may have integral to it the distal steering control means 154 , the proximal control means 154 , the irrigation control means (not shown) and the control means for the stabilization means 151 .
- the stabilization control means 154 may be used to regulate the degree of extension of said stabilization means via a pull-wire or pushrod arrangement or some other suitable tensioning or actuating means know in the art.
- the external control handle 150 may further comprise a pull-rod control aperture 152 , wherein a tab deployment rod 64 and second tab deployment rod (not shown) may be inserted.
- the external control handle 150 is preferably sized to be grasped, held and operated by a user. It should be appreciated that other control and operating interface members, devices, or means may be utilized for the handle. Attached to the proximal end of the control handle 150 is the handle proximal port (not shown) from which anode wires 62 and cathode wires 67 extend in order to make electrical connections to diagnostic or electrical devices (not shown). Electrical wires (for example, shown in FIGS. 6 , 7 , and 11 ) may extend through the proximal portion to each of the electrodes 43 of the epicardial pacing catheter 10 .
- FIG. 15(B) schematically illustrates an example embodiment of the proximal steering control means 153 integral to the control handle 150 .
- the proximal steering control means 153 is controllably connected to the first proximal steering pull-wire 70 and second proximal steering pull-wire 71 .
- FIG. 15(C) schematically illustrates an example embodiment wherein the proximal steering control means 153 integral to the control handle 150 has been activated.
- the proximal steering control means 153 is activated by a user, the first proximal steering pull-wire 70 becomes taught, and the second proximal steering pull-wire 71 loosens, creating slack 155 .
- Both the first proximal steering pull-wire 70 and second proximal steering pull-wire 71 extend longitudinally through the control handle 150 , into the epicardial pacing catheter 10 , and are anchored at the proximal point of curvature 42 .
- the epicardial pacing catheter bends toward the proximal steering anchor and around the proximal point of curvature 42 .
- control handle may have channels for the steering pull wires and thumb wheel knobs for tightening or loosening the pull wires.
- catheter device and epicardial system and their related components discussed herein may can take on all shapes along the entire continual geometric spectrum of manipulation of x, y and z planes to provide and meet the anatomical and structural demands and requirements.
- Step 1 Access and place a guidewire in the pericardial space using our EpiNeedle Access system.
- Step 2 Use a sheath, preferably our EpiSheath, or a general long 8 Fr sheath to place over the guidewire and maintain access.
- Step 3 Place the lead of the subject invention with handle though the sheath.
- Step 4 Guide the lead in the epicardial space using the two steering points and the sheath under fluoroscopic guidance (although this lead may be guided via one or more other imaging methods to include ICE, CT, MRI, Visual Endoscopy, or Echo Methods).
- the lead should be advanced along the border of the heart apically to base along the LV. Once it crosses the AV groove to the LA it should be deflected downward and advanced through the transverse sinus. Once across the transverse sinus it will need to be deflected up to the SVC and then down to the RA and finally the RV.
- Step 5 Segment the sheath back to the inferior portion of the RV.
- Step 6 the handle should be hooked up to an EP analyzer.
- the lead should be clocked for a more anterior position or counter-clocked for a more posterior position until the largest LV signals are found. If multi-chamber pacing is sought one should pick a point when at least two poles of the LV, and of each other chamber, has an amplitude of at least 1 mV in the atrium and 5 mV in the ventricle. Note there is no need for all points to have high amplitudes.
- the tabs should be deployed. This should push the lead more tightly against the heart and actually increase the voltage. Then, pacing should be attempted in the LV. If threshold is less than 2.5 V it is a good site on any pole. The same should then be done with the other points. If no point is good the tab should be let down and then the lead repositioned.
- Step 7 Once a good position is found the handle should be removed and the sheath withdrawn completely outside of the patient.
- Step 8 The lead should be plugged into either a custom ICD/BiV or attached to our wire interface for a standard ICD.
- the poles that are not used to pace should be plugged in this case.
- all poles would be active and the user (or an automated system) may decide when to pace.
- Step 9 The lead extender to the ICD would then either be tunneled back to the ICD in the shoulder (or elsewhere), placed by the nearby abdominal ICD. Or a battery-powered wireless box will be used to communicate with the main ICD in the shoulder. At this point the patient should be recovered. No stitch is needed for the lead access.
- any activity can be repeated, any activity can be performed by multiple entities, and/or any element can be duplicated. Further, any activity or element can be excluded, the sequence of activities can vary, and/or the interrelationship of elements can vary. Unless clearly specified to the contrary, there is no requirement for any particular described or illustrated activity or element, any particular sequence or such activities, any particular size, speed, material, dimension or frequency, or any particularly interrelationship of such elements. Accordingly, the descriptions and drawings are to be regarded as illustrative in nature, and not as restrictive. Moreover, when any number or range is described herein, unless clearly stated otherwise, that number or range is approximate. When any range is described herein, unless clearly stated otherwise, that range includes all values therein and all sub ranges therein.
Abstract
The epicardial pacing system and related method includes an epicardial catheter configured to be disposed in the middle mediastinum of the thorax of a subject for use in electrical pacing of the heart at one or more locations on the epicardial surface. The epicardial pacing catheter may include at least one electrode whereby the electrode is insulated on at least one side to allow pacing of the heart without damage to adjacent anatomical structures.
Description
- The present invention claims priority from U.S. Provisional Application Ser. No. 60/986,786, filed November, 09, 2007, entitled āPassive Fixation, Steerable Epicardial Lead to be Placed via the Subxiphoid Process for Pacing Left Ventricle, Right Ventricle, Right Atrium and Left Atrium and Cardiac Defibrillation,ā and U.S. Provisional Application Ser. No. 61/023,727, filed Jan. 25, 2008, entitled āSteerable Epicardial Lead to be Placed via the Subxiphoid Process for Left Ventricular Pacing and Related Method;ā the disclosures of which are hereby incorporated by reference herein in their entirety.
- This application is related to PCT International Application No. Serial No. PCT/US2008/056643, filed Mar. 12, 2008, entitled, āAccess Needle Pressure Sensor Device and Method of Use,ā the disclosure of which is hereby incorporated by reference herein in its entirety.
- This application is related to PCT International Application No. Serial No. PCT/US2008/056816, filed Mar. 13, 2008, entitled, āEpicardial Ablation Catheter and Method of Use,ā the disclosure of which is hereby incorporated by reference herein in its entirety.
- This application is related to PCT International Application No. Serial No. PCT/US2008/057626, filed Mar. 20, 2008, entitled, āElectrode Catheter for Ablation Purposes and Related Method Thereof,ā the disclosure of which is hereby incorporated by reference herein in its entirety.
- The present technology relates generally to the field of medical devices to be used for cardiological procedures. More specifically, the technology is in the subfield of catheterization devices to be used for epicardial pacing.
- Congestive heart failure effects between 4 and 5 million people in the United States and accounts for about $15 billion per year in hospitalization costs alone. While medical therapy, such as prescription drugs, may benefit a number of patients, side effects prevent some patients from completing therapy. Moreover, few patients are completely cured of their symptoms.
- In recent years simultaneous pacing of both ventricles (via a biventricular pacemaker) has been shown in multiple studies to improve the quality of life and extend survival of such patients. The American College of Cardiology and American Heart Association has, therefore, recommended that all patients having class II, III or IV heart failure with a wide QRS complex (electrocardiograph deflections of the Q, R and S waves) receive a biventricular pacemaker. This recommendation alone encompasses up to one million people per year in the US, and uses for this type of device are expanding.
- Unfortunately, due to inherent difficulties in placing left ventricular (LV) leads, less than 15% of eligible patients are able to receive this device. Unlike the RV, the electrical lead can not be placed directly into the LV due to the unacceptably high risk of stroke. The lead must, therefore, be placed on the surface of the LV. In order to accomplish this placement, a lead is threaded through the right atrium (RA) using a venous system, and passed through the coronary sinus (CS) to any of a number of small veins in communication with the surface of the LV.
- Quantitative clinical results, especially those reporting the statistics of negative outcomes, are seldom published. However, in procedures conducted at the inventors' high volume university hospital, 20% of patients have been found to have a very difficult access to the CS, resulting in an abandonment of the procedure. In an additional 20% of patients, a vein in communication with an optimal location on the LV can not be found within the CS. As an example, if one is trying to place a lead on the lateral aspect of the LV (an ideal location), but there is no vein extending from within the CS to the lateral aspect of the LV, a lead can not be placed here. Worse still, many of these patients have multiple areas of dead heart tissue, so even if a lead can be placed within a vein, it might not pace the heart. Even moving the lead slightly would help, but the vein acts like a railroad track to limit placement. All of these limitations result in an unpredictable procedure time, making it difficult for hospitals and doctors to plan the operation.
- At present, the most effective option to pace the LV is through invasive surgery requiring cardiac surgeons. The newest techniques allow surgeons to either open a patient's chest or cut between the ribs to place the lead anywhere on the LV. Even the most āminimally invasiveā leads currently available require a lateral thoracotomy necessitating a surgeon. Both the NcontactĀ® and HeartlanderĀ® tools, which are not designed to pace, require surgical incisions.
- There are two significant barriers to widespread application of these surgical techniques. First, surgical procedures are generally more invasive and require longer recovery times. Second, most cardiologists consider it the standard of care to attempt an initial placement of a lead via CS access; only after that fails is surgery considered. To avoid the need for additional surgical intervention, a cardiologist may choose a sub-optimal location for lead placement. This is typically in keeping with the wishes of most patients; minimally invasive techniques are preferred whenever possible.
- There is therefore a need in the art whereby one would be able to place a lead for pacing on any optimal site of the LV based solely on what is clinically efficient for the patient and not the heart's anatomy. Moreover, if this could be accomplished by a cardiologist (non-surgeon) without the need for invasive surgery, the procedure would be used more often. Thus, instead of only 15% of patients receiving biventricular pacing, close to 100% of patients could receive it.
- The following U.S. patent documents discuss catheterization tools for cardiology: U.S. Pat. Nos. 7,142,919 to Hine et al.; 7,130,699 to Huff et al.; 7,120,504 to Osypka; 7,101,362 to Vinney; 7,090,637 to Danitz et al.; 7,089,063 to Lesh et al.; 7,059,878 to Hendrixson et al.; 7,041,099 to Thomas et al.; 7,027,876 to Casavant et al.; 7,008,418 to Hall et al.; 6,973,352 to Tsutsui et al.; 6,936,040 to Kramm et al.; 6,921,295 to Sommer et al.; 6,876,885 to Swoyer et al.; 6,868,291 to Bonner et al., all of which are incorporated by reference herein in their entirety. No reference discloses the conceptual arrangements for an integrated cardiological device for epicardial pacing.
- To overcome these limitations, we have conceived the subject device and method of use, as described in the Summary of the Invention and Detailed Description of the Drawings below.
- These and other objects, along with advantages and features of the invention disclosed herein, will be made more apparent from the description, drawings and claims that follow.
- An aspect of an embodiment (or partial embodiment thereof) of the present invention includes an apparatus and means for treating congestive heart failure and arrhythmias (both bradycardias and tachycardias) of the heart. For example, the invention provides for a novel means and method of placing an epicardial lead within a patient for the purpose of permanent multi-site, cardiac pacing and defibrillation, including left ventricular pacing.
- An aspect of an embodiment (or partial embodiment thereof) of the present invention includes a lead that paces LV, RV, LA and RA at the same time or in sequence. It could even pace two separate points on the same chamber (the LV or the RV) at the same time or at some offset. This has an important advantage, for example, if a region of tissue ever dies in heart attack, the present invention method can still pace from elsewhere.
- An aspect of an embodiment (or partial embodiment thereof) of the present invention may include placing a bipolar pacing lead through a subxiphoid incision and then channeling it back to a pacemaker. The procedure may evolve through three distinct stages. In the earliest stage, one would place the lead on the left ventricle and tunnel it underneath the pectoral muscle back to the chest wall where the pacemaker would normally be placed. In the second, one would place the lead back to the subxiphoid process, attach it to a battery that is positioned just on the outside of the xiphoid process and have it wirelessly communicate with the main pacemaker. Lastly one would place a button-like object right on the top of the left ventricle and then communicate wirelessly back to the main pacemaker. Still yet, another embodiment of the means and method of the invention may include having the battery, anode and cathode means all compounded on the end of the lead so that there would not be any need to have another excision to bring any of the components back out of the heart.
- An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises an epicardial pacing system. The system may comprise: an epicardial catheter configured to be disposed in the middle mediastinum of the thorax of a subject for use in electrical pacing of the heart at one or more locations on the epicardial surface. The epicardial pacing catheter comprising: a proximal portion, distal portion, and a longitudinal structure there between; and at least one electrode in communication with the distal portion, wherein the at least one electrode is insulated on at least one side to allow pacing of the heart without damage to adjacent anatomical structures.
- An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises a method for use with an epicardial pacing catheter. The method may comprise: disposing the epicardial pacing catheter in the middle mediastinum of the thorax of a subject; and pacing the heart at one or more locations with electrical energy from an at least one electrode; and at least partially insulating the electrical energy to allow pacing of the heart without damage to adjacent anatomical structures.
- The epicardial pacing system and related method includes an epicardial catheter configured to be disposed in the middle mediastinum of the thorax of a subject for use in electrical pacing (and/or other diagnostic or therapeutic procedure) of the heart at one or more locations on the epicardial surface. The epicardial pacing catheter may include at least one electrode whereby the electrode is insulated on at least one side to allow pacing of the heart without damage to adjacent anatomical structures.
- These and other objects, along with advantages and features of the invention disclosed herein, will be made more apparent from the description, drawings and claims that follow.
- The accompanying drawings, which are incorporated into and form a part of the instant specification, illustrate several aspects and embodiments of the present invention and, together with the description herein, serve to explain the principles of the invention. The drawings are provided only for the purpose of illustrating select embodiments of the invention and are not to be construed as limiting the invention.
-
FIG. 1 schematically illustrates the overall configuration of the epicardial pacing catheter system. -
FIG. 2 schematically illustrates the pericardium and heart alone (FIG. 2(A) ) and an example embodiment in position relative to the heart (FIG. 2(B) ). -
FIG. 3 schematically illustrates an example embodiment passively disposed within the pericardial sack of the heart. - FIGS. 4(A)-(C) schematically illustrate a number of exemplary embodiments of the steering means employed to position the distal portion of an exemplary embodiment of the epicardial pacing catheter in un-tensioned, partial steering, and full steering modes, respectively.
-
FIGS. 5(A)-5(D) schematically illustrate a number of exemplary embodiments of theepicardial pacing catheter 10 near the distal portion. -
FIGS. 6(A)-6(F) schematically illustrate cross sectional views of an exemplary embodiment of the technology from the most distal end to a more proximal point. -
FIGS. 7(A) and (B) schematically illustrate cross sectional views of an exemplary embodiment of the most proximal portion of an exemplary embodiment of the epicardial pacing catheter and the most distal portion of an exemplary embodiment of the control means, respectively. - FIGS. 8(A)-(C) schematically illustrate cross-sectional views of an example embodiment further comprising a stabilization means for stabilizing the example embodiment. The stabilization means illustrated in an un-deployed position, partially deployed position, and deployed position, respectively.
-
FIG. 9 schematically illustrates an example embodiment of the epicardial pacing catheter further comprising deployable electrodes fixed or adjacent to the heart. -
FIG. 10(A) schematically illustrates a top view of an exemplary embodiment of the epicardial pacing catheter. -
FIG. 10(B) schematically illustrates a bottom view of an exemplary embodiment of the epicardial pacing catheter. -
FIG. 10(C) schematically illustrates an axial view of an exemplary embodiment of the epicardial pacing catheter looking at the distal tip of the insulating hood. -
FIG. 10(D) schematically illustrates a perspective view of an exemplary embodiment of the epicardial pacing catheter. -
FIG. 11(A)-11(E) schematically illustrate cross sectional views of an exemplary embodiment of the epicardial pacing catheter from a point located proximal to the at least one electrode and distal to the distal point of curvature to a point located at the most proximal point of the epicardial pacing catheter.FIG. 11(F) schematically illustrates a cross sectional view of an exemplary embodiment of the control handle at the most distal point. -
FIG. 12(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in an un-deployed state. -
FIG. 12(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in a fully-deployed state. -
FIG. 13(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable screw or the like in an un-deployed state. -
FIG. 13(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable screw or the like in a fully-deployed state. -
FIG. 14(A) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in an un-deployed state. -
FIG. 14(B) schematically illustrates a cross section of an exemplary embodiment of the epicardial pacing catheter comprising a deployable anode and cathode in a fully-deployed state. -
FIG. 15(A) schematically illustrates an example embodiment of an external control handle. -
FIG. 15(B) schematically illustrates an example embodiment of the proximal steering control means or a least part of the steering control means integral to the control handle. -
FIG. 15(C) schematically illustrates an example embodiment wherein the proximal steering control means or a least part of the steering control means integral to the control handle has been activated. - The following detailed description is of the best presently contemplated modes of carrying out the invention. This description to be taken in a limiting sense, but is made merely for the purpose of illustrating general principles of embodiments of the invention.
-
FIG. 1 schematically illustrates an overview of an exemplary embodiment of theepicardial pacing system 5 comprising anepicardial pacing catheter 10 in communication with at least oneelectrode 43, a control means or control handle 150, aninterface member 162, aprocessor 164 or computer,power supply 166 or battery, or voice control instrumentation/system 168. - The control means 150 may be in communication with the proximal portion of the
catheter 10, wherein the control means 150 is controllably connected to at least oneelectrode 43. In one embodiment, the control means may be a control handle or controller as desired or required. In another embodiment, the control handle (or control means) may be removable. Theepicardial pacing catheter 10 may further comprises aprocessor 164 or computer. Theprocessor 164 may be in communication with saidepicardial pacing catheter 10 and system. Theprocessor 164 may be located at or near the patient's shoulder, for example. Theepicardial pacing catheter 10 further comprises aninterface member 162 in communication with saidepicardial pacing catheter 10. Theinterface member 162 may be in remote and/or local communication with theprocessor 164, pacingsystem 5,catheter 10,controller 150,power supply 166, and/or voice control instrumentation to provide information to and/or from a patient, physician, technician, or a clinician. Further, any of the components and systems illustrated inFIG. 1 may be in communication with each other, as well as other systems, computers, devices, printers, displays, PDAs, networks, memory storage, and voice control instrumentations as desired or required. - As discussed, the
epicardial pacing system 5 may comprise apower supply 166. Thepower supply 166 may comprise a small battery located at the subxiphoid area, preferably of a silicone silver-gallium kind designed specifically for use in implantable cardiac defibrillators (ICDs). The power characteristics of the particular battery may be such that it can maintain the same voltage for a long period of time before falling off suddenly. - The
epicardial pacing system 5 andepicardial pacing catheter 10 may further comprise a wireless communication system, wherein theprocessor 164,power supply 166,voice control instrumentation 168,interface member 162 or desired components of thesystem 5 may be wirelessly connected to one another. In another embodiment, the battery andprocessor 164 are both located in the subxiphoid area. - It should be appreciated that any of the components or modules referred to with regards to any of the present technology embodiments discussed herein, may be integrally or separately formed with one another. Further, redundant functions or structures of the components or modules may be implemented. Moreover, the various components may be communicated locally and/or remotely with any user/clinician/patient or machine/system/computer/processor. Moreover, the various components may be in communication via wireless and/or hardwire or other desirable and available communication means, systems and hardwares.
- Next, as will be illustrated in Figures that follow, the
epicardial pacing catheter 10 in accordance with the present technology may comprise a proximal portion, a distal portion, and a longitudinal structure there between. It should be appreciated that the distal portion may be considered at the distal end tip of theepicardial pacing catheter 10; or a portion or segment at or in the vicinity of the distal end tip of theepicardial pacing catheter 10 or a portion or segment leading up to (or partially up to but not all the way up to) the distal end of thecatheter 10 as desired or required. The length and location of the distal portion may vary as desired or required in order to practice the technology according to medical procedures and anatomical considerations. - It should also be appreciated that the proximal portion may be considered the tip of the beginning of the
catheter 10; or a portion or segment at or in the vicinity of the proximal end of thecatheter 10 or a portion or segment leading up to (or partially up to but not all the way up to) the proximal end of thecatheter 10 as desired or required. The length and location of the proximal portion may vary as desired or required in order to practice the technology according to medical procedures and anatomical considerations. - The proximal portion, distal portion and longitudinal structure there between may be integrally formed from a biocompatible material having requisite strength and flexibility for deployment within a patient. The proximal portion, distal portion, and longitudinal structure there between may have a lubricious outer surface comprising a material having a low coefficient of friction, such as, but not limited to, silicone, polyurethane, or Teflon, or combination thereof. The proximal portion, distal portion, and longitudinal structure there between may further have an outer surface comprising a drug eluting surface and/or a surface impregnated with sirilimus to prevent the production of fibrosis within a patient. The longitudinal structure may be between about 15 cm and about 100 cm in length, and between about 2 mm and about 6 mm in diameter. It should be appreciated that the length of the longitudinal structure may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations. The cross section of the longitudinal structure comprises an oval, circle, ellipse, polygon, or semi-circular shape. The longitudinal structure may be any one of: lumen, conduit, channel, passage, pip, tunnel or bounded tubular surface.
- The
epicardial pacing catheter 10 further comprises at least oneelectrode 43 in communication with the distal portion, wherein the at least oneelectrode 43 is insulated on at least one side to allow pacing of the heart without damage to adjacent structures. - The at least one
electrode 43 may be constructed of platinum, gold, silver, iridium, or any alloy thereof, or other conducting materials known in the art. The at least oneelectrode 43 may comprise a roughened, profiled, or otherwise prepared surface to increase the total surface area for energy transmission. The at least oneelectrode 43 may be semi-cylindrical or arc-like in shape, and may be contoured to be compatible with proximate anatomical structures. The at least oneelectrode 43 may be between about 0.3 mm and about 4 mm in length, and may be spaced between about 1 mm and about 25 mm from each other. Further, the at least oneelectrode 43 may be a pair of electrodes, commonly referred to as an anode and cathode in the art. Finally, the at least oneelectrode 43 may be deployable. It should be appreciated that the length of the electrodes may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations. - It should be appreciated that the various sheaths, catheters and guidewires, or any related components disclosed herein, may have a circular or oval-shaped cross-section or various combinations thereof. Further, it should be appreciated that various sheaths, catheters and guidewires, or any related components disclosed herein may have any variety of cross sections as desired or required for the medical procedure or anatomy.
- Moreover, it should be appreciated that any of the components or modules referred to with regards to any of the present invention embodiments discussed herein, may be a variety of materials and/or composites as necessary or required. Still further, it should be appreciated that any of the components or modules (or combination thereof) may provide shape, size and volume contoured by adjusting its geometry and flexibility/rigidity according to the target location or anatomy (or region, including structure and morphology of any location) being treated.
-
FIG. 2(A) schematically illustrates the pericardium and heart alone. Thepericardium 22 is shown in close proximity to theepicardium 23. -
FIG. 2(B) schematically illustrates three contiguous sections of an example embodiment implanted around theheart 21. Theepicardial pacing catheter 10 of theepicardial pacing system 5 is positioned in the pericardial space, cavity or sack 24, or the area between thepericardium 22 andepicardium 23. All of theelectrodes 43 are facing theheart 21. Theepicardial pacing catheter 10 further comprises outward facingbumper tabs 31 and inward facingfriction tabs 32 to stabilize theepicardial pacing catheter 10 from moving within thepericardial sack 24, once it is implanted. - Although not shown, an aspect of an embodiment of the present technology may be implemented with an access needle (introducer needle), conduit or the like. The access needle or conduit is adapted to be inserted into the epicardial region or other body part or body space so as to provide an access or guideway for the
epicardial pacing catheter 10. An example of an access system is disclosed in PCT International Application No. Serial No. PCT/US2008/056643, filed Mar. 12, 2008, entitled, āAccess Needle Pressure Sensor Device and Method of Use,ā of which is hereby incorporated by reference herein in its entirety. See for example, but not limited thereto, FIGS. 2 and 5 of the '056643 PCT Application. The access needle sensor device or the like serves as a guideway for introducing other devices into thepericardium 22, for instance, sheath catheters that might subsequently be employed for procedures within thepericardium 22 or other applicable regions, space or anatomy. Other devices that the access device may accommodate with the practice of this invention include, but are not limited thereto, the following: ablation catheters, guide wires, other catheters, visualization and recording devices, drugs, and drug delivery devices, lumens, steering devices or systems, drug or cell delivery catheters, fiber endoscopes, suctioning devices, irrigation devices, electrode catheters, needles, optical fiber sensors, sources of illumination, vital signs sensors, and the like. These devices may be deployed for procedures in an integral body part or space. - It should be appreciated that any data, feedback, readings, or communication from the system (for example, catheters, access needles, sensors, systems, etc.) may be received by the user, clinician, physician, or technician or the like by visual graphics, audible signals (such as voice or tones, for example) or any combination thereof. Additionally, the data, feedback, or communication may be reduced to hard copy (e.g., paper) or computer storage medium. It should be appreciated that the pressure related readings and data may be transmitted not only locally, but remotely as well.
- Moreover, an aspect of the invention may be in the field of voice control over medical systems and devices of use in specialized electrophysiology procedures that employ subxiphoid access for the purpose of navigating an interventional or surgical probe onto the epicardial surface of the heart, via pericardial transit. In its most particular form, the invention may be in the specialized category of voice control over instruments and systems that measure the intrathoracic and intrapericardial pressures during the process of navigating said intrathoracic or surgical probe within the patient following subxiphoid insertion.
- An aspect of an embodiment or partial embodiment of the subject invention (or combinations of various embodiments in whole or in part of the present invention) is one of providing the working electrophysiologist with a means and method for controlling the operational parameters (e.g., the display functions) of diagnostic and therapeutic cardiological equipment by voice, thus eliminating either the need to temporarily take their hands off the patient or the need to have an additional EP Lab technician available to perform such tasks. (Such personnel are often needed to insure that the clinician need never touch anything outside the sterile field.). Generally, examples of voice control instrumentation that teach applications in medical applications but not in electrophysiological approaches to cardiological problems include U.S. Pat. Nos. 7,286,992; 7,259,906; 7,247,139; 6,968,223; 6,278,975; 5,970,457; 5,812,978; 5,544,654 and 5,335,313, all of which are hereby incorporated by reference in their entirety.
- Additionally, present invention system and method may further comprise imaging said the access needle and the epicardial pacing system (and components thereof) with at least one of magnetic resonance imaging, computed tomography, fluoroscopy, or other radiological modalities. In some embodiments, readings are provided from said sensing of pressure for navigating said needle access and the epicardial pacing system (and components thereof).
- Although not shown, as mentioned above, the deploying of the
epicardial pacing catheter 10 into thepericardial sack 24 may be minimally invasive, non-surgical, and/or interventional. The deploying of theepicardial pacing catheter 10 may be performed by a non-surgeon and/or cardiologist through use of an access needle and subsequent passage of a guidewire. The access needle may first be inserted through the chest and into thepericardium 22, with the guidewire then put in place. Theepicardial pacing catheter 10 may then be coaxially slid over the guidewire to access thepericardial sack 24. - Although not shown and involving another approach, the insertion of a sheath into the
pericardial sack 24 may be aided by the use of an access needle and subsequent passage of a guidewire. The access needle may first be inserted into the epicardium, with the guidewire then put in place. The sheath may then be coaxially slid over the guidewire to access thepericardial sack 24. After positioning the sheath in the desired location, theepicardial pacing catheter 10 may then be inserted through the sheath to reach theepicardium 23. - For example, the guideway provides coaxial alignment for the at least one of guide wire, sheath or catheter, which can be inside or outside the needle. The at least one guide wire, sheath, or catheter can also be coaxially aligned with one another. Further, multiple lumens may be implement and configured between the plurality of distal apertures and plurality proximal apertures. It should be appreciated that coaxial alignment does not need to be exact, but rather one conduit, lumen, sheath, or guidewire slid outside or inside of another.
- For example, with the present technology, an epicardial access needle-stick may be implemented in the subxiphoid area of the chest and the
epicardial pacing catheter 10 only need be advanced a short distance to get to theheart 21. However, it may immediately be steered though an acute angle to avoid the heart itself Because of this, aspects of the present invention devices and those used in conventional techniques can be contrasted. For instance, conventional endocardial catheters may typically be up to 100 cm in length or longer since they must go from the shoulder to the heart, while an embodiment of the present technology could be, for example, about 20 cm or less since it may only need to go from the chest to the heart. It should be appreciated that the length may be greater than about 20 cm as well. It should be appreciated that the length of the present invention catheter may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations. - It should be appreciated that as discussed herein, a subject may be a human or any animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g. rat, dog, pig, monkey), etc. It should be appreciated that the subject may be any applicable human patient.
-
FIG. 3 schematically illustrates an example embodiment of theepicardial pacing catheter 10 of theepicardial pacing system 5 passively disposed within the pericardial sack 24 (shown with hash marks) of theheart 21. A cross section of the heart is shown, revealing critical internal structures, including various great vessels. Theepicardial pacing catheter 10 may be used to pace the left ventricle, right ventricle, right atrium, and left atrium. It should be appreciated that the present technology may be used to pace the left ventricle, left atrium, right atrium, right ventricle and/or any combination thereof. Theepicardial pacing catheter 10 may first be inserted into thepericardium 22 at theinsertion point 33, which may be located at an anterior portion (towards the sternum) of thepericardium 22, adjacent to the left ventricle. The catheter is then advanced posteriorly (towards the spine) within thepericardial sack 24 towards the left atrium, right atrium and transverse sinus. The catheter is further advanced around the posterior of the heart, and pushed anteriorly toward the right ventricle. Once the catheter is in contact with the left ventricle, right ventricle, right atrium and left atrium, a deployable stabilization means may be deployed. Both outward facingbumper tabs 31 and inward facingfriction tabs 32 are shown, and prevent the catheter from moving or slipping. The inwardfacing friction tabs 32 may interact with the outside wall of structures such as, but not limited to, the transverse sinus, superior vena cava, right inferior pulmonary vein, and the right superior pulmonary vein to prevent the catheter from dislodging. The outwardfacing bumper tabs 31 may push on the pericardium to further secure thecatheter 10 against the epicardium (for example, as shown inFIG. 2 ). - FIGS. 4(A)-(C) provide schematic illustrations of some of the operational aspects of an exemplary embodiment of the steering means, system or device associated with the
epicardial pacing catheter 10 of the epicardial pacing system. Theepicardial pacing catheter 10 further comprises a distal steering means (not shown) and a proximal steering means (not shown) which may have the steering characteristics taught by Mahapatra et al. in PCT International Application No. PCT/US2008/056816, filed Mar. 13, 2008, entitled, āEpicardial Ablation Catheter and Method of Use,ā hereby incorporated by reference herein in its entirety. The steering means may comprise guidewires, tensioning lines, pull strings, digitating distal tips, magnetic guidance means, wires, rods, chains, bands, chords, ropes, string tubes, filaments, threads, fibers, strands, other extended elements, or any other method known in the art. - For instance, referring to FIGS. 4(A)-(C) of '056816 PCT International Application, there is provided the mechanism of action for obtaining bi-directional steering of the distal tip or portion that may be implemented for the present invention via tensioning or steering means whereby the tip or end is straight, towards the left, and towards the right, respectively.
- Moreover, for instance and referring to FIGS. 7(A)-7(B) of '056816 PCT International Application there is provided some details of an exemplary mechanism of action for directional steering of the proximal segment of the device that may be implemented for the present technology.
- Steering adjustments are made along the proximal point of
curvature 42 and distal point ofcurvature 41 using the proximal steering means (as shown inFIG. 15(B) ) and distal steering means (not shown) respectively. The proximal point ofcurvature 42 may be located between about 1 cm and about 25 cm from the proximal end and the distal point ofcurvature 41 may be located between about 1 cm and about 20 cm from the distal end. It should be appreciated that the proximal and distal points of curvature may be located at other longer or shorter points and may be implemented as may be desired or required according to medical procedures, device/system operations and anatomical considerations. The steering means are used to direct theepicardial pacing catheter 10 through or navigate it within a patient's body. It should be noted that, while two steering means and points of curvature are shown, theepicardial pacing catheter 10 may further comprise a third and fourth steering means for steering theepicardial pacing catheter 10 around a third and fourth point of curvature. Moreover, though a bi-directional distal point ofcurvature 41 is shown, it should be appreciated that all points of curvature may be uni-directional, bi-direction, tri-direction, quadra-directional, or greater than quadra-directional. - Specifically,
FIG. 4(A) shows an embodiment of theepicardial pacing catheter 10 in the non-deflected state.FIG. 4(B) shows theepicardial pacing catheter 10 in a partially-deflected state.FIG. 4(C) shows theepicardial pacing catheter 10 in a fully-deflected state, as would be the case when it has been navigated into the pericardial space of a subject's heart, or other space or structure. In the fully-deflected state, the at least oneelectrode 43 is held against a patient's heart by the stabilization means, shown as the inward facingfriction tabs 32 and outward facingbumper tabs 31. - The devices, systems, compositions and methods of various embodiments of the invention disclosed herein may utilize aspects disclosed in the following references, applications, publications and patents. Similarly, the steering means, actuator means (as will be discussed below) and navigation means of the various embodiments of the invention disclosed herein may utilize aspects disclosed in the following references, applications, publications and patents, and which are hereby incorporated by reference herein in their entirety:
- 1. U.S. Patent Application Publication No. 20050251094, Nov. 10, 2005, āSystem and method for accessing the coronary sinus to facilitate insertion of pacing leadsā, Peterson, Eric D.
- 2. U.S. Patent Application Publication No. 20040147826, Jul. 29, 2004, āSystem and method for accessing the coronary sinus to facilitate insertion of pacing leadsā, Peterson, Eric D.
- 3. U.S. Pat. No. 6,928,313, Aug. 9, 2005, āSystem and method for accessing the coronary sinus to facilitate insertion of pacing leadsā, Peterson, Eric D.
- 4. U.S. Pat. No. 7,004,937, Feb. 28, 2006, āWire reinforced articulation segmentā, Lentz, David J., et al.
- 5. U.S. Patent Application Publication No. 20040024413, Feb. 5, 2004, āWire reinforced articulation segmentā, Lentz, David J., et al.
- 6. U.S. Patent Application Publication No. 20060064056, Mar. 23, 2006, āGuiding catheter assembly for embolic protection by proximal occlusionā, Coyle, James, et al.
- 7. U.S. Patent Application Publication No. 20030181855, Sep. 25, 2003, āPre-shaped catheter with proximal articulation and pre-formed distal endā, Simpson, John A., et al.
- 8. U.S. Pat. No. 6,869,414, Mar. 22, 2005, āPre-shaped catheter with proximal articulation and pre-formed distal endā, Simpson, John A., et al.
- 9. U.S. Patent Application Publication No. 20080262432, Oct. 23, 2008, āSystem and method for manipulating a guidewire through a catheterā, Miller, Sean.
- 10. U.S. Patent Application Publication No. 20070016068, Jan. 18, 2007, āUltrasound methods of positioning guided vascular access devices in the venous systemā, Grunwald, Sorin, et al.
- 11. U.S. Patent Application Publication No. 20070016070, Jan. 18, 2007, āEndovascular access and guidance system utilizing divergent beam ultrasoundā, Grunwald, Sorin, et al.
- 12. U.S. Patent Application Publication No. 20070016072, Jan. 18, 2007, āEndovenous access and guidance system utilizing non-image based ultrasoundā, Grunwald, Sorin, et al.
- 13. U.S. Pat. No. 5,916,194, Jun. 29, 1999, āCatheter/guide wire steering apparatus and methodā, Jacobsen, Stephen C., et al.
- 14. U.S. Patent Application Publication No. 20070016069, Jan. 18, 2007, āUltrasound sensorā, Grunwald, Sorin, et al.
- 15. U.S. Pat. No. 6,500,130, Dec. 31, 2002, āSteerable guidewireā, Kinsella, Bryan, et al.
- 16. U.S. Patent Application Publication No. 20020082523, Jun. 27, 2002, Steerable guidewireā, Kinsella, Bryan, et al. . . .
- 17. U.S. Patent Application Publication No. 20060025705, Feb. 2, 2006, āMethod for use of vascular guidewireā, Whittaker, David R., et al.
- 18. U.S. Patent Application Publication No. 20050020914, Jan. 27, 2005, āCoronary sinus access catheter with forward-imagingā, Amundson, David, et al.
- 19. U.S. Patent Application Publication No. 20040034365, Feb. 19, 2004, āCatheter having articulation systemā, Lentz, David J., et al.
- 20. U.S. Patent Application Publication No. 20060064058, Mar. 23, 2006, āGuiding catheter with embolic protection by proximal occlusionā, Coyle, James.
- 21. U.S. Patent Application No. 20080097399, āCatheter with adjustable stiffness, Sachar, Ravish, et al.
- 22. U.S. Patent Application Publication No. 20080051671, Feb. 28, 2008, āIntravascular filter monitoringā, Broome, Thomas E., et al.
- 23. U.S. Pat. No. 6,616,676, Sep. 9, 2003, āDevices and methods for removing occlusions in vesselsā, Bashiri, Mehran, et al.
- 24. U.S. Patent Application Publication No. 20020072737, Jun. 13, 2002, āSystem and method for placing a medical electrical leadā, Belden, Elisabeth L., et al.
- 25. U.S. Pat. No. 7,004,937, Feb. 28, 2006, āWire reinforced articulation segmentā, Lentz, David J., et al.
- 26. U.S. Patent Application Publication No. 20040024413, Feb. 5, 2004, āWire reinforced articulation segmentā, Lentz, David J, et al.
- 27. U.S. Patent Application Publication No. 20060064056, Mar. 23, 2006, āGuiding catheter assembly for embolic protection by proximal occlusionā, Coyle, James, et al.
- 27. U.S. Pat. No. 6,869,414, Mar. 22, 2005, āPre-shaped catheter with proximal articulation and pre-formed distal endā, Simpson, John A., et al.
- 28. U.S. Patent Application Publication No. 20070016068, Jan. 18, 2007, āUltrasound methods of positioning guided vascular access devices in the venous systemā, Grunwald, Sorin, et al.
- 28. U.S. Patent Application Publication No. 20070016070, āEndovascular access and guidance system utilizing divergent beam ultrasoundā, Grunwald, Sorin, et al.
- 29. U.S. Patent Application Publication No. 20070016072, āEndovenous access and guidance system utilizing non-image based ultrasoundā, Grunwald, Sorin, et al
- 30. U.S. Patent Application Publication No. 20080262432, Oct. 23, 2008, āSystem and method for manipulating a guidewire through a catheterā, Miller, Sean.
- 31. U.S. Patent Application Publication No. 20070016069, Jan. 18, 2007, āUltrasound sensorā, Grunwald, Sorin.
- 32. U.S. Patent Application Publication No. 20060025705, Feb. 2, 2006, āMethod for use of vascular guidewireā, Whittaker, David R., et al.
- 33. U.S. Patent Application Publication No. 20030181855, Sep. 25, 2003, āPre-shaped catheter with proximal articulation and pre-formed distal endā, Simpson, John A., et al.
- 34. U.S. Patent Application Publication No. 20050020914, Jan. 27, 2005, āCoronary sinus access catheter with forward-imagingā, Amundson, David, et al.
- 35. U.S. Pat. No. 5,916,194, Jun. 29, 1999, āCatheter/guide wire steering apparatus and methodā, Jacobsen, Stephen C., et al.
- 36. U.S. Patent Application Publication No. 20060064058, Mar. 23, 2006, āGuiding catheter with embolic protection by proximal occlusionā, Coyle, James.
- 37. U.S. Patent Application Publication No. 20040186507, Sep. 23, 2004, āStent delivery system and method of useā, Hall, Todd A., et al.
- 38. U.S. Patent Application Publication No. 20050027243, Feb. 3, 2005, āSteerable catheterā, Gibson, Charles A.
- 39. U.S. Pat. No. 7,232,422, Jun. 19, 2007, āSteerable catheterā, Gibson, Charles A., et al.
- 40. U.S. Patent Application Publication No. 20060247522, Nov. 2, 2006, āMagnetic navigation systems with dynamic mechanically manipulatable cathetersā, McGee, David L.
- 41. U.S. Pat. No. 6,783,510, Aug. 31, 2004, āSteerable catheterā, Gibson, Charles A., et al.
- 42. U.S. Patent Application Publication No. 20080015625, Jan. 17, 2008, āShapeable for steerable guide sheaths and methods for making and using themā, Ventura, Christine P., et al.
-
FIGS. 5(A)-5(D) schematically illustrate a number of embodiments of theepicardial pacing catheter 10 of the epicardial pacing system near the distal portion. -
FIG. 5(A) schematically illustrates an exemplary embodiment wherein theepicardial pacing catheter 10 may be used to pace the left ventricle (LV) of a patient's heart. A number ofelectrodes 43 are adapted to transmit electrical energy to the left ventricle, and are shown facing the left ventricle. The number ofelectrodes 43 may vary depending on the number of locations required or desired to be paced. Theelectrodes 43 may be insulated on at least one side away from the heart, as to prevent electrical energy from being transmitted to proximate anatomical structures. The insulation may be about 2 mm thick, and may extend longitudinally through theepicardial pacing catheter 10. It should be appreciated that the thickness may be wider or narrower as desired or required according to medical procedures, device/system operations and anatomical considerations. Further, the insulation may comprise Teflon, silicone, polyurethane, and/or any combination thereof or any other non-conductive material known in the art. - Outward facing
bumper tabs 31 are deployable, and are used to stabilize theepicardial pacing catheter 10 by pushing against the pericardium. As shown, the outward facingbumper tabs 31 are in the non-deployed state as to allow theepicardial pacing catheter 10 to move within the pericardium. Although not shown, the epicardial pacing catheter may further comprise inward facingfriction tabs 32 or other stabilization means. - The
epicardial pacing catheter 10 further comprises adistal tip 51 in communication with theepicardial pacing catheter 10. Thedistal tip 51 extends from the body of thecatheter 10 and may further insulate theelectrodes 43 from proximate anatomical structures and/or be used to push through harder anatomical structures and adhesions as desired or required. -
FIG. 5(B) schematically illustrates an exemplary embodiment wherein theepicardial pacing catheter 10 may be used to pace the left ventricle (LV) and left atrium (LA) of a patient's heart.Additional electrodes 43 near the distal point ofcurvature 41 are shown. Theseelectrodes 43 may be in communication with the outside wall of the left atrium in order to pace said structure. Additional outward facingbumper tabs 31 are present to press against the pericardium in more distal locations. Inward facingfriction tabs 32 are now shown. The inwardfacing friction tabs 32 may be deployed to catch, drag, stick to, or pull on adjacent anatomical structures to keep theepicardial pacing catheter 10 from moving.FIG. 5(B) shows an example embodiment wherein both the inward facingfriction tabs 32 and outward facingbumper tabs 33 are in the non-deployed state to allow movement of thecatheter 10. -
FIG. 5(C) schematically illustrates an exemplary embodiment wherein theepicardial pacing catheter 10 may be used to pace the left ventricle (LV), left atrium (LA), and right atrium (RA).Additional electrodes 43 are located near the distal point ofcurvature 41. Theseelectrodes 43 may be in communication with the outside wall of the right atrium in order to pace said structure. Further, additional outward facingbumper tabs 31 are present to press against the pericardium in more distal locations. -
FIG. 5(D) shows an example embodiment wherein theepicardial pacing catheter 10 may be used to pace multiple points on the left ventricle (LV), left atrium (LA), right atrium (RA), and right ventricle (RV).Additional electrodes 43 are shown in a more distal location in order to transmit electrical energy to the right ventricle. Further, additional inward facingbumper tabs 32 are present to catch, drag, stick to, or pull on adjacent anatomical structures to keep theepicardial pacing catheter 10 from moving. - It should be appreciated that in
FIGS. 5(A)-5(D) both the number of inward facingfriction tabs 32 and outward facingbumper tabs 31 may vary as desired or required to stabilize theepicardial pacing catheter 10. Moreover, inward facingfriction tabs 32 may be located proximal or distal to any outward facingbumper tab 31. Further, outward facingbumper tabs 31 may be located proximal or distal to any inward facingfriction tab 32. Further, outward facingbumper tabs 31 and inward facingfriction tabs 32 may be positioned at the same location on theepicardial pacing catheter 10 as desired or required. - It should be appreciated that in
FIGS. 5(A)-5(D) any number ofelectrodes 43 may be present as desired or required to pace a number of locations on the heart of a patient. Moreover, eachelectrode 43 could be turned on separately in a unipolar or bipolar fashion, allowing for pacing of different chambers and different parts of the same chamber at different times. This has an important advantage: if a region of tissue ever dies in heart attack, pacing can be accomplished from a different location. - It should be appreciated that the inward facing friction tabs and outward facing bumper tabs may be alternated with one another, be staggered with one another, or grouped in numbers among each other as desired or required according to medical procedures, device/system operations and anatomical considerations.
-
FIGS. 6(A)-6(F) schematically illustrate cross sectional views of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system from the most distal end to a more proximal point. -
FIG. 6(A) schematically illustrates a cross sectional view of an exemplary embodiment of the most distal portion of theepicardial pacing catheter 10 of the epicardial pacing system. Theepicardial pacing catheter 10 further comprises afluid lumen 61. The fluid lumen occupies internal cross-sectional area of theepicardial pacing catheter 10. Thefluid lumen 61 may extend from an aperture (not shown) in the proximal end of thecatheter 10 to adistal fluid aperture 55. Both thedistal fluid aperture 55 and a proximal fluid aperture (not shown) are adapted for the emitting and extracting of a fluid, drug, or agent. The fluid, drug, or agent may be used, but is not necessarily used, to cool theelectrodes 43, regulate heart activity, or distend proximal anatomical structures. The proximal fluid aperture (not shown) is connected to an external fluid, drug, or agent source (not shown). The emitting and extracting of a fluid, drug, or agent may be controlled by an external control handle 150 (as shown, for example, inFIG. 15 ) in communication with the proximal end and fluid, drug, or agent source. It should be appreciated that the fluid, drug, or agent to flow through theepicardial pacing catheter 10 may be at least one of the following: agent, substance, material, saline solutions, thrombolytic agents, clot lysis agents, chemotherapies, cell slurries, gene therapy vectors, growth factors, contrast agents, angiogenesis factors, radionuclide slurries, anti-infection agents, anti-tumor compounds, receptor-bound agents and/or other types of drugs, therapeutic agent and/or diagnostic agent or any combination thereof. -
FIG. 6(B) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 of the epicardial pacing system located proximal to the distal point ofcurvature 41. Both the first distal steering pull-wire 68 and second distal steering pull-wire 69 occupy internal cross-sectional area of theepicardial pacing catheter 10 and extend longitudinally to the most proximal portion of saidcatheter 10. The first distal steering pull-wire 68 and second distal steering pull-wire 69 may be controllably connected to a control means (as shown, for example, inFIG. 15 ) in communication with the proximal portion of theepicardial pacing catheter 10. - The
epicardial pacing catheter 10 may further comprise a stabilization means. The stabilization means may be deployable and may comprise an inwardfacing friction tab 32, an outward facingbumper tab 31, a non-deployable protrusion, a screw, a hook, or other means known in the art. - In an example embodiment, a
tab deployment rod 64 extends longitudinally from the most proximal portion of theepicardial pacing lead 10 to the most distal inward facingfriction tab 32 or outward facingbumper tab 31. Thetab deployment rod 64 may be a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, or rope. Thetab deployment rod 64 made be made of a non-conductive material having high tensile strength as is known in the art. Thetab deployment rod 64 may further be controllably connected to a control means (as shown, for example, inFIG. 15 ) in communication with theepicardial pacing catheter 10, said control means used to control the deployment of the stabilization means. Further, thetab deployment rod 64 is in communication with a number oftab deployment arms 65, wherein eachtab deployment arm 65 can be actuated to deploy the inward facingfriction tab 32 or outward facingbumper tab 31. -
FIG. 6(C) schematically illustrates a more proximal cross section of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system. Theanode wire 62 extends longitudinally from the most proximal portion of theepicardial pacing catheter 10 to the mostdistal anode 63. Theanode wire 62 may be in communication with one ormore anodes 63 located throughout theepicardial pacing catheter 10. Further, theanode wire 62 is adapted for transmitting and receiving electrical energy. Theanode wire 62 may be controllably connected to a control means (as shown, for example, inFIG. 15 ) in communication with the proximal portion of theepicardial pacing catheter 10. - An outward facing
bumper tab 31 is shown in communication with theepicardial pacing catheter 10. The outwardfacing bumper tab 31 may be deployed by atab deployment arm 65 in communication with thetab deployment rod 64. -
FIG. 6(D) schematically illustrates a more proximal cross section of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system located proximal to the proximal point ofcurvature 42. Theepicardial pacing catheter 10 further comprises a second steering means. The second steering means comprises a first proximal steering pull-wire 70 and a second proximal steering pull-wire 71. Both the first proximal steering pull-wire 70 and second proximal steering pull-wire 71 occupy internal cross-sectional area of theepicardial pacing catheter 10 and extend longitudinally to the most proximal portion of saidcatheter 10. The first proximal steering pull-wire 70 and second proximal steering pull-wire 71 may be controllably connected to a control means (as shown, for example, inFIG. 15 ) in communication the proximal portion of theepicardial pacing catheter 10. -
FIG. 6(E) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 of the epicardial pacing system. Acathode wire 66 extends longitudinally from the most proximal portion of theepicardial pacing catheter 10 to the mostdistal cathode 67. Thecathode wire 66 may be in communication with one ormore cathodes 67 located throughout theepicardial pacing catheter 10. Further, thecathode wire 66 is adapted for transmitting and receiving electrical energy. Thecathode wire 66 may be controllably connected to a control means (as shown, for example, inFIG. 15 ) in communication with the proximal portion of theepicardial pacing catheter 10. -
FIG. 6(F) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 of the epicardial pacing system. An outward facingbumper tab 31 is shown in communication with theepicardial pacing catheter 10. The outwardfacing bumper tab 31 may be deployed by atab deployment arm 65 in communication with atab deployment rod 64. It should be appreciated that the number of port holes, lumens, wires or rods may vary as may be desired or required according to medical procedures, device/system operations and anatomical considerations. -
FIGS. 7(A) and 7(B) schematically illustrate a cross sectional view of an exemplary embodiment of theproximal end 73 of theepicardial pacing catheter 10 of the epicardial pacing system and the mostdistal end 74 of the control means 150 respectively. InFIG. 7(A) , twelve electrode wires, including sixanode wires 62 and sixcathode wires 66, occupy internal cross-sectional area of theepicardial pacing catheter 10. Eachanode wire 62 andcathode wire 66 extends longitudinally through theepicardial pacing catheter 10 towards the distal portion. Thecathode wire 66 may be in communication with one ormore cathodes 67 located throughout theepicardial pacing catheter 10. Theanode wire 62 may be in communication with one ormore anodes 63 located throughout theepicardial pacing catheter 10. - It should be appreciated that any number of
electrodes 43, otherwise known asanodes 63 andcathodes 67, may be present as desired or required to pace a number of locations on the heart of a patient. Asingle anode wire 62 may be used to provide electrical energy to a multitude ofanodes 63, or eachanode wire 62 can provide electrical energy to asingle anode 63. Asingle cathode wire 66 may be used to provide electrical energy to a multitude ofcathodes 67, or eachcathode wire 66 can provide electrical energy to asingle cathode 67. Moreover, electrical energy can be transmitted to eachelectrode 43 separately in a unipolar or bipolar fashion, allowing for pacing of different chambers and different parts of the same chamber at different times. - Further, a first proximal steering pull-
wire 70, first distal steering pull-wire 68, second proximal steering pull-wire 71, and second distal steering pull-wire 69 occupy internal cross-sectional area of theepicardial pacing catheter 10. Each first proximal steering pull-wire 70, first distal steering pull-wire 68, second proximal steering pull-wire 71, and second distal steering pull-wire 69 extends longitudinally through theepicardial pacing catheter 10 towards the distal portion. Each first proximal steering pull-wire 70, first distal steering pull-wire 68, second proximal steering pull-wire 71, and second distal steering pull-wire 69 may comprise guidewires, tensioning lines, pull strings, digitating distal tips, magnetic guidance means, wires, rods, chains, bands, chords, ropes, string tubes, filaments, threads, fibers, strands, other extended elements, or any other method known in the art. - Further, a first
tab deployment rod 64 and secondtab deployment rod 72 occupy internal cross-sectional area of theepicardial pacing catheter 10. Each firsttab deployment rod 64 and secondtab deployment rod 72 extends longitudinally from the mostproximal portion 73 of theepicardial pacing lead 10 to the most distal inward facingfriction tab 32 or outward facingbumper tab 31. The firsttab deployment rod 64 and secondtab deployment rod 72 may comprise a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, magnetic guidance means, chains, bands, chords, or rope. The firsttab deployment rod 64 and secondtab deployment rod 72 may comprise a non-conductive material having high tensile strength as is known in the art. The firsttab deployment rod 64 and secondtab deployment rod 72 may further be controllably connected to thedistal end 74 of a control means 150 in communication with theproximal end 73 of theepicardial pacing catheter 10, said control means used to control the deployment of the tabs. - It should be noted that, while a first
tab deployment rod 64 and secondtab deployment rod 72 are shown, any number of tab deployment rods may be present as desired or required, up to an including the sum of inward facingfriction tabs 32 and outward facing bumper tabs 31 (See FIGS. 6(A)-(E)). - Although not shown, in an example embodiment, a biocompatible cover may be in communication with the most
proximal end 73 of theepicardial pacing catheter 10. The biocompatible cover may prevent fibrosis from occurring around the exposed structures of theepicardial pacing catheter 10. - Although not shown, in an example embodiment, the
proximal end 73 of theepicardial pacing catheter 10 may be located just under the skin of a patient. Theproximal end 73 can be reached by a non-surgical, minimally-invasive incision of the skin, carried out by a clinician or cardiologist. - Although not shown, in an example embodiment, all structures beginning at the
proximal end 73 may protrude from saidproximal end 73 of theepicardial pacing catheter 10. In this way, theproximal end 73 could act as a male connector in a male-female connection. It should be appreciated that the corresponding male-female connection may be reversed as well. -
FIG. 7(B) shows a cross sectional view of an example embodiment of the mostdistal portion 74 of acontrol handle 150. In this particular embodiment, the control handle 150 can be controllably connected to the mostproximal portion 73 of theepicardial pacing catheter 10.Wire grippers 75 around each of the internal structures facilitate a secure connection between structures integral the control handle 150 and structures integral theepicardial pacing catheter 10. - Although not shown, in an example embodiment, all structures within the control handle 150 may end before the
distal end 74. In this way, thedistal end 74 can act as a female connector in a male-female connection. - It should be appreciated that the number of lumens, wires, rods or elements discussed with regards to
FIG. 7 may vary as may be desired or required according to medical procedures, device/system operations and anatomical considerations. - FIGS. 8(A)-(C) schematically illustrate cross-sectional views of an example embodiment wherein the
epicardial pacing catheter 10 further comprises a stabilization means for stabilizing theepicardial pacing catheter 10. The stabilization means may comprise at least one deployable member. The stabilization means allows the rotational orientation of the distal portion of theepicardial pacing catheter 10 to remain fixed in place relative to the surface of the heart. If the distal portion of theepicardial pacing catheter 10 were allowed to rotate so that theelectrodes 43 faced away from the heart, pacing could not be achieved and adjacent anatomical structures would receive harmful electronic energy. - FIGS. 8(A)-(C) illustrate an exemplary embodiment wherein the stabilization means is an inward
facing friction tab 32. The inwardfacing friction tab 32 comprises a catheter-side surface 82 and an anatomical-side surface 83. The anatomical-side surface 83 comprises a lubricious surface that may be navigated through anatomical structures without sticking or catching. The catheter-side surface 82 comprises a rough surface having a larger coefficient of friction than the anatomical-side surface. The catheter-side surface may further comprise a textured surface to increase friction. Both the catheter-side surface 82 and anatomical-side surface 83 comprise a non-conductive material, such as, but not limited to polyurethane, Teflon, silicone, a radio-opaque material, or similarly lubricious material, or other materials known in the art. -
FIG. 8(A) illustrates an exemplary embodiment wherein the stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the inward facingfriction tab 32. Though the stabilizer actuator is illustrated as atab deployment rod 64 in communication with a tab joint 84,tab hinge 81, andtab deployment arm 65, the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof. Further, the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, rope, pole, thread, filament, cord, strand or other means known in the art. The stabilizer actuator may further comprise a micro electrical mechanical system (MEMS). - In an embodiment, a
tab deployment rod 64 extends longitudinally from the most proximal portion of theepicardial pacing lead 10 to the most distal inward facingfriction tab 32. Thetab deployment rod 64 may be a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, pole, thread, filament, cord, strand or rope. Thetab deployment rod 64 made be made of a non-conductive material having high tensile strength as is known in the art. The tab deployment rod may further be controllably connected to a control means or control handle (as shown, for example, inFIG. 15 ) in communication with theepicardial pacing catheter 10 of theepicardial pacing system 5, and the control means may be used to control the deployment of the tabs. - The
tab deployment rod 64 is in communication with a tab joint 84, the tab joint 84 in connection with atab deployment arm 65 having its endpoint within the inward facingfriction tab 32. The tab deployment arm is in further communication with atab hinge 81. - When the inward facing
friction tab 32 is in the non-deployed state, theepicardial pacing catheter 10 may be moved, navigated, or slid within the middle mediastinum. In this way, theepicardial pacing catheter 10 can be inserted, placed, navigated or removed from the pericardial sack. -
FIG. 8(B) illustrates an embodiment wherein the stabilization means is an inwardfacing friction tab 32 in the partially-deployed state. When thetab deployment rod 64 is pushed toward the distal end of theepicardial pacing catheter 10, thetab deployment arm 65 is pulled or tensioned. This causes the inward facingfriction tab 32 to separate from the catheter body, exposing the rough catheter-side 82 to proximate anatomical structures. -
FIG. 8(C) illustrates an embodiment wherein the stabilization means is an inwardfacing friction tab 32 in the fully-deployed state. - Although not shown, the outward facing
bumper tabs 31 may be deployed using the same means and methods as described above. - Although not shown, the stabilization means may comprise one or more protrusions for engaging proximal anatomical structures such as the pericardium and/or the epicardium. The protrusions may be non-deployable. Further, the protrusions may comprise a non-conductive material, such as, but not limited to, silicone, polyurethane, Teflon, a radio-opaque material, or other materials known in the art.
- It should be appreciated that the hinge devices and joint devices may be a number of elements such as, but not limited thereto, a fulcrum, swivel, gear, elbow, pivot, thrust or the like.
- It should be appreciated that the tab devices may be a number of elements such as, but not limited thereto, finger, stud, post, tongue, spring, projection, pin, pedestal, extension, offset, knob, protuberance or the like.
-
FIG. 9 schematically illustrates an example embodiment of theepicardial pacing catheter 10 of the epicardial pacing system in relation to theheart 21 and further comprising at least one deployable member. Theepicardial pacing catheter 10 has been steered around its distal point ofcurvature 41, and is positioned in the pericardial space, cavity or sack 24, or the area between thepericardium 22 andepicardium 23. In an embodiment, the deployable member comprises at least oneelectrode 43, and eachelectrode 43 is facing theheart 21. Theelectrodes 43 may be deployed from theepicardial pacing catheter 10 and are fixed to the epicardium 23 when in the fully-deployed state. Theepicardial pacing catheter 10 may further comprises an insulatinghood 101 in communication with theepicardial pacing catheter 10. -
FIG. 10(A) schematically illustrates a top view of an example embodiment of theepicardial pacing catheter 10 of the epicardial pacing system. The epicardial pacing catheter further comprises a insulatinghood 101 extending from beyond the distal point ofcurvature 41 to adistal tip 51. The hood may serve as a cushioning and/or alignment means for thedistal tip 51 relative to adjacent anatomical structures. It should be appreciated that some portion of the distal tip shall have insulation to protect from adjacent anatomical structures. The shape of the distal tip and hood may vary according to medical procedures, device/system operations and anatomical considerations. -
FIG. 10(B) schematically illustrates a bottom view of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system. Ananode 63 andcathode 67 are shown in communication with theepicardial pacing catheter 10. In an embodiment, the contact zones containing theanode 63 andcathode 67 electrodes are about 2 mm in length and about 1 mm in width, and are located centrally within the underside surface of the insulatinghood 101. It should be appreciated that the width of the electrodes may be longer or shorter as may be desired or required according to medical procedures, device/system operations and anatomical considerations. The insulating hood extends from a distal location beyond the distal point ofcurvature 41 to adistal tip 51. -
FIG. 10(C) schematically illustrates an axial view of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system looking at thedistal tip 51 of the insulatinghood 101. Asingle electrode 43 can be seen on the underside of theepicardial pacing catheter 10. -
FIG. 10(D) schematically illustrates a side view of an exemplary embodiment of theepicardial pacing catheter 10 comprising an insulatinghood 101,distal tip 51, and twoelectrodes 43. The insulatinghood 101 extends over the side of theepicardial pacing catheter 10. - It should be appreciated that in FIGS. 10(A)-(D) any number of
electrodes 43 may be present as desired or required to pace any number of locations on the heart of a patient. Moreover, eachelectrode 43 could be powered separately in a unipolar or bipolar fashion, allowing for pacing of different parts of the same chamber at different times. -
FIG. 11(A)-11(E) schematically illustrate cross sectional views of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system from a point located proximal to the mostdistal anode 62 orcathode 67 and distal to the distal point ofcurvature 41 to a point located at the mostproximal point 73 of theepicardial pacing catheter 10.FIG. 11(F) schematically illustrates a cross sectional view of an exemplary embodiment of the external control handle 150 at the mostdistal point 74. -
FIG. 11(A) schematically illustrates a cross section of an example embodiment of theepicardial pacing catheter 10 located more distal than the distal point ofcurvature 41 and proximal to the mostdistal anode 62 orcathode 67. Ananode wire 62,cathode wire 66, electrode pull-wire 112, and second-electrode pull-wire 113 occupy internal cross-sectional area of theepicardial pacing catheter 10 and extend longitudinally to the mostproximal portion 73 of saidcatheter 10. Theanode wire 62,cathode wire 66, electrode pull-wire 112, and second-electrode pull-wire 113 may comprise longitudinal structures, such as, but not limited to, push-rods, pull-rods, wires, strings, or ropes. Further, theanode wire 62,cathode wire 66, electrode pull-wire 112, and second-electrode pull-wire 113 may be controllably connected to acontrol handle 150 in electrical communication with the mostproximal point 73 of theepicardial pacing catheter 10. - The
anode wire 62 and electrode pull-wire 112 extend longitudinally from the mostproximal portion 73 of theepicardial pacing catheter 10 to the mostdistal anode 63. Thecathode wire 66 and second electrode pull-wire 113 extend longitudinally from the mostproximal portion 73 of theepicardial pacing catheter 10 to the mostdistal cathode 67. -
FIG. 11(B) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 located at the distal point ofcurvature 41. Theepicardial pacing catheter 10 further comprises a first distal steering pull-wire 68 and a second distal steering pull-wire 69 fixed to distal steering anchors 110 in communication with theepicardial pacing catheter 10. The distal steering anchors 110 comprise a material with requisite strength to hold the first distal steering pull-wire 68 and second distal steering pull-wire 69 in place. The first distal steering pull-wire 68 and second distal steering pull-wire 69 occupy internal cross-sectional area of theepicardial pacing catheter 10 and extend longitudinally to the mostproximal point 73 of saidcatheter 10. The first proximal steering pull-wire 68 and second proximal steering pull-wire 69 may be controllably connected to acontrol handle 150 in communication with the mostproximal point 73 of theepicardial pacing catheter 10. -
FIG. 11(C) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 located between the distal point ofcurvature 41 and proximal point ofcurvature 42. -
FIG. 11(D) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 located at the proximal point ofcurvature 42. Theepicardial pacing catheter 10 further comprises a proximal steering pull-wire 70 fixed to aproximal steering anchor 111 in communication with theepicardial pacing catheter 10. Theproximal steering anchor 111 comprises a material with requisite strength to hold the proximal steering pull-wire 70. The proximal steering pull-wire 70 occupies internal cross-sectional area of theepicardial pacing catheter 10 and extends longitudinally to the mostproximal point 73 of saidcatheter 10. The proximal steering pull-wire 70 can be controllably connected to acontrol handle 150 or control means in communication with the mostproximal point 73 of theepicardial pacing catheter 10. -
FIG. 11(E) schematically illustrates a more proximal cross section of an example embodiment of theepicardial pacing catheter 10 located at the mostproximal point 73. - It should be noted that, while a
single anode wire 62, electrode pull-wire 112,cathode wire 66, and second electrode pull-wire 113 are shown, any number ofanode wires 62, electrode pull-wires 112,cathode wires 66, and second electrode pull-wires 113 may be present as desired or required, up to and including, for example, the total number of electrodes 43 (or the sum of theanodes 63 and cathodes 67). - Although not shown, in an example embodiment, a biocompatible cover may be in communication with the most
proximal end 73 of theepicardial pacing catheter 10. The biocompatible cover can prevent fibrosis from occurring around the exposed wires of theepicardial pacing catheter 10. - Although not shown, in an example embodiment, the
proximal end 73 of theepicardial pacing catheter 10 is located just under the skin of a patient (or location(s) as desired or required). Theproximal end 73 can be reached by a non-surgical, minimally-invasive incision of the skin, carried out by a clinician or cardiologist. - Although not shown, in an example embodiment, all structures beginning at the
proximal end 73 may protrude from saidproximal end 73 of theepicardial pacing catheter 10. In this way, theproximal end 73 could act as a male connector in a male-female connection. The male-female arrangement may be reversed if desired or required. -
FIG. 11(F) schematically illustrates a cross sectional view of an example embodiment of the mostdistal portion 74 of acontrol handle 150. In this particular embodiment, the control handle 150 can be controllably connected to the mostproximal portion 73 of theepicardial pacing catheter 10. Wire grippers 75 (or other retention means or devices) around each of the internal structures facilitate a secure connection between structures integral the control handle 150 and structures integral theepicardial pacing catheter 10. - Although not shown, in an example embodiment, all structures within the control handle or control means may end before the
distal end 74. In this way, thedistal end 74 can act as a female connector in a male-female connection (or female-male connection). -
FIG. 12(A) schematically illustrates a cross section of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system comprising a deployable stabilization means in an un-deployed state. The deployable stabilization means comprises ananode 63 andcathode 67 in communication with ahook 124. Thehook 124,anode 63, andcathode 67 comprise conductive materials, such as, but not limited to, copper, platinum, gold, silver or iridium, and/or alloys thereof. - The stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the
anode 63 andcathode 67 in communication with thehooks 124. Though the stabilizer actuator is illustrated as an electrode pull-wire 112 in communication with a joint 121, and hinge 122, the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof. Further, the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, rope, pole, thread, filament, cord, strand or other means known in the art. The stabilizer actuator may further comprise a micro electrical mechanical system (MEMS). - It should be appreciated that the hook devices may be a number of elements such as, but not limited thereto, pin, claw, latch, finger, stud, spring, post, tongue, projection, pin, pedestal, extension, offset, knob, protuberance or the like.
- In an embodiment, an electrode pull-
wire 112 extends longitudinally from the most proximal portion of theepicardial pacing lead 10 to the mostdistal electrode 43, which may comprise ananode 63 orcathode 67. The electrode pull-wire 112 is in communication with a joint 121, the joint 121 in further communication with ahinge 122. - In an embodiment, the electrode pull-
wire 112 may comprise a conductive material having high tensile strength as is known in the art. The electrode-pull wire 112 may further be controllably connected to a control means (for example, as shown inFIG. 15 ) in communication with theepicardial pacing catheter 10 and epicardial pacing system. The control means may be used to control the deployment of theanode 63 andcathode 67 in communication withhooks 124, and any of the devices, systems, subsystems, elements, and devices discussed throughout this disclosure. - In an embodiment, the
epicardial pacing catheter 10 further comprises an insulatingdistal tip 51 in communication with the epicardial pacing catheter. Theepicardial pacing catheter 10 further comprises a number ofbumpers 120 in communication with the bottom of theepicardial pacing catheter 10. In an approach, the bumpers enable theepicardial pacing catheter 10 to sit on the surface of the heart in a non-deployed state without allowing theanode 63 orcathode 67 to be in communication with the epicardium. - When the
deployable anode 63 andcathode 67 are in the non-deployed state, theepicardial pacing catheter 10 may be moved or navigated within the middle mediastinum. In this way, theepicardial pacing catheter 10 can be inserted, placed, navigated or removed from the pericardial sack. -
FIG. 12(B) schematically illustrates a cross section of an exemplary embodiment of theepicardial pacing catheter 10 comprising adeployable anode 63 andcathode 67 in a fully-deployed state. When the electrode pull-wire 112 is pushed toward the distal end of theepicardial pacing catheter 10, theanode 63 andcathode 67 are splayed outward to a 90 degree angle, or an angel(s) as desired or required. This causes theanode 63 andcathode 67 to separate from the catheter body, allowing thehooks 124 to engage proximate anatomical structures, such as the epicardial wall. When thedeployable anode 63 andcathode 67 are in the fully-deployed state, the rotational orientation of the distal portion of theepicardial pacing catheter 10 remains fixed in place relative to the surface of the heart. If the distal portion of theepicardial pacing catheter 10 were allowed to rotate so that theelectrodes 43 faced away from the heart, pacing could not be achieved and adjacent anatomical structures would receive harmful electronic energy. - It should be appreciated that in
FIGS. 12(A) and (B) any number ofdeployable electrodes 43 may be present as desired or required to pace any number of locations on the heart of a patient. - It should be appreciated that when the electrode pull-
wire 112 is pulled toward the proximal end of theepicardial pacing catheter 10, theanode 63 andcathode 67 are drawn back into place within thecatheter 10. -
FIG. 13(A) schematically illustrates a cross section of an exemplary embodiment of theepicardial pacing catheter 10 of the epicardial pacing system comprising a deployable stabilization means in an un-deployed state. The deployable stabilization means comprises a number ofscrews 130 in communication with ananode 63 andcathode 67. Thescrews 130,anode 63, andcathode 67 comprise conductive materials, such as, but not limited to, copper, platinum, gold, silver and/or iridium, and/or alloys thereof. - The stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the
screws 130 in communication with theanode 63 andcathode 67. Though the stabilizer actuator is illustrated as an electrode pull-wire 112 in communication with agear 131, the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof. Further, the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, rope, pole, thread, filament, cord, strand, or other means known in the art. The stabilizer actuator may further comprise a micro electrical mechanical system (MEMS). - It should be appreciated that the screw devices may comprise a number of elements such as, but not limited thereto, any translatable protrusion or extension for instance. Some non-limiting examples may include: toggle, press, slide, spring, stud, post, tongue, projection, pedestal, protuberance, contact, or the like.
- In an embodiment, an electrode pull-
wire 112 extends longitudinally from the most proximal portion of theepicardial pacing lead 10 to the mostdistal electrode 43, which may be ananode 63 orcathode 67. The electrode pull-wire 112 may be a longitudinal structure, such as, but not limited to, a push-rod, pull-rod, wire, string, or rope. The electrode pull-wire 112 may be made of a conductive material having high tensile strength as is known in the art. The electrode-pull wire 112 may further be controllably connected to a control means (as shown, for example, inFIG. 15 ) in communication with theepicardial pacing catheter 10 and epicardial pacing system. The control means may be used to control the deployment of thescrews 130 in communication with theanode 63 andcathode 67. - The
epicardial pacing catheter 10 further comprises an insulatingdistal tip 51 in communication with the epicardial pacing catheter. - When the
screws 130 are in the non-deployed state, theepicardial pacing catheter 10 may be moved or navigated within the middle mediastinum. In this way, theepicardial pacing catheter 10 can be inserted, placed, navigated, translated, rotated or removed from the pericardial sack. -
FIG. 13(B) schematically illustrates a cross section of an exemplary embodiment of theepicardial pacing catheter 10 comprising fully-deployedscrews 130 in communication with theanode 63 andcathode 67. When the electrode pull-wire 112 is pushed toward the distal end of theepicardial pacing catheter 10, thegears 131 are activated and thescrews 130 are rotationally-actuated. This causes thescrews 130 to engage proximate anatomical structures, such as the epicardial wall. When thescrews 130 are in the fully-deployed state, the rotational orientation of the distal portion of theepicardial pacing catheter 10 remains fixed in place relative to the surface of the heart. The electrical energy is transmitted from theanode 63 andcathode 67 through thescrews 130 and into the heart. - It should be appreciated that in
FIGS. 13(A) and (B) any number ofdeployable screws 130 may be present as desired or required to pace any number of locations on the heart of a patient. -
FIG. 14(A) schematically illustrates a cross section of an exemplary embodiment of theepicardial pacing catheter 10 epicardial pacing system comprising a deployable stabilization means in an un-deployed state. The deployable stabilization means comprises ananode 63 andcathode 67 in communication with ahook 124. Thehooks 124,anode 63, andcathode 67 comprise conductive materials, such as, but not limited to, copper, platinum, gold, silver and/or iridium, or alloys thereof. - The deployable stabilization means further comprises a stabilizer actuator, wherein said stabilizer actuator deploys the
anode 63 andcathode 67 in communication with thehooks 124. Though the stabilizer actuator is illustrated as an electrode pull-wire 112 and second electrode pull-wire 113 in communication with a number ofjoints 121, and hinges 122, the stabilizer actuator may comprise any longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof. Further, the longitudinal member may be, for example, a push-rod, pull-wire, wire, string, thread, filament, cord, strand, rope, pole, or other means known in the art. The stabilizer actuator may further comprise a micro electrical mechanical system (MEMS). - In an embodiment, an electrode pull-
wire 112 and second electrode pull-wire 113 extend longitudinally from the most proximal portion of theepicardial pacing lead 10 to the mostdistal anode 63 andcathode 67 respectively. The electrode pull-wire and second electrode pull-wire 113 are in communication with a number ofjoints 121, thejoints 121 in further communication with a number ofhinges 122. The electrode pull-wire 112 and second electrode pull-wire 113 may comprise longitudinal structures, such as, but not limited to, push-rods, pull-rods, wires, thread, filament, cord, strand, strings, or ropes. The electrode pull-wire 112 and second electrode pull-wire 113 may be made of a conductive material having high tensile strength as is known in the art. The electrode-pull wire 112 and second electrode pull-wire 113 may further be controllably connected to a control means (for example, as shown inFIG. 15 ) in communication with theepicardial pacing catheter 10 and epicardial pacing system. The control means may used to control the deployment of theanode 63 andcathode 67 in communication withhooks 124. - The
epicardial pacing catheter 10 further comprises an insulatingdistal tip 51 in communication with the epicardial pacing catheter. Theepicardial pacing catheter 10 may further comprise a number ofbumpers 120 in communication with theepicardial pacing catheter 10. Thebumpers 120 enable theepicardial pacing catheter 10 to sit on the surface of the heart in a non-deployed state without allowing theanode 63 orcathode 67 to communicate with the heart. - When the
deployable anode 63 andcathode 67 are in the non-deployed state, theepicardial pacing catheter 10 may be moved or navigated within the middle mediastinum. In this way, theepicardial pacing catheter 10 can be inserted, placed, navigated, translated, rotated or removed from the pericardial sack. -
FIG. 14(B) schematically illustrates a cross section of an exemplary embodiment of theepicardial pacing catheter 10 comprising adeployable anode 63 andcathode 67 in a fully-deployed state. When the electrode pull-wire 112 and second electrode pull-wire 113 are pulled toward the proximal end of theepicardial pacing catheter 10, theanode 63 andcathode 67 are splayed outward to a 90 degree angle. This causes theanode 63 andcathode 67 to separate from the catheter body, allowing thehooks 124 to engage proximate anatomical structures, such as the epicardial wall. When thedeployable anode 63 andcathode 67 are in the fully-deployed state, the rotational orientation of the distal portion of theepicardial pacing catheter 10 remains fixed in place relative to the surface of the heart. The electrical energy is transmitted from theanode 63 andcathode 67 through thehooks 124 and into the heart. - It should be appreciated that in
FIGS. 14(A) and (B) any number ofdeployable anodes 63 andcathodes 67 may be present as desired or required to pace any number of locations on the heart of a patient. - It should be appreciated that when the electrode pull-
wire 112 and second electrode pull-wire are pushed toward the distal end of theepicardial pacing catheter 10, theanode 63 andcathode 67 are drawn back into place within thecatheter 10. - It should be appreciated that regarding deployment discussed throughout, varying degrees of deployment may be achieved or implemented as desired or required.
-
FIG. 15(A) schematically illustrates an example embodiment of an external control handle 150 (that may be associated with, although not shown, the epicardial pacing catheter of the system). The epicardial pacing catheter and system further comprises a control means, wherein said control means is anexternal control handle 150. The external control handle 150 may be in communication with the mostproximal point 73 of theepicardial pacing catheter 10. The external control handle 150 may have integral to it the distal steering control means 154, the proximal control means 154, the irrigation control means (not shown) and the control means for the stabilization means 151. The stabilization control means 154 may be used to regulate the degree of extension of said stabilization means via a pull-wire or pushrod arrangement or some other suitable tensioning or actuating means know in the art. The external control handle 150 may further comprise a pull-rod control aperture 152, wherein atab deployment rod 64 and second tab deployment rod (not shown) may be inserted. - The external control handle 150 is preferably sized to be grasped, held and operated by a user. It should be appreciated that other control and operating interface members, devices, or means may be utilized for the handle. Attached to the proximal end of the control handle 150 is the handle proximal port (not shown) from which
anode wires 62 andcathode wires 67 extend in order to make electrical connections to diagnostic or electrical devices (not shown). Electrical wires (for example, shown inFIGS. 6 , 7, and 11) may extend through the proximal portion to each of theelectrodes 43 of theepicardial pacing catheter 10. -
FIG. 15(B) schematically illustrates an example embodiment of the proximal steering control means 153 integral to thecontrol handle 150. The proximal steering control means 153 is controllably connected to the first proximal steering pull-wire 70 and second proximal steering pull-wire 71. -
FIG. 15(C) schematically illustrates an example embodiment wherein the proximal steering control means 153 integral to the control handle 150 has been activated. As the proximal steering control means 153 is activated by a user, the first proximal steering pull-wire 70 becomes taught, and the second proximal steering pull-wire 71 loosens, creatingslack 155. Both the first proximal steering pull-wire 70 and second proximal steering pull-wire 71 extend longitudinally through the control handle 150, into theepicardial pacing catheter 10, and are anchored at the proximal point ofcurvature 42. As the first steering pull-wire 70 becomes taught, the epicardial pacing catheter bends toward the proximal steering anchor and around the proximal point ofcurvature 42. - For example, the control handle may have channels for the steering pull wires and thumb wheel knobs for tightening or loosening the pull wires.
- One skilled in the art can see that many other embodiments of means and methods for using the
epicardial pacing catheter 10 of the epicardial pacing system according to the technique of the technology, and other details of construction and use thereof, constitute non-inventive variations of the novel and insightful conceptual means, system and technique which underlie the present invention. - The devices, systems, compositions, computer program products, and methods of various embodiments of the invention disclosed herein may utilize aspects disclosed in the following references, applications, publications and patents and which are hereby incorporated by reference herein in their entirety:
- 1. U.S. Pat. No. 6,973,352 B1 to Tsutsui, D., et. al., entitled āSteerable Cardiac Pacing and Sensing Catheter and Guidewire for Implanting Leadsā, Dec. 6, 2005.
- 2. U.S. Pat. No. 7,264,587 B2 to Chin, A., entitled āEndoscopic Subxiphoid Surgical Proceduresā, Sep. 4, 2007.
- 3. U.S. Pat. No. 7,226,458 to Kaplan, et al., issued May 2007.
- 4. U.S. Pat. No. 7,226,448 to Bertolero, et. al., issued May 2007.
- 5. U.S. Pat. No. 7,142,919 to Hine, et al., issued May 2006.
- 6. U.S. Pat. No. 7,130,699 to Huff, et al., issued October 2006.
- 7. U.S. Pat. No. 7,120,504 to Osypka, issued October 2006.
- 8. U.S. Pat. No. 7,101,362 to Vinne, issued September 2006.
- 9. U.S. Pat. No. 7,090,637 to Danitz, et al., issued August 2006.
- 10. U.S. Pat. No. 7,089,063 to Lesh, et al., issued August 2006.
- 11. U.S. Pat. No. 7,059,878 to Hendrixson, issued August 2006.
- 12. U.S. Pat. No. 7,041,099 to Thomas, et al., issued May 2006.
- 13. U.S. Pat. No. 7,027,876 to Casavant, et al., issued April 2006.
- 14. U.S. Pat. No. 7,008,418 to Hall, et al., issued March 2006.
- 15. U.S. Pat. No. 6,973,352 to Tsutsui, et al., issued December 2005.
- 16. U.S. Pat. No. 6,936,040 to Kramm, et al., issued August 2005.
- 17. U.S. Pat. No. 6,921,295 to Sommer, et al., issued July 2005.
- 18. U.S. Pat. No. 6,918,908 to Bonner, et al., issued August 2005.
- 19. U.S. Pat. No. 6,899,710 to Hooven, issued May 2005.
- 20. U.S. Pat. No. 6,876,885 to Swoyer, et al., issued May 2005.
- 21. U.S. Pat. No. 6,868,291 to Bonner, et al., issued March 2005.
- 22. U.S. Pat. No. 6,837,886 to Collins, et al., issued January 2005.
- 23. U.S. Pat. No. 6,835,193 to Epstein, et al., issued December 2004.
- 24. U.S. Pat. No. 6,527,767 to Wang, et al., issued March 2003.
- 25. U.S. Pat. No. 6,314,963 to Vaska, et al., issued November 2001.
- 26. U.S. Pat. No. 6,270,476 to Santoianni, et al., issued August 2001.
- 27. U.S. Pat. No. 6,263,241 to Rosborough, et al., issued July 2001.
- 28. U.S. Pat. No. 6,237,605 to Vaska, et al., issued May 2001.
- 29. U.S. Pat. No. 6,123,084 to Jandak, et al., issued September 2000.
- 30. U.S. Pat. No. 6,036,685 to Mueller, et al., issued March 2000.
- 31. U.S. Pat. No. 5,733,280 to Avitall, issued March 1998.
- 32. U.S. Pat. No. 5,213,570 to Van Deripe, et al., issued May 1993.
- 33. U.S. Patent Application Publication No. 2007/0038052 to Swoyer, et al., issued February 2007.
- 34. U.S. Patent Application Publication No. 2006/0270900 to Chin, et al., issued November 2006.
- 35. U.S. Patent Application Publication No. 2006/0122591 to Keidar, issued June 2006.
- 36. U.S. Patent Application Publication No. 2006/0025762 to Mohan, et al., February 2006.
- 37. U.S. Patent Application Publication No. 20040267326 to Ocel, et al., issued December 2004.
- 38. U.S. Patent Application Publication No. 2004/0138526 to Guenst, issued July 2004.
- 39. U.S. Patent Application Publication No. 2004/0087831 to Michels, et al., issued May 2004.
- 40. U.S. Patent Application Publication No. 2003/0069572 to Wellman, et al., issued April 2003.
- 41. U.S. Patent Application Publication No. 2003/0065318 to Pendekanti, issued April 2003.
- 42. U.S. Patent Application Publication No. 2003/0028187 to Vaska, et al., issued February 2003.
- 43. International Patent Application Publication No. WO97/33526, issued September 1997.
- 44. International Patent Application Publication No. WO95/15115, issued
- June 1995.
- 45. International Patent Application Publication No. WO93/20878, issued October 1993.
- 46. International Patent Application Publication No. WO87/04081, issued July 1987. 47. M. Tomaske et al., āDo Daily Threshold Trend Fluctuations of Epicardial Leads Correlate with Pacing and Sensing Characteristics in Paediatric Patients,ā Europace, doi:10.1093/europace/eum100, (2007).
- 48. A. d'Avila et al., āTransthoracic Epicardial Catheter Ablation of Ventricular Tachycardia,ā Heart Rhythmn, Vol. 3, pp. 1110-1111, (2006).
- 49 E. Sosa et al., āEpicardial Mapping and Ablation Techniques to Control Ventricular Tachycardia,ā Journal of Cardiovascular Electrophysiology, Vol. 16, pp. 449-452, (2005).
- 50. S. Mahapatra et al., āIncidence and Predictors of Cardiac Perforation after permanent Pacemaker Placement,ā Heart Rhythm, Vol. 2, pp. 907-911, (2005).
- 51. D. L. Packer et al., āMultimodality 3-D Ultrasound and Computed Tomographic Image Fusion: A Novel Basis for Catheter Navigation and Electroanatomic Mapping,ā Circulation, Vol. 112, p. U684, (2005).
- 52. E. Sosa et al., āNonsurgical Transthoracic Epicardial Approach in Patients with Ventricular Tachycardia and Previous Cardiac Surgery,ā Journal of Interventional Cardiac Electrophysiology, Vol. 10, pp. 281-288, (2004).
- 53. J. Derose, Jr. et al., āRobotically Assisted Left Ventricular Epicardial Lead Implantation for Biventricular Pacing: the Posterior Approach,ā Annals of Thoracic Surgery, Vol. 77, pp. 1472-1474, (2004).
- 54. B. Hansky et al., āLead Selection and Implantation Technique for Biventricular Pacing,ā European Heart Journal Supplements, Vol. 6, D112-D116, (2004).
- 55. H. Mair et al., āEpicardial Lead Implantation Techniques for Biventricular Pacing via Left Lateral Mini-Thoracotomy, Video-Assisted Thoracoscopy, and Robotic Approach, The Heart Surgery Forum, Vol. 6, #2003-4883, (2003).
- 56. A. V. Sarabanda, et al., āEfficacy and Safety of Circumferential Pulmonary Vein Isolation Using a Novel Cryothermal Balloon Ablation Systemā Journal of the American College of Cardiology, Vol. 46, pp. 1902-1912 (2005).
- 57. S. Mahapatra et al., G. T. Gillies, āAccess Device and Manometric Monitoring System for Epicardial Electrophysiology: Improved Porototype and Use in Human Trialsā, Technical Report UVA/640419/MAE08/102.
- It should be appreciated that various sizes, dimensions, contours, rigidity, shapes, flexibility and materials of any of the embodiments discussed throughout may be varied and utilized as desired or required.
- It should be appreciated that the catheter device and epicardial system and their related components discussed herein may can take on all shapes along the entire continual geometric spectrum of manipulation of x, y and z planes to provide and meet the anatomical and structural demands and requirements.
- Practice of the invention will be still more fully understood from the following examples and experimental results, which are presented herein for illustration only and should not be construed as limiting the invention in any way.
- Step 1āAccess and place a guidewire in the pericardial space using our EpiNeedle Access system.
- Step 2āUse a sheath, preferably our EpiSheath, or a general long 8 Fr sheath to place over the guidewire and maintain access.
- Step 3āPlace the lead of the subject invention with handle though the sheath.
- Step 4āGuide the lead in the epicardial space using the two steering points and the sheath under fluoroscopic guidance (although this lead may be guided via one or more other imaging methods to include ICE, CT, MRI, Visual Endoscopy, or Echo Methods). The lead should be advanced along the border of the heart apically to base along the LV. Once it crosses the AV groove to the LA it should be deflected downward and advanced through the transverse sinus. Once across the transverse sinus it will need to be deflected up to the SVC and then down to the RA and finally the RV.
-
Step 5āSlide the sheath back to the inferior portion of the RV. - Step 6āAt this point the handle should be hooked up to an EP analyzer. The lead should be clocked for a more anterior position or counter-clocked for a more posterior position until the largest LV signals are found. If multi-chamber pacing is sought one should pick a point when at least two poles of the LV, and of each other chamber, has an amplitude of at least 1 mV in the atrium and 5 mV in the ventricle. Note there is no need for all points to have high amplitudes. Next, the tabs should be deployed. This should push the lead more tightly against the heart and actually increase the voltage. Then, pacing should be attempted in the LV. If threshold is less than 2.5 V it is a good site on any pole. The same should then be done with the other points. If no point is good the tab should be let down and then the lead repositioned.
- Step 7āOnce a good position is found the handle should be removed and the sheath withdrawn completely outside of the patient.
- Step 8āThe lead should be plugged into either a custom ICD/BiV or attached to our wire interface for a standard ICD. The poles that are not used to pace should be plugged in this case. In the custom ICD, all poles would be active and the user (or an automated system) may decide when to pace.
- Step 9āThe lead extender to the ICD would then either be tunneled back to the ICD in the shoulder (or elsewhere), placed by the nearby abdominal ICD. Or a battery-powered wireless box will be used to communicate with the main ICD in the shoulder. At this point the patient should be recovered. No stitch is needed for the lead access.
- In summary, while the present invention has been described with respect to specific embodiments, many modifications, variations, alterations, substitutions, and equivalents will be apparent to those skilled in the art. The present invention is not to be limited in scope by the specific embodiment described herein. Indeed, various modifications of the present invention, in addition to those described herein, will be apparent to those of skill in the art from the foregoing description and accompanying drawings. Accordingly, the invention is to be considered as limited only by the spirit and scope of the following claims, including all modifications and equivalents.
- Still other embodiments will become readily apparent to those skilled in this art from reading the above-recited detailed description and drawings of certain exemplary embodiments. It should be understood that numerous variations, modifications, and additional embodiments are possible, and accordingly, all such variations, modifications, and embodiments are to be regarded as being within the spirit and scope of this application. For example, regardless of the content of any portion (e.g., title, field, background, summary, abstract, drawing figure, etc.) of this application, unless clearly specified to the contrary, there is no requirement for the inclusion in any claim herein or of any application claiming priority hereto of any particular described or illustrated activity or element, any particular sequence of such activities, or any particular interrelationship of such elements. Moreover, any activity can be repeated, any activity can be performed by multiple entities, and/or any element can be duplicated. Further, any activity or element can be excluded, the sequence of activities can vary, and/or the interrelationship of elements can vary. Unless clearly specified to the contrary, there is no requirement for any particular described or illustrated activity or element, any particular sequence or such activities, any particular size, speed, material, dimension or frequency, or any particularly interrelationship of such elements. Accordingly, the descriptions and drawings are to be regarded as illustrative in nature, and not as restrictive. Moreover, when any number or range is described herein, unless clearly stated otherwise, that number or range is approximate. When any range is described herein, unless clearly stated otherwise, that range includes all values therein and all sub ranges therein. Any information in any material (e.g., a United States/foreign patent, United States/foreign patent application, book, article, etc.) that has been incorporated by reference herein, is only incorporated by reference to the extent that no conflict exists between such information and the other statements and drawings set forth herein. In the event of such conflict, including a conflict that would render invalid any claim herein or seeking priority hereto, then any such conflicting information in such incorporated by reference material is specifically not incorporated by reference herein.
Claims (134)
1. An epicardial pacing system, said system comprising:
an epicardial catheter configured to be disposed in the middle mediastinum of the thorax of a subject for use in electrical pacing of the heart at one or more locations on the epicardial surface, said epicardial pacing catheter comprising:
a proximal portion, distal portion, and a longitudinal structure there between; and
at least one electrode in communication with the distal portion, wherein the at least one electrode is insulated on at least one side to allow pacing of the heart without damage to adjacent anatomical structures.
2. The system of claim 1 , wherein said disposing comprises a minimally invasive procedure.
3. The system of claim 1 , wherein said disposing comprises a non-surgical procedure.
4. The system of claim 1 , wherein said disposing comprises an interventional procedure.
5. The system of claim 1 , wherein the middle mediastinum includes the pericardial space.
6. The system of claim 1 , wherein said epicardial pacing catheter is a lead.
7. The system of claim 1 , further comprising at least one electrical wire in communication with said at least one electrodes, said electrical wire extending longitudinally through said longitudinal structure toward the proximal end, wherein said at least one electrical wire is adapted for transmitting and receiving electrical energy.
8. The system of claim 7 , further comprising a control means in communication with the proximal portion, wherein said control means is controllably connected to said at least one electrical wire.
9. The system of claim 8 , wherein said control means is removable.
10. The system of claim 9 , wherein said control means is a control handle.
11. The system of claim 1 , wherein said at least one electrode comprises a conducting material.
12. The system of claim 11 , wherein said conducting material comprises at least one of the following: copper, platinum, gold, silver, iridium and/or alloys thereof.
13. The system of claim 1 , said catheter further comprising an insulating material, said insulating material in communication with said at least one electrode and a portion of said catheter located opposite the heart.
14. The system of claim 13 , wherein said insulating material is non-conductive.
15. The system of claim 13 , wherein said insulating material mitigates the transmission of electrical energy away from the heart.
16. The system of claim 1 , said catheter further comprising a distal tip, wherein said distal tip comprises a non-conducting material.
17. The system of claim 1 , wherein said at least one electrode is semi-cylindrical or arc-like in shape.
18. The system of claim 1 , wherein the surface of said at least one electrode is roughened, profiled, or otherwise prepared so as to maximize surface area.
19. The system of claim 1 , wherein said at least one electrode comprises at least one electrode pair.
20. The system of claim 19 , wherein said at least one electrode pair comprises an anode and cathode.
21. The system of claim 1 , wherein said at least one electrode is deployable.
22. The system of claim 1 , wherein the cross section of said longitudinal structure comprises an oval, circle, ellipse, or semi-circular shape.
23. The system of claim 1 , wherein at least a portion of said longitudinal structure comprises a biocompatible material.
24. The system of claim 1 , wherein at least a portion of said longitudinal structure comprises a lubricious material having a low coefficient of friction.
25. The system of claim 1 , wherein at least a portion of said longitudinal structure comprises at least one of the following: silicone, polyurethane, or Teflon, any combination thereof, or similarly lubricious material.
26. The system of claim 1 , wherein at least a portion of said longitudinal structure is impregnated with sirilimus.
27. The system of claim 1 , wherein at least a portion of said longitudinal structure comprises a drug eluting surface.
28. The system of claim 1 , wherein said longitudinal structure is between about 15 and about 100 centimeters in length.
29. The system of claim 1 , wherein said longitudinal structure is between about 2 and about 6 millimeters in diameter.
30. The system of claim 1 , further comprising at least one distal fluid aperture located at the distal tip of said distal portion, said at least one distal fluid aperture in communication with a fluid lumen extending longitudinally through said longitudinal structure toward said proximal portion, wherein said at least one distal fluid aperture is adapted for passage of fluid.
31. The system of claim 30 , wherein said passage comprises emitting fluid.
32. The system of claim 30 , wherein said passage comprises extracting fluid.
33. The system of claim 30 , wherein said passage comprises emitting and extracting fluid.
34. The system of claim 30 , wherein said passage comprises emitting a drug or agent.
35. The system of claim 30 , further comprising at least one proximal fluid aperture at said proximal portion, wherein the at least one proximal fluid aperture is in communication with said fluid lumen, and wherein the at least one proximal fluid aperture is adapted for passage of fluid.
36. The system of claim 35 , wherein said passage comprises emitting fluid.
37. The system of claim 35 , wherein said passage comprises extracting fluid.
38. The system of claim 35 , wherein said passage comprises emitting and extracting fluid.
39. The system of claim 35 , wherein said passage comprises emitting a drug or agent.
40. The system of claim 35 , further comprising a fluid control means for controlling said fluid passage.
41. The system of claim 40 , wherein said control means comprises a control handle in communication with said epicardial pacing catheter.
42. The system of claim 40 , wherein said control means is in communication with an external fluid source.
43. The system of claim 40 , wherein said control means is in communication with an external drug or agent source.
44. The system of claim 1 , wherein said catheter further comprising a stabilization means for stabilizing said epicardial pacing catheter.
45. The system of claim 44 , wherein said stabilization means comprises at least one deployable member.
46. The system of claim 45 , wherein said deployable member comprises a screw, hook, or tab.
47. The system of claim 45 , wherein said deployable member is in communication with said at least one electrode.
48. The system of claim 45 , wherein said deployable member comprises a conductive material.
49. The system of claim 48 , wherein said conducting material comprises at least one of the following: copper, platinum, gold, silver, or iridium, and/or alloys thereof.
50. The system of claim 45 , further comprising a stabilizer actuator, wherein said stabilizer actuator deploys said at least one deployable member.
51. The system of claim 50 , wherein said stabilizer actuator comprises:
at least one longitudinal member in communication with at least one of the following: gear, hinge, joint, rack and pinion, pulley, linear actuator, or linear-rotational actuator, or any combination thereof.
52. The system of claim 51 , wherein said at least one longitudinal member comprises at least one of the following: push-rod, pull-rod, wire, string, pole, thread, filament, cord, strand or rope.
53. The system of claim 50 , wherein said stabilizer actuator comprises a micro electrical mechanical system (MEMS).
54. The system of claim 44 , further comprising a control means for controlling said stabilization.
55. The system of claim 54 , wherein said control means comprises a control handle.
56. The system of claim 45 , wherein said at least one deployable member comprises a catheter-side surface and anatomical-side surface.
57. The system of claim 56 , wherein said catheter-side surface comprises a rough surface and said anatomical-side surface comprises a lubricious surface.
58. The system of claim 56 , wherein said at least one deployable member is adapted to engage proximate anatomical structures.
59. The system of claim 56 , wherein said catheter-side and anatomical-side surfaces comprise non-conductive materials.
60. The system of claim 56 , wherein said catheter-side surface comprises a material having a larger coefficient of friction than said anatomical-side surface.
61. The system of claim 56 , wherein said at least one deployable member in a deployed state prevents or impedes said distal portion from slipping or moving.
62. The system of claim 56 , wherein said distal portion can be moved around within the middle mediastinum when said stabilization means is in a non-deployed state.
63. The system of claim 56 , wherein said anatomical-side surface comprises at least one of the following: silicone, polyurethane, or Teflon, combination thereof, or similarly lubricious material.
64. The system of claim 56 , wherein said catheter-side surface comprises a textured surface to increase friction.
65. The system of claim 56 , wherein said at least one deployable member comprises a radio-opaque material.
66. The system of claim 44 , wherein said stabilization means comprises one or more protrusions for engaging proximal anatomical structures.
67. The system of claim 66 , wherein at least one of said one or more protrusions is non-deployable.
68. The system of claim 66 , wherein said one or more protrusions comprise a non-conducting material.
69. The system of claim 68 , wherein said non-conducting material comprises at least one of the following: silicone, polyurethane, or Teflon, combination thereof, or similarly lubricious material.
70. The system of claim 68 , wherein the non-conducting material comprises a radio-opaque material.
71. The system of claim 1 , further comprising a steering means for positioning the epicardial pacing catheter.
72. The system of claim 71 , further comprising a second steering means for steering said epicardial pacing catheter.
73. The system of claim 71 , further comprising a third and fourth steering means for steering said epicardial pacing catheter.
74. The system of claim 71 , wherein said steering means allows orientation of said epicardial pacing catheter about one point of curvature.
75. The system of claim 71 , wherein said steering means allows orientation of said epicardial pacing lead about two or more points of curvature.
76. The system of claim 75 , wherein the most proximal point of curvature is located about 15 cm from the proximal end.
77. The system of claim 75 , wherein the most distal point of curvature is located between about 1 and about 20 cm from the distal end.
78. The system of claim 75 , wherein the most distal point of curvature is a bidirectional center of curvature.
79. The system of claim 75 , wherein the most distal point of curvature is greater than tri-directional.
80. The system of claim 71 , wherein said steering means comprises at least one of the following: guide wire, pull string, digitating member or tensioning line.
81. The system of claim 71 , wherein said steering means comprises a non-conductive material.
82. The system of claim 71 , wherein said steering means comprises a material of high-tensile strength.
83. The system of claim 71 , further comprising a control means for controlling said steering means.
84. The system of claim 83 , wherein said control means comprises a removable handle in communication with the proximal portion.
85. The system of claim 1 , wherein said epicardial pacing catheter is adapted to be in communication with a power supply.
86. The system of claim 85 , wherein said epicardial pacing catheter is adapted to be in communication with a processor.
87. The system of claim 86 , wherein said epicardial pacing catheter is adapted to be in communication with said power supply and said processor by hardwire, wireless, or a combination thereof.
88. The system of claim 87 , wherein said wireless comprises BlueTooth, Infrared, other optical, photo-optical, or radio-based type of telemetry or communication.
89. The system of claim 85 , further comprising an interface member in communication with said power supply and processor.
90. The system of claim 89 , wherein said interface member is used by a patient, a physician, a technician, or a clinician.
91. The system of claim 90 , wherein said interface member may be in remote or local communication with a control means.
92. The system of claim 91 , wherein said control means comprises an external control handle.
93. The system of claim 1 , wherein navigation of said epicardial pacing catheter is carried out through a puncture of the thorax.
94. The system of claim 93 , wherein said puncture comprises a sub-xiphoid puncture.
95. The system of claim 93 , wherein a pressure probe needle is used in navigating the epicardial pacing catheter.
96. The system of claim 95 , wherein said pressure probe needle comprises an access needle.
97. The system of claim 95 , wherein said pressure probe needle comprises a sensor for sensing pressure in the thorax.
98. The system of claim 1 , further comprising an access needle, the access needle adapted to be inserted into the thorax.
99. The system of claim 98 , further comprising a guidewire, wherein the guidewire is adapted to be inserted into said access needle.
100. The system of claim 98 , wherein said guidewire and said access needle are navigated into the pericardial sack.
101. The system of claim 100 , wherein said epicardial pacing catheter is adapted to be inserted into or around said guidewire.
102. The system of claim 1 , wherein said epicardial pacing catheter is configured to be used with a sheath, said sheath comprising a distal portion, proximal portion, and a longitudinal structure there between, wherein said sheath is adapted for receiving said epicardial pacing catheter therein.
103. A method for use with an epicardial pacing catheter, said method comprising:
disposing said epicardial pacing catheter in the middle mediastinum of the thorax of a subject;
pacing the heart at one or more locations with electrical energy from an at least one electrode; and
at least partially insulating the electrical energy to allow pacing of the heart without damage to adjacent anatomical structures.
104. The method of claim 103 , wherein said disposing comprises a minimally invasive procedure.
105. The method of claim 103 , wherein said disposing comprises a non-surgical procedure.
106. The device of claim 103 , wherein said disposing comprises an interventional procedure.
107. The method of claim 103 , wherein said middle mediastinum includes the pericardial space.
108. The method of claim 103 , wherein said at least one electrode may be used to stabilize said epicardial pacing catheter.
109. The method of claim 103 , wherein said at least one electrode is deployed.
110. The method of claim 103 , further comprising irrigating said middle mediastinum.
111. The method of claim 110 , wherein said irrigating comprises emitting a fluid, drug, or agent.
112. The method of claim 110 , wherein said irrigating comprises extracting a fluid, drug, or agent.
113. The method of claim 110 , wherein said irrigating comprises both emitting and extracting a fluid, drug, or agent.
114. The method of claim 103 , further comprising stabilizing said epicardial pacing catheter.
115. The method of claim 114 , further comprising a at least one deployable member, wherein said deployable member is used for stabilizing.
116. The method of claim 115 , wherein said at least one deployable member comprises a screw, hook, or tab.
117. The method of claim 115 , wherein said at least one deployable member comprises a non-conductive material.
118. The method of claim 115 , wherein said at least one deployable member comprises a conductive material.
119. The method of claim 118 , wherein said at least one deployable member is in electrical communication with said at least one electrode.
120. The method of claim 103 , further comprising steering said epicardial pacing catheter.
121. The method of claim 120 , wherein said steering is about at least one point of curvature.
122. The method of claim 103 , further comprising supplying power to said epicardial pacing catheter.
123. The method of claim 103 , further comprising processing data received from said epicardial pacing catheter.
124. The method of claim 103 , further comprising controlling said at least one electrode.
125. The method of claim 124 , wherein said controlling comprises controllably connecting a control handle to said epicardial pacing catheter.
126. The method of claim 103 , wherein said disposing is carried out through a puncture of the thorax.
127. The method of claim 126 , wherein said puncture comprises a sub-xiphoid puncture.
128. The method of claim 126 , wherein said disposing is carried out through a pressure probe needle.
129. The method of 128, wherein said pressure probe needle comprises an access needle.
130. The method of 128, wherein said pressure probe needle comprises a sensor for sensing pressure in the thorax.
131. The method of claim 103 , further comprising inserting an access needle into the thorax of said subject.
132. The method of claim 131 , further comprising inserting a guidewire into said access needle.
133. The method of claim 132 , further comprising inserting a sheath over said guidewire.
134. The method of claim 133 , further comprising inserting said epicardial pacing catheter into said sheath.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/741,710 US20100241185A1 (en) | 2007-11-09 | 2008-11-07 | Steerable epicardial pacing catheter system placed via the subxiphoid process |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98678607P | 2007-11-09 | 2007-11-09 | |
US2372708P | 2008-01-25 | 2008-01-25 | |
US12/741,710 US20100241185A1 (en) | 2007-11-09 | 2008-11-07 | Steerable epicardial pacing catheter system placed via the subxiphoid process |
PCT/US2008/082835 WO2009062061A1 (en) | 2007-11-09 | 2008-11-07 | Steerable epicardial pacing catheter system placed via the subxiphoid process |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/082835 A-371-Of-International WO2009062061A1 (en) | 2007-11-09 | 2008-11-07 | Steerable epicardial pacing catheter system placed via the subxiphoid process |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/960,137 Continuation US11951303B2 (en) | 2018-04-23 | Steerable epicardial pacing catheter system placed via the subxiphoid process |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100241185A1 true US20100241185A1 (en) | 2010-09-23 |
Family
ID=40626198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/741,710 Abandoned US20100241185A1 (en) | 2007-11-09 | 2008-11-07 | Steerable epicardial pacing catheter system placed via the subxiphoid process |
Country Status (2)
Country | Link |
---|---|
US (1) | US20100241185A1 (en) |
WO (1) | WO2009062061A1 (en) |
Cited By (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110224600A1 (en) * | 2008-08-08 | 2011-09-15 | Fabio Orlandi | Irrigation and suction system, in particular for laparoscopic surgery |
US8282565B2 (en) | 2007-03-19 | 2012-10-09 | University Of Virginia Patent Foundation | Access needle pressure sensor device and method of use |
WO2015143327A1 (en) * | 2014-03-21 | 2015-09-24 | Mayo Foundation For Medical Education And Research | Multi-electrode epicardial pacing |
US9211405B2 (en) | 2007-03-22 | 2015-12-15 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
US9218752B2 (en) | 2010-02-18 | 2015-12-22 | University Of Virginia Patent Foundation | System, method, and computer program product for simulating epicardial electrophysiology procedures |
US20160262600A1 (en) * | 2013-12-26 | 2016-09-15 | Olympus Corporation | Pneumoperitoneum apparatus |
US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US9526909B2 (en) | 2014-08-28 | 2016-12-27 | Cardiac Pacemakers, Inc. | Medical device with triggered blanking period |
US9592391B2 (en) | 2014-01-10 | 2017-03-14 | Cardiac Pacemakers, Inc. | Systems and methods for detecting cardiac arrhythmias |
US9636512B2 (en) | 2014-11-05 | 2017-05-02 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system having multiple common polarity extravascular defibrillation electrodes |
US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US9669230B2 (en) | 2015-02-06 | 2017-06-06 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US9717923B2 (en) | 2013-05-06 | 2017-08-01 | Medtronic, Inc. | Implantable medical device system having implantable cardioverter-defibrillator (ICD) system and substernal leadless pacing device |
US9724170B2 (en) | 2012-08-09 | 2017-08-08 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US9853743B2 (en) | 2015-08-20 | 2017-12-26 | Cardiac Pacemakers, Inc. | Systems and methods for communication between medical devices |
US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US9999465B2 (en) | 2014-10-14 | 2018-06-19 | Iowa Approach, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10028682B2 (en) | 2012-10-12 | 2018-07-24 | University Of Virginia Patent Foundation | Oxidation measurement system and related method thereof |
US10029107B1 (en) | 2017-01-26 | 2018-07-24 | Cardiac Pacemakers, Inc. | Leadless device with overmolded components |
US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
US10046167B2 (en) | 2015-02-09 | 2018-08-14 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
US10065041B2 (en) | 2015-10-08 | 2018-09-04 | Cardiac Pacemakers, Inc. | Devices and methods for adjusting pacing rates in an implantable medical device |
US10092760B2 (en) | 2015-09-11 | 2018-10-09 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10137305B2 (en) | 2015-08-28 | 2018-11-27 | Cardiac Pacemakers, Inc. | Systems and methods for behaviorally responsive signal detection and therapy delivery |
US10159782B2 (en) | 2012-09-19 | 2018-12-25 | University Of Virginia Patent Foundation | Method and system for enhanced imaging visualization of deep brain anatomy using infusion |
US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10166066B2 (en) | 2007-03-13 | 2019-01-01 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10183170B2 (en) | 2015-12-17 | 2019-01-22 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
US10213610B2 (en) | 2015-03-18 | 2019-02-26 | Cardiac Pacemakers, Inc. | Communications in a medical device system with link quality assessment |
US10220213B2 (en) | 2015-02-06 | 2019-03-05 | Cardiac Pacemakers, Inc. | Systems and methods for safe delivery of electrical stimulation therapy |
US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
US10265502B2 (en) | 2013-02-19 | 2019-04-23 | Beth Israel Deaconess Medical Center, Inc. | Adjustable stiffness catheter |
US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
US10350423B2 (en) | 2016-02-04 | 2019-07-16 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
US10357159B2 (en) | 2015-08-20 | 2019-07-23 | Cardiac Pacemakers, Inc | Systems and methods for communication between medical devices |
US10391319B2 (en) | 2016-08-19 | 2019-08-27 | Cardiac Pacemakers, Inc. | Trans septal implantable medical device |
US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
US10426962B2 (en) | 2016-07-07 | 2019-10-01 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
US10434317B2 (en) | 2016-10-31 | 2019-10-08 | Cardiac Pacemakers, Inc. | Systems and methods for activity level pacing |
US10434314B2 (en) | 2016-10-27 | 2019-10-08 | Cardiac Pacemakers, Inc. | Use of a separate device in managing the pace pulse energy of a cardiac pacemaker |
US10433906B2 (en) | 2014-06-12 | 2019-10-08 | Farapulse, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10463305B2 (en) | 2016-10-27 | 2019-11-05 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
US10471267B2 (en) | 2013-05-06 | 2019-11-12 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system including substernal lead |
US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US10512784B2 (en) | 2016-06-27 | 2019-12-24 | Cardiac Pacemakers, Inc. | Cardiac therapy system using subcutaneously sensed P-waves for resynchronization pacing management |
US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
US10532203B2 (en) | 2013-05-06 | 2020-01-14 | Medtronic, Inc. | Substernal electrical stimulation system |
US10556117B2 (en) | 2013-05-06 | 2020-02-11 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system including substernal pacing lead |
US10561330B2 (en) | 2016-10-27 | 2020-02-18 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
US10583301B2 (en) | 2016-11-08 | 2020-03-10 | Cardiac Pacemakers, Inc. | Implantable medical device for atrial deployment |
US10583303B2 (en) | 2016-01-19 | 2020-03-10 | Cardiac Pacemakers, Inc. | Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device |
US10617874B2 (en) | 2016-10-31 | 2020-04-14 | Cardiac Pacemakers, Inc. | Systems and methods for activity level pacing |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US10632313B2 (en) | 2016-11-09 | 2020-04-28 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for setting cardiac pacing pulse parameters for a cardiac pacing device |
US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10661080B2 (en) | 2016-04-01 | 2020-05-26 | Kobara Medical Inc. | Shaped epicardial lead and placement system and method |
US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10688304B2 (en) | 2016-07-20 | 2020-06-23 | Cardiac Pacemakers, Inc. | Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US10722720B2 (en) | 2014-01-10 | 2020-07-28 | Cardiac Pacemakers, Inc. | Methods and systems for improved communication between medical devices |
US10737102B2 (en) | 2017-01-26 | 2020-08-11 | Cardiac Pacemakers, Inc. | Leadless implantable device with detachable fixation |
US10758724B2 (en) | 2016-10-27 | 2020-09-01 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
US10765871B2 (en) | 2016-10-27 | 2020-09-08 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
US10780278B2 (en) | 2016-08-24 | 2020-09-22 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing |
US10821288B2 (en) | 2017-04-03 | 2020-11-03 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate |
US10835753B2 (en) | 2017-01-26 | 2020-11-17 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US10870008B2 (en) | 2016-08-24 | 2020-12-22 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
US10874861B2 (en) | 2018-01-04 | 2020-12-29 | Cardiac Pacemakers, Inc. | Dual chamber pacing without beat-to-beat communication |
US10881863B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with multimode communication |
US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
US10894163B2 (en) | 2016-11-21 | 2021-01-19 | Cardiac Pacemakers, Inc. | LCP based predictive timing for cardiac resynchronization |
US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
US10905889B2 (en) | 2016-09-21 | 2021-02-02 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
US10918875B2 (en) | 2017-08-18 | 2021-02-16 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
US10994145B2 (en) | 2016-09-21 | 2021-05-04 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
US11052258B2 (en) | 2017-12-01 | 2021-07-06 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker |
US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
US11058880B2 (en) | 2018-03-23 | 2021-07-13 | Medtronic, Inc. | VFA cardiac therapy for tachycardia |
US11065459B2 (en) | 2017-08-18 | 2021-07-20 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11071870B2 (en) | 2017-12-01 | 2021-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
US11116988B2 (en) | 2016-03-31 | 2021-09-14 | Cardiac Pacemakers, Inc. | Implantable medical device with rechargeable battery |
US11147979B2 (en) | 2016-11-21 | 2021-10-19 | Cardiac Pacemakers, Inc. | Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing |
US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
US11207527B2 (en) | 2016-07-06 | 2021-12-28 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11235163B2 (en) | 2017-09-20 | 2022-02-01 | Cardiac Pacemakers, Inc. | Implantable medical device with multiple modes of operation |
US11235161B2 (en) | 2018-09-26 | 2022-02-01 | Medtronic, Inc. | Capture in ventricle-from-atrium cardiac therapy |
US11235159B2 (en) | 2018-03-23 | 2022-02-01 | Medtronic, Inc. | VFA cardiac resynchronization therapy |
US11260216B2 (en) | 2017-12-01 | 2022-03-01 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker |
US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
US11285326B2 (en) | 2015-03-04 | 2022-03-29 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
US11400296B2 (en) | 2018-03-23 | 2022-08-02 | Medtronic, Inc. | AV synchronous VfA cardiac therapy |
US11433232B2 (en) | 2013-05-06 | 2022-09-06 | Medtronic, Inc. | Devices and techniques for anchoring an implantable medical device |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11813463B2 (en) | 2017-12-01 | 2023-11-14 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with reversionary behavior |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11951303B2 (en) | 2018-04-23 | 2024-04-09 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8906056B2 (en) | 2009-05-01 | 2014-12-09 | University Of Virginia Patent Foundation | Access trocar and related method thereof |
US8346373B2 (en) | 2010-08-03 | 2013-01-01 | Medtronic, Inc. | Method and apparatus for delivering a lead to a heart |
US9640198B2 (en) | 2013-09-30 | 2017-05-02 | Biosense Webster (Israel) Ltd. | Controlling a system using voiceless alaryngeal speech |
Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3794026A (en) * | 1970-07-29 | 1974-02-26 | H Jacobs | Ventilating apparatus embodying selective volume or pressure operation and catheter means for use therewith |
US4280510A (en) * | 1979-02-08 | 1981-07-28 | Medtronic, Inc. | Sutureless myocardial lead introducer |
US4349023A (en) * | 1980-10-09 | 1982-09-14 | Abbott Laboratories | Epidural needle catheter and adapter |
US4607644A (en) * | 1985-04-01 | 1986-08-26 | Cordis Corporation | Self-suturing porous epicardial electrode assembly |
US4817634A (en) * | 1987-06-18 | 1989-04-04 | Medtronic, Inc. | Epicardial patch electrode |
US4935008A (en) * | 1988-07-20 | 1990-06-19 | Lewis Jr Ronald L | Double lumen introducing needle |
US4971070A (en) * | 1987-06-18 | 1990-11-20 | Medtronic, Inc. | Epicardial patch electrode |
US4991603A (en) * | 1989-10-30 | 1991-02-12 | Siemens-Pacesetter, Inc. | Transvenously placed defibrillation leads via an inferior vena cava access site and method of use |
US5033477A (en) * | 1987-11-13 | 1991-07-23 | Thomas J. Fogarty | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US5071428A (en) * | 1989-09-08 | 1991-12-10 | Ventritex, Inc. | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US5158097A (en) * | 1990-06-08 | 1992-10-27 | Allegheny-Singer Research Institute | Paraneural stimulating lead |
US5213570A (en) * | 1990-12-14 | 1993-05-25 | Mallinckrodt Medical, Inc. | System and method for oxygenation of the pericardium |
US5269326A (en) * | 1991-10-24 | 1993-12-14 | Georgetown University | Method for transvenously accessing the pericardial space via the right auricle for medical procedures |
US5300110A (en) * | 1992-10-15 | 1994-04-05 | Angeion Corporation | Dirk-based epicardial defibrillation electrode |
US5335313A (en) * | 1991-12-03 | 1994-08-02 | Douglas Terry L | Voice-actuated, speaker-dependent control system for hospital bed |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5395349A (en) * | 1991-12-13 | 1995-03-07 | Endovascular Technologies, Inc. | Dual valve reinforced sheath and method |
US5465711A (en) * | 1991-05-29 | 1995-11-14 | Origin Medsystems, Inc. | Surgical procedures using endoscopic inflatable retraction devices |
US5484423A (en) * | 1990-11-05 | 1996-01-16 | Te Me Na Logistics | Needle, for example epidural needle |
US5500012A (en) * | 1992-07-15 | 1996-03-19 | Angeion Corporation | Ablation catheter system |
US5509924A (en) * | 1994-04-12 | 1996-04-23 | Ventritex, Inc. | Epicardial stimulation electrode with energy directing capability |
US5544654A (en) * | 1995-06-06 | 1996-08-13 | Acuson Corporation | Voice control of a medical ultrasound scanning machine |
US5662647A (en) * | 1991-07-22 | 1997-09-02 | Transamerican Technologies International | Electrode assembly for electrosurgical instrument |
US5669882A (en) * | 1996-04-23 | 1997-09-23 | Pyles; Stephen | Curved epidural needle system |
US5702438A (en) * | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
US5725504A (en) * | 1996-01-19 | 1998-03-10 | Smiths Industries Public Limited Company | Spinal epidural needle assemblies |
US5733280A (en) * | 1995-11-15 | 1998-03-31 | Avitall; Boaz | Cryogenic epicardial mapping and ablation |
US5779699A (en) * | 1996-03-29 | 1998-07-14 | Medtronic, Inc. | Slip resistant field focusing ablation catheter electrode |
US5792217A (en) * | 1996-06-28 | 1998-08-11 | Medtronic, Inc. | Temporary bipolar heart wire |
US5797870A (en) * | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
US5800428A (en) * | 1996-05-16 | 1998-09-01 | Angeion Corporation | Linear catheter ablation system |
US5807249A (en) * | 1996-02-16 | 1998-09-15 | Medtronic, Inc. | Reduced stiffness, bidirectionally deflecting catheter assembly |
US5812978A (en) * | 1996-12-09 | 1998-09-22 | Tracer Round Associaties, Ltd. | Wheelchair voice control apparatus |
US5827216A (en) * | 1995-06-07 | 1998-10-27 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
US5843048A (en) * | 1996-08-06 | 1998-12-01 | The Kendall Company | Epidural catheter needle |
US5846239A (en) * | 1996-04-12 | 1998-12-08 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using segmented porous electrode structures |
US5885217A (en) * | 1995-01-20 | 1999-03-23 | Tyco Group S.A.R.L. | Catheter introducer |
US5916194A (en) * | 1996-05-24 | 1999-06-29 | Sarcos, Inc. | Catheter/guide wire steering apparatus and method |
US5928191A (en) * | 1993-07-30 | 1999-07-27 | E.P. Technologies, Inc. | Variable curve electrophysiology catheter |
US5931810A (en) * | 1996-12-05 | 1999-08-03 | Comedicus Incorporated | Method for accessing the pericardial space |
US5970457A (en) * | 1995-10-25 | 1999-10-19 | Johns Hopkins University | Voice command and control medical care system |
US5972013A (en) * | 1997-09-19 | 1999-10-26 | Comedicus Incorporated | Direct pericardial access device with deflecting mechanism and method |
US6032674A (en) * | 1992-01-07 | 2000-03-07 | Arthrocare Corporation | Systems and methods for myocardial revascularization |
US6036685A (en) * | 1996-03-29 | 2000-03-14 | Eclipse Surgical Technologies. Inc. | Lateral- and posterior-aspect method for laser-assisted transmyocardial revascularization and other surgical applications |
US6051008A (en) * | 1996-12-02 | 2000-04-18 | Angiotrax, Inc. | Apparatus having stabilization members for percutaneously performing surgery and methods of use |
US6123084A (en) * | 1998-12-18 | 2000-09-26 | Eclipse Surgical Technologies, Inc. | Method for improving blood flow in the heart |
US6148825A (en) * | 1998-02-13 | 2000-11-21 | Anderson; Bernard Bradley | Method of using a dedicated internal shunt and stent for the inferior vena cava |
US6156018A (en) * | 1994-11-03 | 2000-12-05 | Daig Corporation | Guiding introducer system for use in medical procedures in the left ventricle |
US6200315B1 (en) * | 1997-12-18 | 2001-03-13 | Medtronic, Inc. | Left atrium ablation catheter |
US6200303B1 (en) * | 1997-04-30 | 2001-03-13 | Beth Israel Deaconess Medical Center, Inc. | Method and kit for transvenously accessing the pericardial space via the right atrium |
US6206874B1 (en) * | 1998-04-08 | 2001-03-27 | Siemens-Elema Ab | Apparatus and method for locating electrically active sites with an animal |
US6206004B1 (en) * | 1996-12-06 | 2001-03-27 | Comedicus Incorporated | Treatment method via the pericardial space |
US6216704B1 (en) * | 1997-08-13 | 2001-04-17 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
US6231518B1 (en) * | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
US20010001214A1 (en) * | 1994-03-10 | 2001-05-17 | Bernstein Joseph B. | Technique for producing interconnecting conductive links |
US6237605B1 (en) * | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US6263241B1 (en) * | 1999-04-30 | 2001-07-17 | Intermedics, Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6266567B1 (en) * | 1999-06-01 | 2001-07-24 | Ball Semiconductor, Inc. | Implantable epicardial electrode |
US6270476B1 (en) * | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6270484B1 (en) * | 1999-02-17 | 2001-08-07 | Inbae Yoon | Safety penetrating instrument with expandible portion and method of penetrating anatomical cavity |
US6273877B1 (en) * | 2000-07-20 | 2001-08-14 | Becton, Dickinson And Company | Epidural needle with secondary bevel |
US20010020166A1 (en) * | 1996-04-30 | 2001-09-06 | Michael Daly | System for simultaneous unipolar multi-electrode ablation |
US20010025178A1 (en) * | 1998-07-07 | 2001-09-27 | Mulier Peter M.J. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6314963B1 (en) * | 1996-10-22 | 2001-11-13 | Epicor, Inc. | Method of ablating tissue from an epicardial location |
US6322536B1 (en) * | 1998-03-06 | 2001-11-27 | Cornell Research Foundation, Inc. | Minimally invasive gene therapy delivery and method |
US20010056280A1 (en) * | 1992-01-07 | 2001-12-27 | Underwood Ronald A. | Systems and methods for electrosurgical spine surgery |
US20020019626A1 (en) * | 2000-02-25 | 2002-02-14 | Sharkey Hugh R. | Apparatus and method for accessing and performing a function within an intervertebral disc |
US20020045895A1 (en) * | 1996-10-22 | 2002-04-18 | Epicor, Inc. | Methods and devices for ablation |
US20020055714A1 (en) * | 1999-05-18 | 2002-05-09 | Rothschild Richard B. | Method and apparatus for the non-surgical placement of a subcutaneously tunnelled catheter through the skin into a central vein |
US20020058925A1 (en) * | 1999-09-16 | 2002-05-16 | Kaplan Aaron V. | Methods and apparatus for pericardial access |
US20020072737A1 (en) * | 2000-12-08 | 2002-06-13 | Medtronic, Inc. | System and method for placing a medical electrical lead |
US20020077600A1 (en) * | 2000-12-19 | 2002-06-20 | Laksen Sirimanne | Percutaneous catheter assembly |
US20020082523A1 (en) * | 2000-12-21 | 2002-06-27 | Bryan Kinsella | Steerable guidewire |
US6416505B1 (en) * | 1998-05-05 | 2002-07-09 | Scimed Life Systems, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and pressure application probe for use with same |
US20020161361A1 (en) * | 1998-05-05 | 2002-10-31 | Sherman Marshall L. | RF ablation system and method having automatic temperature control |
US6527767B2 (en) * | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US20030065318A1 (en) * | 2001-09-28 | 2003-04-03 | Rajesh Pendekanti | Method and tool for epicardial ablation around pulmonary vein |
US20030069572A1 (en) * | 2001-09-28 | 2003-04-10 | Wellman Parris S. | Transmural ablation tool and method |
US6551289B1 (en) * | 1999-09-14 | 2003-04-22 | Dr. Japan Co., Ltd. | Outer needle of anesthetic needle assembly for epidural |
US6579288B1 (en) * | 1997-10-10 | 2003-06-17 | Scimed Life Systems, Inc. | Fluid cooled apparatus for supporting diagnostic and therapeutic elements in contact with tissue |
US6711436B1 (en) * | 1997-08-08 | 2004-03-23 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
US20040068312A1 (en) * | 2002-10-02 | 2004-04-08 | Medtronic, Inc. | Delivery of active fixation implatable lead systems |
US6811544B2 (en) * | 1999-05-11 | 2004-11-02 | Alan K. Schaer | Catheter positioning system |
US20050096522A1 (en) * | 2003-11-05 | 2005-05-05 | Ge Medical Systems Global Technology Company, Llc | Cardiac imaging system and method for quantification of desynchrony of ventricles for biventricular pacing |
US20060041243A1 (en) * | 2001-01-13 | 2006-02-23 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20060106442A1 (en) * | 2004-05-19 | 2006-05-18 | The Board Of Trustees Of The Leland Stanford Junior University | Devices and methods for treating cardiac pathologies |
US20070043397A1 (en) * | 2002-01-25 | 2007-02-22 | Ocel Jon M | Cardiac mapping instrument with shapeable electrode |
US20090030469A1 (en) * | 2005-08-11 | 2009-01-29 | Gideon Meiry | Cardiac Resynchronization Therapy Systems and Methods |
US20100069849A1 (en) * | 2006-06-30 | 2010-03-18 | Kassab Ghassan S | Percutaneous intravascular access to cardiac tissue |
US20100211064A1 (en) * | 2007-03-22 | 2010-08-19 | University Of Virginia Patent Foundation | Electrode Catheter for Ablation Purposes and Related Method Thereof |
US8048072B2 (en) * | 2006-07-12 | 2011-11-01 | Les Hospitaux Universitaires de Geneva | Medical device for tissue ablation |
US8271095B2 (en) * | 2005-09-26 | 2012-09-18 | Biosense Webster, Inc. | System and method for monitoring esophagus proximity |
-
2008
- 2008-11-07 US US12/741,710 patent/US20100241185A1/en not_active Abandoned
- 2008-11-07 WO PCT/US2008/082835 patent/WO2009062061A1/en active Application Filing
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3794026A (en) * | 1970-07-29 | 1974-02-26 | H Jacobs | Ventilating apparatus embodying selective volume or pressure operation and catheter means for use therewith |
US4280510A (en) * | 1979-02-08 | 1981-07-28 | Medtronic, Inc. | Sutureless myocardial lead introducer |
US4349023A (en) * | 1980-10-09 | 1982-09-14 | Abbott Laboratories | Epidural needle catheter and adapter |
US4607644A (en) * | 1985-04-01 | 1986-08-26 | Cordis Corporation | Self-suturing porous epicardial electrode assembly |
US4817634A (en) * | 1987-06-18 | 1989-04-04 | Medtronic, Inc. | Epicardial patch electrode |
US4971070A (en) * | 1987-06-18 | 1990-11-20 | Medtronic, Inc. | Epicardial patch electrode |
US5033477A (en) * | 1987-11-13 | 1991-07-23 | Thomas J. Fogarty | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US4935008A (en) * | 1988-07-20 | 1990-06-19 | Lewis Jr Ronald L | Double lumen introducing needle |
US5071428A (en) * | 1989-09-08 | 1991-12-10 | Ventritex, Inc. | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US4991603A (en) * | 1989-10-30 | 1991-02-12 | Siemens-Pacesetter, Inc. | Transvenously placed defibrillation leads via an inferior vena cava access site and method of use |
US5158097A (en) * | 1990-06-08 | 1992-10-27 | Allegheny-Singer Research Institute | Paraneural stimulating lead |
US5484423A (en) * | 1990-11-05 | 1996-01-16 | Te Me Na Logistics | Needle, for example epidural needle |
US5213570A (en) * | 1990-12-14 | 1993-05-25 | Mallinckrodt Medical, Inc. | System and method for oxygenation of the pericardium |
US5465711A (en) * | 1991-05-29 | 1995-11-14 | Origin Medsystems, Inc. | Surgical procedures using endoscopic inflatable retraction devices |
US5662647A (en) * | 1991-07-22 | 1997-09-02 | Transamerican Technologies International | Electrode assembly for electrosurgical instrument |
US5269326A (en) * | 1991-10-24 | 1993-12-14 | Georgetown University | Method for transvenously accessing the pericardial space via the right auricle for medical procedures |
US5335313A (en) * | 1991-12-03 | 1994-08-02 | Douglas Terry L | Voice-actuated, speaker-dependent control system for hospital bed |
US5395349A (en) * | 1991-12-13 | 1995-03-07 | Endovascular Technologies, Inc. | Dual valve reinforced sheath and method |
US6032674A (en) * | 1992-01-07 | 2000-03-07 | Arthrocare Corporation | Systems and methods for myocardial revascularization |
US20010056280A1 (en) * | 1992-01-07 | 2001-12-27 | Underwood Ronald A. | Systems and methods for electrosurgical spine surgery |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5500012A (en) * | 1992-07-15 | 1996-03-19 | Angeion Corporation | Ablation catheter system |
US5300110A (en) * | 1992-10-15 | 1994-04-05 | Angeion Corporation | Dirk-based epicardial defibrillation electrode |
US5928191A (en) * | 1993-07-30 | 1999-07-27 | E.P. Technologies, Inc. | Variable curve electrophysiology catheter |
US20010001214A1 (en) * | 1994-03-10 | 2001-05-17 | Bernstein Joseph B. | Technique for producing interconnecting conductive links |
US5509924A (en) * | 1994-04-12 | 1996-04-23 | Ventritex, Inc. | Epicardial stimulation electrode with energy directing capability |
US6156018A (en) * | 1994-11-03 | 2000-12-05 | Daig Corporation | Guiding introducer system for use in medical procedures in the left ventricle |
US5885217A (en) * | 1995-01-20 | 1999-03-23 | Tyco Group S.A.R.L. | Catheter introducer |
US5544654A (en) * | 1995-06-06 | 1996-08-13 | Acuson Corporation | Voice control of a medical ultrasound scanning machine |
US6162195A (en) * | 1995-06-07 | 2000-12-19 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
US5797870A (en) * | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
US5827216A (en) * | 1995-06-07 | 1998-10-27 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
US5702438A (en) * | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
US6278975B1 (en) * | 1995-10-25 | 2001-08-21 | Johns Hopkins University | Voice command and control medical care system |
US5970457A (en) * | 1995-10-25 | 1999-10-19 | Johns Hopkins University | Voice command and control medical care system |
US5733280A (en) * | 1995-11-15 | 1998-03-31 | Avitall; Boaz | Cryogenic epicardial mapping and ablation |
US5725504A (en) * | 1996-01-19 | 1998-03-10 | Smiths Industries Public Limited Company | Spinal epidural needle assemblies |
US5807249A (en) * | 1996-02-16 | 1998-09-15 | Medtronic, Inc. | Reduced stiffness, bidirectionally deflecting catheter assembly |
US5779699A (en) * | 1996-03-29 | 1998-07-14 | Medtronic, Inc. | Slip resistant field focusing ablation catheter electrode |
US6036685A (en) * | 1996-03-29 | 2000-03-14 | Eclipse Surgical Technologies. Inc. | Lateral- and posterior-aspect method for laser-assisted transmyocardial revascularization and other surgical applications |
US5846239A (en) * | 1996-04-12 | 1998-12-08 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using segmented porous electrode structures |
US5669882A (en) * | 1996-04-23 | 1997-09-23 | Pyles; Stephen | Curved epidural needle system |
US20010020166A1 (en) * | 1996-04-30 | 2001-09-06 | Michael Daly | System for simultaneous unipolar multi-electrode ablation |
US5800428A (en) * | 1996-05-16 | 1998-09-01 | Angeion Corporation | Linear catheter ablation system |
US5916194A (en) * | 1996-05-24 | 1999-06-29 | Sarcos, Inc. | Catheter/guide wire steering apparatus and method |
US5792217A (en) * | 1996-06-28 | 1998-08-11 | Medtronic, Inc. | Temporary bipolar heart wire |
US5843048A (en) * | 1996-08-06 | 1998-12-01 | The Kendall Company | Epidural catheter needle |
US20020045895A1 (en) * | 1996-10-22 | 2002-04-18 | Epicor, Inc. | Methods and devices for ablation |
US6314963B1 (en) * | 1996-10-22 | 2001-11-13 | Epicor, Inc. | Method of ablating tissue from an epicardial location |
US20030028187A1 (en) * | 1996-10-22 | 2003-02-06 | Epicor, Inc. | Device and method for forming a lesion |
US6237605B1 (en) * | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US6051008A (en) * | 1996-12-02 | 2000-04-18 | Angiotrax, Inc. | Apparatus having stabilization members for percutaneously performing surgery and methods of use |
US6156009A (en) * | 1996-12-05 | 2000-12-05 | Comedicus Incorporated | Apparatus for accessing the pericardial space |
US5931810A (en) * | 1996-12-05 | 1999-08-03 | Comedicus Incorporated | Method for accessing the pericardial space |
US6206004B1 (en) * | 1996-12-06 | 2001-03-27 | Comedicus Incorporated | Treatment method via the pericardial space |
US5812978A (en) * | 1996-12-09 | 1998-09-22 | Tracer Round Associaties, Ltd. | Wheelchair voice control apparatus |
US6200303B1 (en) * | 1997-04-30 | 2001-03-13 | Beth Israel Deaconess Medical Center, Inc. | Method and kit for transvenously accessing the pericardial space via the right atrium |
US20010039410A1 (en) * | 1997-04-30 | 2001-11-08 | Verrier Richard L. | Kit for transvenously accessing the pericardial space via the right atrium |
US6711436B1 (en) * | 1997-08-08 | 2004-03-23 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
US6216704B1 (en) * | 1997-08-13 | 2001-04-17 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
US5972013A (en) * | 1997-09-19 | 1999-10-26 | Comedicus Incorporated | Direct pericardial access device with deflecting mechanism and method |
US6579288B1 (en) * | 1997-10-10 | 2003-06-17 | Scimed Life Systems, Inc. | Fluid cooled apparatus for supporting diagnostic and therapeutic elements in contact with tissue |
US6200315B1 (en) * | 1997-12-18 | 2001-03-13 | Medtronic, Inc. | Left atrium ablation catheter |
US6325776B1 (en) * | 1998-02-13 | 2001-12-04 | Bernard Bradley Anderson | Internal by-pass shunt apparatus for the inferior vena cava |
US6148825A (en) * | 1998-02-13 | 2000-11-21 | Anderson; Bernard Bradley | Method of using a dedicated internal shunt and stent for the inferior vena cava |
US6322536B1 (en) * | 1998-03-06 | 2001-11-27 | Cornell Research Foundation, Inc. | Minimally invasive gene therapy delivery and method |
US6206874B1 (en) * | 1998-04-08 | 2001-03-27 | Siemens-Elema Ab | Apparatus and method for locating electrically active sites with an animal |
US6416505B1 (en) * | 1998-05-05 | 2002-07-09 | Scimed Life Systems, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and pressure application probe for use with same |
US20020161361A1 (en) * | 1998-05-05 | 2002-10-31 | Sherman Marshall L. | RF ablation system and method having automatic temperature control |
US6527767B2 (en) * | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US6231518B1 (en) * | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
US20010025178A1 (en) * | 1998-07-07 | 2001-09-27 | Mulier Peter M.J. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6123084A (en) * | 1998-12-18 | 2000-09-26 | Eclipse Surgical Technologies, Inc. | Method for improving blood flow in the heart |
US6270484B1 (en) * | 1999-02-17 | 2001-08-07 | Inbae Yoon | Safety penetrating instrument with expandible portion and method of penetrating anatomical cavity |
US6270476B1 (en) * | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6263241B1 (en) * | 1999-04-30 | 2001-07-17 | Intermedics, Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6811544B2 (en) * | 1999-05-11 | 2004-11-02 | Alan K. Schaer | Catheter positioning system |
US20020055714A1 (en) * | 1999-05-18 | 2002-05-09 | Rothschild Richard B. | Method and apparatus for the non-surgical placement of a subcutaneously tunnelled catheter through the skin into a central vein |
US6266567B1 (en) * | 1999-06-01 | 2001-07-24 | Ball Semiconductor, Inc. | Implantable epicardial electrode |
US6551289B1 (en) * | 1999-09-14 | 2003-04-22 | Dr. Japan Co., Ltd. | Outer needle of anesthetic needle assembly for epidural |
US20020058925A1 (en) * | 1999-09-16 | 2002-05-16 | Kaplan Aaron V. | Methods and apparatus for pericardial access |
US6423051B1 (en) * | 1999-09-16 | 2002-07-23 | Aaron V. Kaplan | Methods and apparatus for pericardial access |
US20020019626A1 (en) * | 2000-02-25 | 2002-02-14 | Sharkey Hugh R. | Apparatus and method for accessing and performing a function within an intervertebral disc |
US6273877B1 (en) * | 2000-07-20 | 2001-08-14 | Becton, Dickinson And Company | Epidural needle with secondary bevel |
US20020072737A1 (en) * | 2000-12-08 | 2002-06-13 | Medtronic, Inc. | System and method for placing a medical electrical lead |
US20020077600A1 (en) * | 2000-12-19 | 2002-06-20 | Laksen Sirimanne | Percutaneous catheter assembly |
US20020082523A1 (en) * | 2000-12-21 | 2002-06-27 | Bryan Kinsella | Steerable guidewire |
US6500130B2 (en) * | 2000-12-21 | 2002-12-31 | Scimed Life Systems, Inc. | Steerable guidewire |
US20060041243A1 (en) * | 2001-01-13 | 2006-02-23 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20030065318A1 (en) * | 2001-09-28 | 2003-04-03 | Rajesh Pendekanti | Method and tool for epicardial ablation around pulmonary vein |
US20030069572A1 (en) * | 2001-09-28 | 2003-04-10 | Wellman Parris S. | Transmural ablation tool and method |
US20070043397A1 (en) * | 2002-01-25 | 2007-02-22 | Ocel Jon M | Cardiac mapping instrument with shapeable electrode |
US20040068312A1 (en) * | 2002-10-02 | 2004-04-08 | Medtronic, Inc. | Delivery of active fixation implatable lead systems |
US20050096522A1 (en) * | 2003-11-05 | 2005-05-05 | Ge Medical Systems Global Technology Company, Llc | Cardiac imaging system and method for quantification of desynchrony of ventricles for biventricular pacing |
US20060106442A1 (en) * | 2004-05-19 | 2006-05-18 | The Board Of Trustees Of The Leland Stanford Junior University | Devices and methods for treating cardiac pathologies |
US20090030469A1 (en) * | 2005-08-11 | 2009-01-29 | Gideon Meiry | Cardiac Resynchronization Therapy Systems and Methods |
US8271095B2 (en) * | 2005-09-26 | 2012-09-18 | Biosense Webster, Inc. | System and method for monitoring esophagus proximity |
US20100069849A1 (en) * | 2006-06-30 | 2010-03-18 | Kassab Ghassan S | Percutaneous intravascular access to cardiac tissue |
US8048072B2 (en) * | 2006-07-12 | 2011-11-01 | Les Hospitaux Universitaires de Geneva | Medical device for tissue ablation |
US20100211064A1 (en) * | 2007-03-22 | 2010-08-19 | University Of Virginia Patent Foundation | Electrode Catheter for Ablation Purposes and Related Method Thereof |
Cited By (173)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10166066B2 (en) | 2007-03-13 | 2019-01-01 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US11937872B2 (en) | 2007-03-13 | 2024-03-26 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US10702335B2 (en) | 2007-03-13 | 2020-07-07 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
US8282565B2 (en) | 2007-03-19 | 2012-10-09 | University Of Virginia Patent Foundation | Access needle pressure sensor device and method of use |
US9314265B2 (en) | 2007-03-19 | 2016-04-19 | University Of Virginia Patent Foundation | Access needle pressure sensor device and method of use |
US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
US9211405B2 (en) | 2007-03-22 | 2015-12-15 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
US20110224600A1 (en) * | 2008-08-08 | 2011-09-15 | Fabio Orlandi | Irrigation and suction system, in particular for laparoscopic surgery |
US9314554B2 (en) * | 2008-08-08 | 2016-04-19 | Ab Medica Holding S.P.A. | Irrigation and suction system, in particular for laparoscopic surgery |
US11083381B2 (en) | 2009-09-11 | 2021-08-10 | University Of Virginia Patent Foundation | Systems and methods for determining pressure frequency changes in a subject |
US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US9218752B2 (en) | 2010-02-18 | 2015-12-22 | University Of Virginia Patent Foundation | System, method, and computer program product for simulating epicardial electrophysiology procedures |
US9724170B2 (en) | 2012-08-09 | 2017-08-08 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US9861802B2 (en) | 2012-08-09 | 2018-01-09 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure |
US10159782B2 (en) | 2012-09-19 | 2018-12-25 | University Of Virginia Patent Foundation | Method and system for enhanced imaging visualization of deep brain anatomy using infusion |
US10028682B2 (en) | 2012-10-12 | 2018-07-24 | University Of Virginia Patent Foundation | Oxidation measurement system and related method thereof |
US10369328B2 (en) | 2013-02-19 | 2019-08-06 | Beth Israel Deaconess Medical Center, Inc. | Adjustable stiffness catheter |
US10265502B2 (en) | 2013-02-19 | 2019-04-23 | Beth Israel Deaconess Medical Center, Inc. | Adjustable stiffness catheter |
US11344737B2 (en) | 2013-05-06 | 2022-05-31 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system including substernal lead |
US9717923B2 (en) | 2013-05-06 | 2017-08-01 | Medtronic, Inc. | Implantable medical device system having implantable cardioverter-defibrillator (ICD) system and substernal leadless pacing device |
US11524157B2 (en) | 2013-05-06 | 2022-12-13 | Medtronic, Inc. | Substernal leadless electrical stimulation system |
US10556117B2 (en) | 2013-05-06 | 2020-02-11 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system including substernal pacing lead |
US11857779B2 (en) | 2013-05-06 | 2024-01-02 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system including substernal pacing lead |
US10525272B2 (en) | 2013-05-06 | 2020-01-07 | Medtronic, Inc. | Implantable medical device system having implantable cardioverter-defibrillator (ICD) system and substernal leadless pacing device |
US10471267B2 (en) | 2013-05-06 | 2019-11-12 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system including substernal lead |
US10668270B2 (en) | 2013-05-06 | 2020-06-02 | Medtronic, Inc. | Substernal leadless electrical stimulation system |
US11344720B2 (en) | 2013-05-06 | 2022-05-31 | Medtronic, Inc. | Substernal electrical stimulation system |
US11433232B2 (en) | 2013-05-06 | 2022-09-06 | Medtronic, Inc. | Devices and techniques for anchoring an implantable medical device |
US10532203B2 (en) | 2013-05-06 | 2020-01-14 | Medtronic, Inc. | Substernal electrical stimulation system |
US9861265B2 (en) * | 2013-12-26 | 2018-01-09 | Olympus Corporation | Pneumoperitoneum apparatus |
US20160262600A1 (en) * | 2013-12-26 | 2016-09-15 | Olympus Corporation | Pneumoperitoneum apparatus |
US11589919B2 (en) | 2014-01-06 | 2023-02-28 | Boston Scientific Scimed, Inc. | Apparatus and methods for renal denervation ablation |
US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
US10722720B2 (en) | 2014-01-10 | 2020-07-28 | Cardiac Pacemakers, Inc. | Methods and systems for improved communication between medical devices |
US9592391B2 (en) | 2014-01-10 | 2017-03-14 | Cardiac Pacemakers, Inc. | Systems and methods for detecting cardiac arrhythmias |
EP3119470A4 (en) * | 2014-03-21 | 2018-02-28 | Mayo Foundation for Medical Education and Research | Multi-electrode epicardial pacing |
US11020589B2 (en) | 2014-03-21 | 2021-06-01 | Mayo Foundation For Medical Education And Research | Multi-electrode epicardial pacing |
US10279170B2 (en) | 2014-03-21 | 2019-05-07 | Mayo Foundation For Medical Education And Research | Multi-electrode epicardial pacing |
WO2015143327A1 (en) * | 2014-03-21 | 2015-09-24 | Mayo Foundation For Medical Education And Research | Multi-electrode epicardial pacing |
US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US11622803B2 (en) | 2014-06-12 | 2023-04-11 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US10433906B2 (en) | 2014-06-12 | 2019-10-08 | Farapulse, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US11241282B2 (en) | 2014-06-12 | 2022-02-08 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US9526909B2 (en) | 2014-08-28 | 2016-12-27 | Cardiac Pacemakers, Inc. | Medical device with triggered blanking period |
US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US9999465B2 (en) | 2014-10-14 | 2018-06-19 | Iowa Approach, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US9636512B2 (en) | 2014-11-05 | 2017-05-02 | Medtronic, Inc. | Implantable cardioverter-defibrillator (ICD) system having multiple common polarity extravascular defibrillation electrodes |
US11020595B2 (en) | 2015-02-06 | 2021-06-01 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US9669230B2 (en) | 2015-02-06 | 2017-06-06 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US11224751B2 (en) | 2015-02-06 | 2022-01-18 | Cardiac Pacemakers, Inc. | Systems and methods for safe delivery of electrical stimulation therapy |
US10238882B2 (en) | 2015-02-06 | 2019-03-26 | Cardiac Pacemakers | Systems and methods for treating cardiac arrhythmias |
US10220213B2 (en) | 2015-02-06 | 2019-03-05 | Cardiac Pacemakers, Inc. | Systems and methods for safe delivery of electrical stimulation therapy |
US10046167B2 (en) | 2015-02-09 | 2018-08-14 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
US11020600B2 (en) | 2015-02-09 | 2021-06-01 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
US11285326B2 (en) | 2015-03-04 | 2022-03-29 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
US10213610B2 (en) | 2015-03-18 | 2019-02-26 | Cardiac Pacemakers, Inc. | Communications in a medical device system with link quality assessment |
US11476927B2 (en) | 2015-03-18 | 2022-10-18 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
US10946202B2 (en) | 2015-03-18 | 2021-03-16 | Cardiac Pacemakers, Inc. | Communications in a medical device system with link quality assessment |
US9853743B2 (en) | 2015-08-20 | 2017-12-26 | Cardiac Pacemakers, Inc. | Systems and methods for communication between medical devices |
US10357159B2 (en) | 2015-08-20 | 2019-07-23 | Cardiac Pacemakers, Inc | Systems and methods for communication between medical devices |
US10709892B2 (en) | 2015-08-27 | 2020-07-14 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10589101B2 (en) | 2015-08-28 | 2020-03-17 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10137305B2 (en) | 2015-08-28 | 2018-11-27 | Cardiac Pacemakers, Inc. | Systems and methods for behaviorally responsive signal detection and therapy delivery |
US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
US10092760B2 (en) | 2015-09-11 | 2018-10-09 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
US10065041B2 (en) | 2015-10-08 | 2018-09-04 | Cardiac Pacemakers, Inc. | Devices and methods for adjusting pacing rates in an implantable medical device |
US10933245B2 (en) | 2015-12-17 | 2021-03-02 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
US10183170B2 (en) | 2015-12-17 | 2019-01-22 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
US10709891B2 (en) | 2016-01-05 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11020179B2 (en) | 2016-01-05 | 2021-06-01 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10433908B2 (en) | 2016-01-05 | 2019-10-08 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10842561B2 (en) | 2016-01-05 | 2020-11-24 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11589921B2 (en) | 2016-01-05 | 2023-02-28 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10512779B2 (en) | 2016-01-05 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10583303B2 (en) | 2016-01-19 | 2020-03-10 | Cardiac Pacemakers, Inc. | Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device |
US10350423B2 (en) | 2016-02-04 | 2019-07-16 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
US11116988B2 (en) | 2016-03-31 | 2021-09-14 | Cardiac Pacemakers, Inc. | Implantable medical device with rechargeable battery |
US10661080B2 (en) | 2016-04-01 | 2020-05-26 | Kobara Medical Inc. | Shaped epicardial lead and placement system and method |
US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US11497921B2 (en) | 2016-06-27 | 2022-11-15 | Cardiac Pacemakers, Inc. | Cardiac therapy system using subcutaneously sensed p-waves for resynchronization pacing management |
US10512784B2 (en) | 2016-06-27 | 2019-12-24 | Cardiac Pacemakers, Inc. | Cardiac therapy system using subcutaneously sensed P-waves for resynchronization pacing management |
US11207527B2 (en) | 2016-07-06 | 2021-12-28 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US10426962B2 (en) | 2016-07-07 | 2019-10-01 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
US10688304B2 (en) | 2016-07-20 | 2020-06-23 | Cardiac Pacemakers, Inc. | Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US10391319B2 (en) | 2016-08-19 | 2019-08-27 | Cardiac Pacemakers, Inc. | Trans septal implantable medical device |
US10780278B2 (en) | 2016-08-24 | 2020-09-22 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing |
US10870008B2 (en) | 2016-08-24 | 2020-12-22 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
US11464982B2 (en) | 2016-08-24 | 2022-10-11 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing |
US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
US10905889B2 (en) | 2016-09-21 | 2021-02-02 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
US10994145B2 (en) | 2016-09-21 | 2021-05-04 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US10463305B2 (en) | 2016-10-27 | 2019-11-05 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
US10765871B2 (en) | 2016-10-27 | 2020-09-08 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
US10758724B2 (en) | 2016-10-27 | 2020-09-01 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
US10434314B2 (en) | 2016-10-27 | 2019-10-08 | Cardiac Pacemakers, Inc. | Use of a separate device in managing the pace pulse energy of a cardiac pacemaker |
US11305125B2 (en) | 2016-10-27 | 2022-04-19 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
US10561330B2 (en) | 2016-10-27 | 2020-02-18 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
US10617874B2 (en) | 2016-10-31 | 2020-04-14 | Cardiac Pacemakers, Inc. | Systems and methods for activity level pacing |
US10434317B2 (en) | 2016-10-31 | 2019-10-08 | Cardiac Pacemakers, Inc. | Systems and methods for activity level pacing |
US10583301B2 (en) | 2016-11-08 | 2020-03-10 | Cardiac Pacemakers, Inc. | Implantable medical device for atrial deployment |
US10632313B2 (en) | 2016-11-09 | 2020-04-28 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for setting cardiac pacing pulse parameters for a cardiac pacing device |
US10881863B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with multimode communication |
US11147979B2 (en) | 2016-11-21 | 2021-10-19 | Cardiac Pacemakers, Inc. | Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing |
US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
US10894163B2 (en) | 2016-11-21 | 2021-01-19 | Cardiac Pacemakers, Inc. | LCP based predictive timing for cardiac resynchronization |
US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
US10029107B1 (en) | 2017-01-26 | 2018-07-24 | Cardiac Pacemakers, Inc. | Leadless device with overmolded components |
US10835753B2 (en) | 2017-01-26 | 2020-11-17 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
US11590353B2 (en) | 2017-01-26 | 2023-02-28 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
US10737102B2 (en) | 2017-01-26 | 2020-08-11 | Cardiac Pacemakers, Inc. | Leadless implantable device with detachable fixation |
US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
US10821288B2 (en) | 2017-04-03 | 2020-11-03 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate |
US11357978B2 (en) | 2017-04-27 | 2022-06-14 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for signal generation |
US10016232B1 (en) | 2017-04-27 | 2018-07-10 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US11833350B2 (en) | 2017-04-28 | 2023-12-05 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US11065459B2 (en) | 2017-08-18 | 2021-07-20 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
US10918875B2 (en) | 2017-08-18 | 2021-02-16 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
US11235163B2 (en) | 2017-09-20 | 2022-02-01 | Cardiac Pacemakers, Inc. | Implantable medical device with multiple modes of operation |
US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
US11071870B2 (en) | 2017-12-01 | 2021-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
US11260216B2 (en) | 2017-12-01 | 2022-03-01 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker |
US11813463B2 (en) | 2017-12-01 | 2023-11-14 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with reversionary behavior |
US11052258B2 (en) | 2017-12-01 | 2021-07-06 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker |
US10874861B2 (en) | 2018-01-04 | 2020-12-29 | Cardiac Pacemakers, Inc. | Dual chamber pacing without beat-to-beat communication |
US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
US11058880B2 (en) | 2018-03-23 | 2021-07-13 | Medtronic, Inc. | VFA cardiac therapy for tachycardia |
US11400296B2 (en) | 2018-03-23 | 2022-08-02 | Medtronic, Inc. | AV synchronous VfA cardiac therapy |
US11819699B2 (en) | 2018-03-23 | 2023-11-21 | Medtronic, Inc. | VfA cardiac resynchronization therapy |
US11235159B2 (en) | 2018-03-23 | 2022-02-01 | Medtronic, Inc. | VFA cardiac resynchronization therapy |
US11951303B2 (en) | 2018-04-23 | 2024-04-09 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
US10709502B2 (en) | 2018-05-07 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11235161B2 (en) | 2018-09-26 | 2022-02-01 | Medtronic, Inc. | Capture in ventricle-from-atrium cardiac therapy |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
US11738200B2 (en) | 2019-09-17 | 2023-08-29 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10688305B1 (en) | 2019-09-17 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11951313B2 (en) | 2019-11-14 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
US11684408B2 (en) | 2019-11-20 | 2023-06-27 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11931090B2 (en) | 2019-11-20 | 2024-03-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
Also Published As
Publication number | Publication date |
---|---|
US20180361145A1 (en) | 2018-12-20 |
WO2009062061A1 (en) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100241185A1 (en) | Steerable epicardial pacing catheter system placed via the subxiphoid process | |
US11027119B2 (en) | Systems and methods for implanting a medical device | |
US10702335B2 (en) | Electrode catheter for ablation purposes and related method thereof | |
EP2291212B1 (en) | Delivery catheter including side port and electrodes | |
US9597514B2 (en) | Epicardial heart rhythm management devices, systems and methods | |
CA2699536C (en) | Epicardial mapping and ablation catheter | |
CA2134904C (en) | Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers | |
EP0745406B1 (en) | Coronary sinus catheter | |
US7542807B2 (en) | Conduction block verification probe and method of use | |
JP2018089431A (en) | Catheters, catheter systems, and methods of piercing through tissue structure | |
WO2007073435A1 (en) | Helical electrodes for intramyocardial pacing and sensing | |
US8315716B2 (en) | Sheath and electrical lead | |
CA2160510A1 (en) | Process for the treatment of atrial arrhythmia using a catheter guided by shaped guiding introducers | |
EP3052031A1 (en) | Methods and devices for diastolic assist | |
US11951303B2 (en) | Steerable epicardial pacing catheter system placed via the subxiphoid process | |
US20210077810A1 (en) | Implanting a lead in the internal thoracic vasculature | |
US20220395324A1 (en) | Method and device for intramyocardial infusion of conductive nanoparticles | |
US20040138651A1 (en) | Pericardial maze procedure | |
WO2022264012A1 (en) | Method and device for intrmyocardial infusion of conductive nanoparticles | |
JPH09173343A (en) | Non-surgical mapping for atrial arrhythmia and induced introducer shaped for medical treatment | |
JP2004275786A (en) | Non-surgical mapping for atrial arrhythmia and shaped guiding introducer for medical treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY OF VIRGINIA PATENT FOUNDATION, VIRGINIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:UNIVERSITY OF VIRGINIA;REEL/FRAME:024834/0274 Effective date: 20100810 Owner name: UNIVERSITY OF VIRGINIA, VIRGINIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAHAPATRA, SRIJOY;GILLIES, GEORGE T.;SIGNING DATES FROM 20100615 TO 20100802;REEL/FRAME:024834/0178 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |